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Abstract 
Protein PEGylation (covalent attachment of poly(ethylene glycol) or PEG 
to proteins) is an excellent example of a drug delivery system that 
improves pharmacokinetics and pharmacodynamic properties of 
therapeutics. However, although PEGylation is clinically proven and 
attracts both scientific and commercial interest, the technique is 
associated with many process constraints, in particular related to 
controlling the number of conjugated PEG chains. A novel, solid-phase 
PEGylation methodology was attempted to overcome the drawbacks of 
the commonly used solution-phase methods for preparing PEGylated 
products. The solid-phase PEGylation methodology involved conjugating 
protein onto a tethered PEG derivative attached onto a solid matrix, 
followed by hydrolytic cleavage of the PEG chain from the solid matrix 
under mild conditions to yield PEGylated protein in free solution.   
 
PEGs with molecular weights (MWs) 2000 and 4000 Da were used and a 
heterobifunctional PEG derivative, α-(β-alanine)-ω-carboxy PEG, with a 
cleavable β-alanine ester terminal was prepared for surface grafting and 
protein conjugation. The amine terminal of this PEG derivative was used 
for grafting PEG onto carboxy functionalized hydrophilic Sephadex and 
hydrophobic polystyrene derivatives. The free carboxyl terminal was 
used for protein conjugation via amine coupling. A kinetic study of PEG-
surface grafting was performed to understand the influence of a number 
of parameters on the PEG surface concentration and its conformation, 
including temperature, reaction time, nature of the matrix, solvent and 
base, and MW of PEG. PEG grafted matrices were characterized using 
various surface characterization tools including Fourier transform 
infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and 
X-ray photoelectron spectroscopy (XPS).  
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Higher PEG grafting was observed with polystyrene matrices (up to 0.3 
mmol/g) than either of the Sephadex derivatives (less than 0.15 mmol/g) 
using both molecular weights. Detailed surface characterization using 
XPS studies showed a layer thickness of 11.87 nm was achieved with 
polystyrene matrices using 4000 Da PEG derivatives after a grafting 
period of 72 hours at 40°C, indicating the presence of brush 
conformations for the grafted PEGs. In contrast, mushroom 
conformations were observed for PEG molecules grafted on both 
carboxymethyl and carboxypentyl Sephadex derivatives after the same 
reaction period, with a layer thickness of 2.62 nm and 4.14 nm 
respectively. 
 
Optimized PEG grafting and hydrolysis conditions were developed for 
solid-phase protein PEGylation using Cytochrome c as a model protein. 
The presence of PEGylated species were detected by size exclusion 
chromatography (SEC) from Sephadex derivatives but were absent when 
using polystyrene matrices. Both Sephadex derivatives gave mainly 
multi-PEGylated species with poor yields, in place of the expected mono-
PEGylated products. A solution-phase PEGylation using the same PEG 
derivatives was performed successfully and various PEGylated species 
were identified and characterized using SEC and gel electrophoresis, 
based on their viscosity radius.  
 
An examination of the surface characteristics of the PEG-grafted was 
carried out by XPS, showing that protein conjugation was greatly 
influenced by surface force interactions, which depended on the PEG 
grafting densities and the nature of the solid matrices. Finally, fluorescent 
images obtained using confocal microscope with fluorescein 
isothiocyanate labelled Cytochrome c provided supporting evidence 
regarding the factors that constrained the solid-phase PEGylation process.  
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1 Introduction 
 
1.1 Background and significance 
 
Innovative drug delivery technologies are key components of drug 
development, with commercial as well as intellectual values. PEGylation, 
the process of attaching poly(ethylene glycol) (PEG) to a molecule, is an 
excellent example of such a delivery system characterized by its 
remarkable improvement in pharmacokinetics and the pharmacodynamic 
values of therapeutics, especially for proteins, peptides and even small 
molecule pharmaceuticals.  PEG, a non-toxic biocompatible polymer, can 
be attached to a therapeutic molecule through a permanent or reversible 
linkage and will provide a protective covering to the molecule from 
proteolytic degradation and renal clearance. Consequently, the method 
has resulted in the development of a number of drugs with enhanced 
blood circulatory life and lower administration frequency than a non-
PEGylated drug (Figure 1-1).  
 
 
Figure 1-1: Pharmacokinetics of  PEGylated drugs (Bruckdorfer 2008) 
 
 
Single application of PEGylated drug 
Single dose of non-PEGylated drug 
Repeated 
dose of 
non-
PEGylated 
drug 
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Although there are a number of FDA-approved PEGylated drugs already 
in the market and many under clinical trials, this technology is 
accompanied by various processing challenges such as difficulty with 
controlling reaction selectivity, the extent of PEG conjugation, positional 
isomerism, low efficiency in the separation of various PEGylated 
products and unreacted starting materials, and often low yields of the 
desired PEGylated product (Fee and Van Alstine 2006).  Consequently, 
current processes commonly result in a mixture of mono, di and oligo-
PEGylated products (Fee 2003), requiring complex and multistep 
downstream purification steps to isolate the required product. The very 
high cost of therapeutic proteins and the high costs associated with the 
above PEGylation processing and separation issues results in extremely 
expensive products. 
 
Consequently, there is significant scientific interest and importance in 
developing a novel reaction engineering design to improve the efficiency 
and yield of the existing PEGylation process. Paramount requirements 
include minimizing the variation between batches and significantly 
improving the yield and selectivity of the PEGylation process. This 
should result in lower production costs and improved availability of the 
resulting therapeutics. Also this technology will enable the 
pharmaceutical and biotech industries to manufacture drugs consistently 
with specific characteristics and with minimal variations between batches 
to meet stringent regulatory requirements. 
 
1.2 Solid-phase protein PEGylation – an innovative approach 
 
Considering the various limitations and process variations associated 
with the existing technology, a novel and innovative solid-phase 
PEGylation design was proposed to minimize the variations between the 
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batches and to increase the specificity and yield of the process. The 
concept involves the use of a tethered PEG molecule attached to a 
modified solid matrix through a cleavable linker. The free end terminal of 
the PEG molecule would be modified with a functional group capable of 
selective conjugation with a particular functional moiety on the protein 
surface.  Taking advantage of surface force interactions between the PEG 
grafted matrix and protein, an accumulation of protein was anticipated 
near the terminal end of tethered PEG chains and thereby expected to 
result in conjugation. Finally, the PEGylated protein would be separated 
from the matrix by cleaving off the labile linker using mild hydrolytic 
conditions.   
 
1.3 Project objectives 
 
The main goal of the current project was to develop a novel solid-phase 
PEGylation strategy through the following objectives: 
 
• The preparation and evaluation of a suitable heterobifunctional 
PEG derivative capable of tethering a conjugated protein onto a 
solid-phase resin through a cleavable linker.  
• The optimization of the PEG grafting conditions to obtain a 
preferred conformation which enables successful conjugation of 
protein onto the matrix.  
• The establishment of suitable hydrolysis conditions to release the 
PEGylated product from the resin after protein conjugation 
without denaturing the protein. 
• An exploration of the adaptability of the solid-phase PEGylation 
technique using various solid matrices 
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• The systematic study, using suitable analytical tools, of various 
conformational behaviours of surface grafted PEG molecules and 
correlating these with theoretical predictions.  
• The study of the various surface force interactions exerted 
between the protein and PEG grafted matrices during conjugation 
and their influence on the performance of the solid-phase 
PEGylation system.   
 
1.4 Thesis organization 
 
Based on the objectives, remainder of this thesis is organized as follows: 
 
Chapter 2: Following a brief overview of the development of protein 
PEGylation in terms of the improvement in conjugation chemistry and 
various process modifications, the requirement for an improved 
methodology to overcome the present drawbacks is described. The 
concept of the novel methodology is presented with a concise description 
of its various components and finally a theoretical prediction of the 
performance of the technique is included.   
 
Chapter 3: This chapter describes the various synthetic strategies for 
preparing heterobifunctional PEG derivatives and their solution-phase 
PEGylation with the model protein.  
 
Chapter 4: The optimization of PEG grafting, hydrolysis and solid-phase 
PEGylation form the main focus of this chapter. The preparation of 
carboxy tethered matrices and the influence of various reaction 
parameters on the PEG grafting are also included.  
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Chapter 5: The surface characterization of PEG grafted matrices using 
various analytical tools is described. A prediction concerning the protein 
interaction with PEG grafted matrices and their influence on the 
performance of the developed solid-phase system is included.  
 
Chapter 6: In this chapter a detailed analysis of the overall results is 
included based on XPS data and various surface force interactions.  
 
Chapter 7: Conclusion and recommendations for future studies are 
summarized in this chapter.  
 
Appendices A and B: A brief summary of other attempted synthetic 
approaches and XPS supplementary results are given in these appendices.   
 
  
2-1 
2 Literature review  
 
2.1 Introduction 
 
This chapter mainly describes the development of a versatile and 
clinically proven polymeric drug delivery system known as protein 
PEGylation, followed by various process considerations and constraints 
of the existing method, and finally the strategy behind the development 
of an improved technique. A detailed insight into various conjugation 
chemistries as well as process variations is also included. The need is 
ascertained for a highly selective and specific methodology to improve 
on the existing ones, considering the pharmacological and commercial 
importance of the PEGylated drugs. An innovative solid-phase 
PEGylation system is described, that has an emphasis on reducing the 
variation between the batches and the heterogeneity of the PEGylated 
products. A prediction of the performance of the proposed technique, 
based on theoretical calculations, is also included in this chapter.  
 
2.2 Bioconjugation and polymer therapeutics 
 
The rapid growth in biotechnology and molecular biology during the last 
two decades has contributed to a substantial increase in the number of 
biotechnological and biological products such as proteins, peptides, 
hormones and enzymes for pharmaceutical applications (Blohm et al. 
1988; Lubiniecki 1997).  This  pharmaceutical significance of these 
biomolecules can be mainly attributed to their high specificity, rapid 
onset of action and requirement for relatively smaller dosage forms 
compared to conventional synthetic molecules (Wu-Pong and 
Rojanasakul 1999). Unfortunately, most of these biomolecules are 
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characterized by their short circulating lives, low stability due to 
proteolytic and enzymatic degradations in vivo and fast clearance of small 
molecules from the body via glomerular (kidney) filtration (Nucci et al. 
1991; Pasut and Veronese 2007).  
 
In order to overcome these drawbacks, these biomolecules can be 
protected by converting them into a macromolecular complex through a 
covalent binding process with another molecule known as bioconjugation 
(Veronese and Morpurgo 1999).  Many polymers having biological and 
synthetic origins are proved and extensively used to protect 
biomolecules, to overcome the above-mentioned drawbacks. The 
resulting “polymer bioconjugates” (Figure 2-1) are characterized by some 
additional favourable properties such as reduced immunogenicity, 
decreased antibody recognition, increased in vivo residence time, 
increased drug targeting specificity and bioavailability, and improved 
pharmacokinetics (Veronese and Morpurgo 1999; Duncan 2003; 
Khandare and Minko 2006; Lutz and Borner 2008; Gaspar and Duncan 
2009).     
 
Figure 2-1: Concept of polymer bioconjugation (Lutz and Borner 2008) 
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Taking advantage of these improvements, the concept of polymer 
bioconjugation is extended to small, high-value prodrugs and leads into a 
new era of polymeric drug delivery systems and polymer therapeutics 
(Khandare and Minko 2006). Commonly used polymers in drug delivery 
applications include poly(N-(2-hydroxypropyl) methacrylamide) 
(PHPMA) (Schoemaker et al. 2002; Seymour et al. 2002; Tao et al. 
2009), poly(oligoethylene glycol methyl ether methacrylate) (POEGMA) 
(Lele et al. 2005; Popescu et al. 2005; Lutz et al. 2007), poly(D,L-lactic-
co-glycolic acid) (PLGA) (Nam and Park 1999), poly(glutamic acid) 
(PGA) (Bhatt et al. 2001; Zou et al. 2001), poly(N-isopropyl acrylamide) 
(PNIPAM) (Chen and Hoffman 1993; Takei et al. 1993; Gil and Hudson 
2004), poly(N,N'-diethyl acrylamide) (PDEAM) (Gil and Hudson 2004), 
polystyrene (Velonia et al. 2002) and poly(ethylene glycol) (PEG).  
 
2.3 PEG – the polymer of choice 
 
The specific characteristic properties of PEG such as biocompatibility, 
lack of immunogenicity, antigenicity and toxicity, solubility in water and 
other organic solvents, ready clearance from the body and high mobility 
in solution make this the polymer of choice for bioconjugation (Harris 
1992; Roberts et al. 2002; Pasut and Veronese 2006). The conjugation of 
a biomolecule with PEG will result in the modification of its 
physiochemical properties, particularly size, and increase the systemic 
retention of the therapeutic agent in the body; it will also enable the 
moiety to cross the cell membranes by endocytosis to reach particular 
intracellular targets (Khandare and Minko 2006). Moreover, PEG is one 
among the small number of synthetic polymers approved by the US FDA 
for internal administration (Bhattarai et al. 2005). Detailed descriptions of 
the various properties of PEGs are given in Section 2.6.4.  
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2.4 Protein PEGylation  
 
In the late 1970s, Prof. Frank Davis and his colleagues covalently linked 
methoxy-PEG (mPEG) to bovine serum albumin (Abuchowski et al. 
1977a) and  bovine liver catalase (Abuchowski et al. 1977b), using 
cyanuric chloride as an activating agent. Their studies showed that 
“hanging a bit of PEG onto a protein” markedly improved the overall 
properties and stability of the protein (Davis 2002; Katsnelson 2006). 
This technique is now well established and is known as “PEGylation”. 
The applications of PEGylation can be extended to peptides, enzymes, 
antibody fragments, nucleotides and even small organic molecules to 
meet the challenges of improving the safety and efficiency of many 
therapeutics (Matsushima et al. 1996; Riley and Riggs-Sauthier 2008).  
 
2.4.1 Pharmaceutical significance of protein PEGylation 
 
PEGylation can impart several significant and distinct pharmacological 
advantages over the unmodified form, including improved drug 
solubility, reduced dosage frequency, toxicity and rate of kidney 
clearance, extended circulating life, increased drug stability, enhanced 
protection from proteolytic degradation, decreased immunogenicity and 
antigenicity, and minimal loss of biological activity (Nucci et al. 1991; 
Bailon and Berthold 1998; Kozlowski and Harris 2001; Veronese and 
Pasut 2005). 
 
The reduced kidney clearance of PEGylated proteins can be attributed to 
an apparent shielding of protein surface charges as well as an increased 
hydrodynamic volume of the conjugated product (Caliceti and Veronese 
2003) due to the ability of PEG molecules to coordinate with two to three 
water molecules per monomer unit (Antonsen and Hoffman 1992) 
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(Section 2.6.4.2.1). Furthermore, these hydrated polymer chains provide 
a protecting mask for the protein epitope, thereby resulting in a decreased 
immunogenicity and antigenicity, which is found to decrease with an 
increase in the number and molecular weights of the attached PEGs. 
Moreover, the masking of these recognition sites and charges reduces the 
phagocytic uptake by parenchimal cells, by preventing the opsonisation 
processes and increasing their residence period in systemic circulation 
(Caliceti and Veronese 2003; Hamidi et al. 2006).   
 
In addition to these pharmacological advantages, PEGylation can 
substantially alter many physicochemical properties of the parent protein, 
including changes in conformation, electrostatic binding, and 
hydrophobicity (Bailon and Berthold 1998). PEGylation significantly 
influences the elimination pathway of the molecule, by shifting from a 
renal to a hepatic pathway with an increase in the number and molecular 
weights of the attached PEG molecule. The tissue-organ distribution 
profile of the molecule is also greatly influenced by PEGylation, as 
PEGylated proteins medicated by an intravenous administration 
preferably follow a peripheral distribution (Caliceti and Veronese 2003; 
Hamidi et al. 2006). The pharmaceutical value of PEGylation is now well 
accepted, with many FDA approved drugs already launched in the market 
and many in clinical trials. A summary of PEGylated drugs marketed and 
in various developmental stages is given in Table 2-1 and 2-2. 
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Table 2-1: PEGylated drugs on the market (Storz and Lu 2008) 
 
Name Company (Year) Indication Parent molecule PEG 
Adagen® Enzon (1990) Severe combined 
immunodeficiency disease 
(SCID) 
adenosine 
deaminase 
11-17  
5 kDa linear  
Oncasper® Enzon (1994) Lymphoblastic leukemia asparaginase 11-17  
5 kDa linear  
PEG-Intron® Schering- Plough 
/ Enzon (2001) 
Hepatitis C Interferon-α-2b 12 kDa linear 
Neulasta® Amgen (2002) Neutropenia during 
chemotherapy 
G-CSF 20 kDa linear 
Pegasys® Roche (2002) Hepatitis C Interferon-α-2a 40 kDa branched 
Somavert® Pfizer (2003) Acromegaly growth hormone 
receptor 
4-5  
5 kDa linear  
Macugen® Eyetech (2004) Age-related macular 
degeneration 
anti-VEGF 24-mer 
oligonucleotide 
40 kDa branched 
Mircera® Roche /  
Nektar 
(2007) 
Anemia in chronic kidney 
disease (CKD) 
Β-EPO 30 kDa linear 
Cimzla®  UCB / Nektar 
(2008) 
Crohn’s disease anti-TNF-αhAB 
fragment 
two  
2 kDa branched 
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Table 2-2: PEGylated drugs in development (Storz and Lu 2008) 
 
Name Company  Indication 
(Approximate clinical status) 
Parent molecule PEG 
Hematide™ Affymax/ 
Takeda/ Nektar 
Anemia in CKD and cancer 
(Phase III) 
12-18 amino acid 
peptide dimer 
two  
20 kDa linear 
PEG-hGRF Serono Growth hormone deficiency  
(Phase I) 
29 amino acid 
peptide 
Mixture of two mono 5 
kDa PEGylated isomers 
3DP-3534 J&J Thrombocytopen-ia 
(Preclinical) 
14 amino acid 
peptide dimer 
two  
20 kDa linear 
PEG-
thymalfasin 
SciClone / 
Nektar 
HBV, HCV, melanoma, liver 
cancer 
(Preclinical) 
Zadaxin (thymosin-
α1,  28 amino acid 
peptide) 
 --  
PEG-
glucagon-like 
peptide-1 
Bayer Diabetes  
(Preclinical) 
30-35 amino acid 
peptide 
22 or 43  kDa 
PEG-
vapreotide 
Debiopha-rm Various cancers 
(Preclinical) 
synthetic 
octapeptide 
somatostatin analog  
5 or 2 kDa linear 
PEG-
c(RGDyK)-
peptide 
University of 
California / 
UIPS 
Angiogenesis inhibitors  
(Preclinical) 
Cyclic pentapeptid-
es 
various 
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2.4.2 The chemistry of protein conjugation 
 
The development of PEGylation technology is signified with a marked 
improvement in conjugation strategy, from non-specific random 
conjugations in the early stages, known as the “first generation 
PEGylation,” to the recent site-specific conjugation methods known as 
the “second generation PEGylation” (Pasut and Veronese 2006). This 
increase in specificity of PEGylation can be mainly credited to the 
availability of more specific functionalization of PEG molecules capable 
of reacting to a particular functional moiety present with the protein 
under conjugation. This results in controlled, well-defined conjugated 
products with an improvement in product profile over those obtained 
from non-specific random conjugations.  
 
2.4.2.1 Amine conjugation 
 
Owing to the availability of a number of accessible primary amino groups 
on the surface of a protein, conjugation through this functional group is 
the most extensively used method in protein PEGylation. Lysine, 
ornithine and N-terminal amino groups are the most commonly explored 
anchoring sites for PEG conjugation (Bruckdorfer 2008). Early stage 
developments of PEGylation were mainly based on this chemistry, 
targeting N-terminal amino groups of lysine. The very first reactions 
reported by Davis and his colleagues involved the reaction of cyanuric 
chloride activated PEG with the primary amine groups present on bovine 
serum albumin (Abuchowski et al. 1977a)  and bovine liver catalase 
(Abuchowski et al. 1977b), through alkylation of their respective amine 
terminals (Figure 2-2). Thereafter, PEG-tresylate was also developed for 
protein conjugation through alkylation (Gais and Ruppert 1995) but all 
these reactions resulted in non-specific multiple conjugated products.  
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Figure 2-2: Protein conjugation using cyanuric chloride activated PEG 
 
A greater specificity and selectivity in N-alkyl conjugation strategy was 
developed after the introduction of PEG aldehyde derivatives, 
particularly mPEG-propionaldehyde  (Harris and Sedaghat-Herati 1993), 
capable of forming a  stable secondary amine linkage with amino groups 
through reductive amination using sodium cyanoborohydride (Borch et 
al. 1971; Baxter and Reitz 2002) (Figure 2-3). Because the reactivity of 
aldehyde groups depends on the nucleophilicity of amine groups, reaction 
will take place only when the pH of the medium is near or above the pKa 
of that particular amine terminal. Hence by controlling the pH of the 
reaction medium, the heterogeneity of the product profile can be greatly 
reduced  (Roberts et al. 2002).  This conjugation strategy was adopted for 
the development of Neulasta® (PEG-G-CSF), where a linear 20 kDa 
mPEG-aldehyde derivative was selectively attached to an N-terminal 
methionine residue of filgrastim through reductive alkylation under mild 
acidic conditions (Kinstler et al. 2002; Veronese and Mero 2008).  
Another example using this reductive alkylation chemistry is the 
PEGylation of a recombinant soluble tumor necrosis factor receptor type 
I (sTNF-RI) from E. coli, for use in treating chronic inflammatory 
diseases (Edwards et al. 2003).  
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Figure 2-3: Protein conjugation using PEG aldehyde derivative 
 
The acylation of the N-terminal amino acids results in the formation of 
stable amide (RCO-NR'2) and urethane (R-O-CO-NR'2) linkages and is 
extensively used as a conjugation strategy in protein PEGylation, 
especially with first generation PEGylation chemistries. PEG derivatives 
activated with succinimidyl succinate (PEG-SS) (Zalipsky and Lee 
1992), succinimidyl carbonate  (PEG-SC) (Zalipsky et al. 1991), 
benzotriazole carbonate (PEG-BTC) (Dolence et al. 1996), phenyl 
carbonate (Veronese et al. 1985; Woodward and Kaufman 1996), 
carbonylimidazole (Beauchamp et al. 1983), and thiazolidine-2-thione 
(Greenwald et al. 1996) were used in earlier stages for protein 
conjugation, following the N-terminal acylation pathway. Adagen® 
(PEG-adenosine deaminase) and Oncaspar® (PEG-asparaginase), the very 
first PEGylated products launched in the market, are prepared based on 
this chemistry by conjugating succinimidyl succinate activated PEGs 
with their respective proteins (Davis 2003) (Figure 2-4).   
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Figure 2-4: Protein conjugation using PEG-SS 
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PEG-Intron® is prepared by conjugating interferon-α-2b with a single 
chain 12 kDa PEG-SC via a urethane bond (Figure 2-5), where the PEG 
is mainly conjugated on to the histidine residue (Wang et al. 2002). 
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Figure 2-5: Protein conjugation using PEG-SC 
 
The introduction of monosubstituted propionic and butanoic acid PEG 
derivatives by Harris and Kozlowski (1997) resulted in a substantial 
improvement in PEG product profile and their subsequent activation 
using succinimide derivatives contributed a significant improvement in 
amine conjugation approach. Pegasys® is prepared by mono-PEGylation 
of interferon-α-2a with an N-hydroxysuccinimide (NHS) activated 40 
kDa branched PEG molecule (Bailon et al. 2001) (Figure 2-6).  
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Figure 2-6: Conjugation chemistry for Pegasys® 
 
Another PEGylated drug, Somavert®, is also prepared by conjugating 4 – 
5 NHS activated 5 kDa PEG derivatives with a lysine terminal of human 
growth hormone antagonist (Olson et al. 1997; Parkinson et al. 2003). 
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Due to the selectivity of NHS active esters towards primary amine 
terminals, this conjugation technique is now used as one of the most 
common conjugation strategies for amine coupling (Hermanson 1996). 
Even though the amine conjugation is widely accepted and clinically 
proven, the method is associated with some potential disadvantages, 
including loss of bioactivity due to the inactivation of critical functional 
groups, and the formation of multi-PEGylated products due to the 
presence of multiple amino groups available for conjugation (Zappe et al. 
2008).   
 
2.4.2.2 Thiol conjugation 
 
Selective thiol conjugation at the natural or genetically engineered 
unpaired cysteine residues provided another site-specific conjugation 
methodology for protein PEGylation, with the advantage of minimal loss 
in bioactivity. Thiol selective derivatives such as PEG-maleimide, 
vinylsulfone, iodoacetamide, and orthopyridyl disulfide are used for 
cysteine conjugation through the formation of thioether or disulfide 
linkages (Roberts et al. 2002). Examples of thiol conjugation using PEG-
maleimide include those at the genetically introduced cysteine residue of 
trichosanthin (TCS) using 5 and 20 kDa (He et al. 1999), antitumor 
necrosis factor-α-scFv fragment (anti-TNF-α-a scFv) using 5, 20 and 40 
kDa (Yang et al. 2003) and recombinant staphylokinase (Sak) using 5, 10 
and 20 kDa derivatives (Moreadith and Collen 2003)  (Figure 2-7).  
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Figure 2-7: Cysteine conjugation using PEG-maleimide 
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Because of the limited availability of cysteine residues and the chances of 
protein dimerization resulting from the introduction of genetically 
engineered cysteines, the use of this strategy is restricted and further 
modifications in this methodology are preferred.  Taking advantage of a 
higher number of accessible disulfide linkages present with paired 
cysteines compared to the free unpaired ones, Balan et al. reported a thiol 
specific bis-alkylation PEGylation, with the two sulphur atoms which 
were generated by the mild reduction of these disulfide bonds (Balan et 
al. 2007; Brocchini et al. 2008). A selective reduction of the disulfide 
bridges was performed using dithiothreitol (DTT) in neutral conditions or 
tris-(2-carboxyethyl) phosphine hydrochloride (TCEP-HCl) in slightly 
acidic conditions. The reduced protein was then treated with an active 
ester PEG-monosulfone at an acidic pH (Figure 2-8).   
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where intermediate A represents PEG-monosulfone with the following structure 
 
PEG-NH
O O
SO2
 
 
Figure 2-8: Disulfide bridging PEGylation and structure of PEG-
monosulfone (Balan et al. 2007) 
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Steric shielding by the attached PEG molecule against a second molecule 
approaching the same reduced site, an important requirement for the 
bridged structure, prevented heterogeneity of the product profile and 
resulted predominantly in the mono-PEGylated derivative. Also, 
retaining the protein’s tertiary structure and selectivity and reversibility 
of the thiol conjugation are some of the attractive features of this 
technique.     
 
2.4.2.3 Oxidized carbohydrate or N-terminal conjugation 
 
The enzymatic (e.g., glucose oxidase) or chemical (e.g., sodium 
periodate) oxidation of carbohydrates present with glycoproteins or N-
terminal serine or threonine residues generates reactive aldehyde groups, 
which can be further conjugated with PEG hydrazide or amine 
derivatives (Hermanson 1996; Zalipsky and Menon-Rudolph 1997; 
Roberts et al. 2002) (Figure 2-9). Zalipsky and his colleagues used this 
methodology for PEGylating immunoglobulin G (IgG), which contains 
nearly 4% carbohydrate; it was first oxidized with periodate and then 
conjugated with mPEG-hydrazide derivative (Zalipsky and Menon-
Rudolph 1997). Following the same chemistry, periodate oxidized Ricin 
A-chain (RTA), an excellent immunotoxin source, was successfully 
conjugated with a 5 kDa mPEG-hydrazide (Youn et al. 2005).  
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a) Oxidation of glycoprotein to generate aldehyde groups 
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b) PEG conjugation with oxidised protein derivatives 
 
Figure 2-9: Oxidized carbohydrate or N-terminal conjugation 
 
2.4.2.4 Transglutaminase (TGase) mediated enzymatic conjugation 
 
A novel site specific PEGylation methodology targeting glutamine 
residues was reported by Sato (2002), in which a TGase catalysed acyl 
transfer reaction between the glutamine (Gln) terminal and PEG primary 
amino group was used for protein conjugation. Taking advantage of the 
capability of TGase to recognize a wide variety of alkylamine donors and 
their high affinity towards long chain aliphatic chains, Sato developed 
this distinctive strategy by incorporating a short sequence of Gln residue 
at the protein terminal, without disturbing its flexibility and 
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conformation, and modified it with primary amine derivatives of PEGs in 
the presence of TGase (Figure 2-10).  
 
Protein NH2
O
H2N-PEG
TGase
Protein
O
NH-PEG NH3
Gln residue of protein
+ +
 
Figure 2-10: TGase catalysed conjugation 
 
Compared to other methodologies, TGase mediated conjugations are 
found to be more site-specific, reliable, reproducible and versatile 
(Fontana et al. 2008).  TGase catalysed selective PEGylations of 
apomyoglobin (apoMb), α-lactalbumin (α-LA), human growth hormone 
(hGH) human granulocyte colony-stimulating factor (hG-CSF) and 
human interlukin-2 (hIL-2) with PEG amines are some of the proven 
examples of this new technique (Fontana et al. 2008; Mero et al. 2009).   
 
2.4.2.5 Miscellaneous conjugation chemistries 
 
DeFrees et al (2006) reported a new site specific process known as 
GlycoPEGylation, using an enzymatic N-acetylgalactosamine (GalNAc) 
O-glycolization, followed by PEGylation of the introduced O-glycans 
using a PEG sialic acid derivative. The emerging new click chemistry 
strategies (Hein et al. 2008) were are also found to be an important role in 
PEGylation (Droumaguet and Velonia 2008). Deiters et al (2004) 
reported a site specific PEGylation of genetically modified superoxide 
dismutase (SOD) using a PEG-alkyne derivative, resulting in 
predominant monoconjugation on the azide terminal (Figure 2-11). 
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Figure 2-11: Site specific PEGylation using click chemistry 
(Droumaguet and Velonia 2008) 
 
Even though it has attracted little attention and pharmaceutical  
relevance, PEGylation of human serum albumin using PEG-phenyl-
isothiocyanate (Meng et al. 2008) and PEG-epoxide (Bergstrom and 
Holmberg 1991) is also cited in literature.  
 
2.4.3 Reversible PEGylation 
 
The improved physicochemical properties of protein PEGylation were 
overshadowed in many cases by a substantial reduction in the protein 
activity arising from the permanent linkages formed during PEG 
conjugation. Consequently, a reversible (or releasable) PEGylation 
concept is formulated, in which proteins are attached to PEG derivatives 
through controlled releasable cleavable linkages, which release the 
protein in vivo under physiological conditions at a predetermined kinetic 
rate (Veronese and Pasut 2009). An example of such reversible 
PEGylation is the release of PEGylated lysozyme using a 1,6-benzyl 
elimination mechanism (Lee et al. 2001; Greenwald et al. 2003) (Figure 
2-12).    
O
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Figure 2-12: Reversible PEGylation using 1,6-benzyl elimination 
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A number of similar PEG derivatives capable of forming releasable 
conjugates are also reported, such as bicin, oligo-lactic acid ester, 
succinic ester, disulfide and β-alanine ester linkers (Filpula and Zhao 
2008; Pasut et al. 2008).  Even though this technique provided a 
controlled release of proteins in their fully active forms, the chances of 
some unwanted residual tags remaining with the protein and the in vivo 
formation of unwanted reaction by-products are some of the areas of 
great concern with this promising technique.  
 
2.4.4 Structure of PEGs  
 
The development of PEGylation is also characterised by a marked 
improvement and variation in the nature of the PEGs used for protein 
conjugation. Early stage PEGylations were performed mainly with linear 
and low molecular weight PEGs. These PEG derivatives were also 
characterized by higher diol contents (around 15%) and polydispersity 
contributed to an increasing heterogeneity of the product profile (Roberts 
et al. 2002; Pasut and Veronese 2006). The commercial availability of 
pure and low polydisperse PEG derivatives has resulted in a much 
improved product profile in recent years.  
 
The introduction of branched PEG derivatives resulted in an 
improvement in pharmacological properties due to their improved 
masking and protection of the conjugated protein. The very first branched 
PEG derivative for protein conjugation was prepared by Matsushima et 
al.  (1980) from the reaction between cyanuric chloride and mPEG and 
the resulting branched activated species were conjugated with E. coli 
asparaginase (Figure 2-13). Another branched PEG derivative, namely  
mPEG2-COOSu prepared by linking mPEG to both α and ε amino groups 
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of lysine (Monfardini et al. 2002), forms the basic conjugation strategy 
for manufacturing Pegasys® (Figure 2-6).   
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Figure 2-13: PEGylation using cyanuric chloride activated branched 
PEG 
 
The introduction of PEG dendrimers resulted in further advances in 
polymer therapeutics, with an increased protection due to the addition of 
very high molecular weights. In one such instance,  Meireles et al (2008) 
introduced a branched PEG derivative having a dendrimer-like structure 
with four mPEG branches, with a terminal COOH group available for 
protein conjugation (Figure 2-14). They successfully conjugated this 
four-branched PEG dendrimer with a number of therapeutic proteins 
including IFN-α2b, recombinant streptokinase (r-SK), erythropoietin 
(EPO), granulocyte-colony stimulating factor (G-CSF) and epidermal 
growth factor (EGF), through NHS activation and found improved 
pharmacological properties for these products compared with those 
obtained from two branched-structure of similar molecular mass.   
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Figure 2-14: Four-branched mPEG-COOH dendrimer derivative 
 
Recent developments in the synthesis of linear and branched 
multifunctional PEG derivatives, known as Multi-PEGs (Figure 2-15), 
have contributed a substantial improvement in the pharmacological 
advantages of PEGylation technology (Schiavon et al. 2004; Pasut et al. 
2005; Liu et al. 2007; Zacchigna et al. 2007; Drioli et al. 2008).   
 
 
Figure 2-15: A Multi-PEG derivative (TetraPEG6000-(OH)10) (Drioli et 
al. 2008) 
 
2.4.5 Process considerations  
 
The overall PEGylation processes so far used for protein conjugation can 
be broadly classified into two types, namely a solution-phase batch 
process and an on-column fed-batch process (Fee and Van Alstine 2006). 
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The simple to use and commonly adopted batch process involves the 
mixing of all reagents together in a suitable buffer solution, preferably at 
a temperature between 4–6 °C, followed by the separation and 
purification of the desired product  using a suitable technique based on its 
physicochemical properties, including sixe exclusion chromatography 
(SEC), ion exchange chromatography (IEX), hydrophobic interaction 
chromatography (HIC) and using aqueous two phase systems (Fee 2009).  
 
Normally with the batch process, prolonged contact between reacting 
species and products results in multiple conjugations and gives rise to a 
number of PEG isomers. Consequently a heterogeneous product mixture 
results, constituting unreacted starting materials, hydrolysed activating 
agents and a wide range of PEGylated product with varying degrees of 
conjugation. Hence extensive multistep purifications and downstream 
processing are required to isolate the desired product (Fee and Van 
Alstine 2006), making this process commercially non-viable and less 
attractive in many cases. The high cost of the therapeutic proteins, along 
with the cost of separating the desired PEGylated protein from these 
resulting mixtures, makes the products extremely expensive. A typical 
SEC elution profile for various PEGylated α-lactalbumin products 
obtained from a batch process is illustrated in Figure 2-16.  
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Figure 2-16: SEC elution profile of various PEGylated α-lactalbumin products obtained from batch process  
(Fee 2003) 
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Taking into considering the improvement of the product profile, a 
number of on-column PEGylation techniques were attempted, mainly to 
improve the specificity of the conjugation. The very first variation in the 
PEG conjugation process was introduced by Felix et al (Lu and Felix 
1994; Felix 1997). They developed a site-specific solid-phase peptide 
PEGylation, in which a peptide sequence was tethered onto a Rink amide 
MBHA-resin and was conjugated with a PEG derivative through a side 
chain lysine or aspartic acid. Finally the mono-PEGylated peptide was 
cleaved off from the resin using trifluoroacetic acid (TFA). In a similar 
pattern, folate was derivatised with a PEG derivative attached to HMP 
resin through a peptide linker and peptide-PEG-folate conjugate was 
cleaved off from the resin using TFA (Niculescu-Duvaz et al. 2008). 
Because of the utilization of very harsh chemicals like TFA for the 
release of PEGylated products, direct application of this methodology is 
not viable with highly sensitive species like proteins.  
 
Utilizing the ion exchange interactions between protein and ion exchange 
resins, Monkarsh et al (1997) prepared and separated various positional 
isomers of PEGylated interferon-α-2a (PEG-INF) using an on-column 
process. INF was first adsorbed to a strong anion exchange resin and the 
activated PEG derivative was then circulated through the column. After 
eluting the unreacted PEGs and by-products, PEG-INF was collected by 
increasing the salt concentration. Unfortunately, this method resulted in 
multi-PEGylated products without any improvement in the product 
profile.  
 
Similarly, Lee et al (2007) PEGylated recombinant interferon-α-2a 
(rhIFN-α-2a) by adsorbing on a CM-Sepharose cation exchange resin 
through ion exchange interactions. After washing out the unbound rhIFN-
α-2a, mPEG-aldehyde and sodium cyanoborohydride solutions were 
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passed through the column. Similarly Suo et al (2009) PEGylated bovine 
haemoglobin loaded onto CM-Sepharose using mPEG-succinimidyl 
carbonate and their studies showed that the selectivity of this method was 
increased with an increase in the molecular weight of the added PEG. A 
schematic illustration of the concept of their on-column “solid-phase 
PEGylation” is illustrated in Figure 2-17. Even though these methods 
resulted in preparing mono-PEGylated products up to 75% yield, based 
on the loaded native protein, consistency in the reaction efficiency is 
highly unlikely due to random orientations of adsorbed protein on the ion 
exchange matrix.   
 
 
Figure 2-17: Schematic illustration of on-column solid-phase 
PEGylation based on ion exchange interactions (Suo et al. 2009) 
 
A unique on-column PEGylation methodology, known as size exclusion 
reaction chromatography (SERC), was introduced by Fee (2003), 
incorporating the principle of SEC in separating various molecular sized 
species based on their different linear velocities through a column packed 
with porous beads (Figure 2-18).  In this method, both activated PEG and 
protein were injected into the column, which subsequently forms an in-
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situ moving reaction zone within the column. As the reaction proceeds, 
owing to the increased linear velocity associated with the larger 
molecule, the PEGylated protein, having a larger size than either of the 
reagents, moves ahead of the reaction zone. Consequently a simultaneous 
reaction as well as the separation of the various PEGylated products can 
be achieved in a single operation.  
 
 
Figure 2.18: Principle of SEC 
(http://www.sci.sdsu.edu/TFrey/Bio750/Chromatography.htm)  
 
Unfortunately, SEC is characterized by its own inherent inability to 
identify and separate the various positional isomers with the same 
number of PEG molecules attached through the different conjugation 
sites of a given protein. This drawback also extended to SERC, even with 
its other advantages.     
 
2.4.6 Requirement for an improved technique  
 
Even though nearly four decades of development of PEGylation 
technology have proved its pharmacological advantages and 
acceptability, the technology still lags in providing a commercially 
attractive and versatile process to yield the desired products with high 
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specificity, quantity and quality. Being a multi-million dollar business 
annually, and with the growing influence of emerging biotechnology and 
the interest of multinational pharmaceutical companies, there is a great 
scientific and commercial interest in improving on the various drawbacks 
of the present methodologies and in the need for innovative process 
variations.  
 
 2.5 Concept of novel solid-phase protein PEGylation 
 
In order to overcome these drawbacks, a novel and innovative solid-
phase protein PEGylation design is proposed, with its characteristic 
unidirectional and single pass process to minimise the variation between 
batches and to increase the specificity and yield of the process. The new 
design, solid-phase PEGylation resin, involves the use of a tethered PEG 
molecule on a modified solid matrix. A schematic representation of the 
proposed solid-phase PEGylation matrix is illustrated in Figure 2-19. 
Because of the high mobility of the end terminal of the tethered PEG 
molecules and due to the presence of inter-repulsive forces exerted 
between the hydrated PEG chains, there is a strong possibility of single 
PEG molecule conjugation with the approaching protein. Consequently a 
predominant mono-PEGylated product can be expected with a reduction 
in product heterogeneity, allowing the production of PEGylated species 
with high yields and purity, which significantly reduces separation and 
purification requirements.   
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Figure 2-19: Schematic representation of the concept of solid-phase 
PEGylation system 
 
The solid-phase PEGylation technique involves the grafting of a 
functionally modified PEG onto a functionalized solid matrix through a 
pH-sensitive labile linkage. The free end terminal of the PEG is modified 
with a functional group capable of selective conjugation with a particular 
functional group available on the protein surface. After protein 
conjugation, the PEGylated protein will be released from the solid 
support by cleaving the labile linkage, by a mild change in pH or the use 
of a suitable reagent, without disturbing the protein-PEG linkage or 
denaturing the protein.  This novel solid-phase PEGylation matrix is 
anticipated to have the following characteristics: 
1. It can be used for both batch and on-column processing.  
2. It reduces heterogeneity and improved product profile. 
3. It minimises the variation between batches and increase the 
specificity and yield of the process. 
4. The amount of protein required for conjugation can be calculated 
based on the activated PEG on the solid matrix, which results in a 
reduction in the wastage of protein. 
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5. It allows recycling of unreacted and excess protein for further 
conjugation.  
6. The end terminal functional group of the tethered PEG can be 
easily modified to adapt this technique for a wide variety of site 
specific PEGylation strategies.  
7. It is ready to use and can be stored under inert atmosphere. 
 
2.6 Components of solid-phase protein PEGylation matrix 
 
The proposed solid-phase protein PEGylation matrix can be divided into 
three main components, the functionalized matrix, a cleavable linker and 
a heterobifunctionalized PEG derivative. Here follows a brief discussion 
about the choice of these various components, along with the model 
protein Cytochrome c, more relevant discussions particularly related to 
the project can be find in the specifically concerned chapters.   
 
2.6.1 Cytochrome c 
 
Cytochrome c from bovine heart is used as the model protein for 
conjugation studies. Because of the presence of a homologous structure 
(Margoliash 1963) and its characteristic electron-transferring capabilities 
(Mirkin et al. 2008), Cytochrome c is one of the most extensively used 
model  globular proteins. Cytochrome c is characterised by a single 
polypeptide chain consisting of 104 amino acids covalently attached to a 
heme group and having a molecular weight of 12,130 Da and a 
hydrodynamic radius of 3.4 nm.  As Cytochrome c is a lysine rich protein 
with 19 lysine residues distributed on the protein surface (Prakash and 
Mazumdar 2009) (Figure 2-20), amine reactive conjugation strategy can 
be easily applicable for any modifications.  
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Figure 2-20: Structure of Cytochrome c showing reactive lysine residues 
(Prakash and Mazumdar 2009) 
 
2.6.2 Functionalized solid matrix 
 
The basic requirement of this matrix is to provide a structural support for 
the functionalized PEG derivative during protein conjugation, without 
denaturing the protein or interfering with conjugation reactions. 
Examples of various solid-phase support matrices with a special 
emphasis on the immobilization of biomolecules include cross linked 
natural organic polymers such as agarose  (O'Shannessy 1989; Manta et 
al. 2003), dextran (Veronese and Morpurgo 1999; Mehvar 2000), 
cellulose (Bora et al. 2005), chitin and chitosan (Chan et al. 2007); 
synthetic polymers like polystyrene (Zalipsky et al. 1994; Van Delden et 
al. 1996; Steven A. Kates et al. 1998), polypyrrol (Dong et al. 2009) and 
polymethacrylate (Chan et al. 2007); inorganic polymers such as silica 
and glass (Choi et al. 2005), and some functionalized nanoparticles (Jiang 
et al. 2004; Yang et al. 2007). These matrices are used in various forms 
such as beads, solid surface and membrane, depending on the purpose. 
 
In this thesis, experiments are planned mainly using two different types 
of solid matrices, namely hydrophilic and hydrophobic matrices, to 
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understand their influence on the nature of the novel PEGylated system. 
Sephadex™ (GE Healthcare Ltd, Uppsala) is selected for the former class 
and polystyrene is selected for the latter one.  
 
2.6.2.1 Sephadex  
 
Sephadex is a crosslinked dextran that is widely used as a 
chromatographic medium for the separation and purification of a wide 
variety of biomolecules. A variety of Sephadex derivatives is available in 
the market, based on the difference in their cross linking and the degree 
of swelling. Sephadex derivatised with cation exchangers, such as 
carboxymethyl Sephadex (CM Sephadex), sulfopropyl Sephadex (SP 
Sephadex) and anion exchangers such as diethylaminoethyl Sephadex 
(DEAE Sephadex) and diethyl-(2-hydroxypropyl) aminoethyl Sephadex 
(QAE Sephadex) are also available for chromatographic purposes. 
 
Sephadex is prepared by cross linking low molecular weight dextran with 
epichlorohydrin in the presence of alkali (Flodin 1962; Flodin 1998). The 
resulting gel is then neutralized, ground, dehydrated, dried and sieved to 
isolate the desired particle sized fractions. Dextran, the basic structural 
component of Sephadex, is a complex branched glucan (α-D-
glucopyranose) with mainly α 1-6 glycosidic linkage between glucose 
molecules, and about 5% α 1-4, α 1-2 and α 1-3 linkages. The reactivity 
of various OH groups in the dextran molecule varies with their position, 
and studies showed that the OH group on C2 position is more reactive 
than other OH groups (Ramirez et al. 1994; Lee et al. 1999).  This is 
mainly due to the presence of neighbouring oxygen atoms in the ring and 
on the C1 position, which enable the interaction of their lone pair of 
electrons through space, resulting in an increased electron density at the 
C2 position and thereby making the OH group more nucleophilic.  This 
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type of cross linking with epichlorohydrin will occur mainly at the C2 
positions between the dextran moieties and the basic structure of 
Sephadex can be presented as shown in Figure 2-21. The remaining OH 
group at C2 positions, left behind after cross linking, are the major targets 
for further modifications.   
 
The cross linking of dextran base units results in the formation of well 
defined three dimensional networks of interstices or pores with a large 
number of hydroxyl groups, making these gels polar, and consequently 
these gels swell significantly in water and aqueous solutions (Flodin 
1962; Vavruch 1968).  
 
Figure 2-21: Basic structure of Sephadex (Flodin 1962) 
 
2.6.2.2 Polystyrene 
 
The introduction of cross-linked polystyrene for the solid-phase peptide 
synthesis by Merrifield (1963) attracted an overwhelming interest in 
solid-phase chemistry. In contrast to Sephadex, the absence of any 
hydrophilic and polar functional group on the polystyrene polymer chain 
(Figure 2-22) makes it hydrophobic and results in good swelling 
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properties with organic solvents such as dichloromethane and dimethyl 
formamide (Park and Lee 2000).    
 
PhPh Ph
Ph Ph
X
Polystyrene chain
Crosslinking
Functional group for modification
 
Figure 2-22: Basic structure of polystyrene (Campbell 2000) 
 
2.6.3 Cleavable linker 
 
A cleavable linker between the matrix and the PEG derivative is 
anticipated to enable the release of PEGylated product from the matrix 
after protein conjugation. Even though a large variety of cleavable linkers 
are available for conventional solid-phase and combinatorial synthesis 
(Guillier et al. 2000), the choice of a suitable linker for solid-phase 
PEGylation was limited by the presence of protein in the reaction system. 
Very mild cleavage conditions were the primary requirement considering 
the very high denaturing tendency of the conjugated protein and 
consequently labile ester linkages were selected (Section 3.2.1.1). 
 
As an alternate to labile ester linkages, the use of selective and site 
specific proteins tags (Terpe 2003) also attracted attention while drafting 
the methodology. Due to the very specific selectivity of these recognition 
sites by cleaving enzymes, these tags were found to be very important in 
protein expression and purification as well as protein synthesis (Bang and 
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Kent 2005; Gaberc-Porekar and Menart 2005). Some commercially 
available cleavage enzymes and their recognition sites are summarized in 
Table 2-3. The insertion of such a tag between the resin and one terminal 
of the PEG derivative is a good option to improve the yield and 
selectivity of the PEG release, as well as to reduce the chances of 
denaturing the protein 
 
Table 2-3: Examples for recognition site and enzymes (Gaberc-Porekar 
and Menart 2005) 
 
Recognition site Cleavage enzyme 
Ile-Glu/Asp-Gly-Arg▼ Factor Xa 
Leu-Val-Pro-Arg▼Gly-Ser Thrombin 
Leu-Glu-Val-Leu-Phe-Gln▼Gly-Pro PreScission 
Asp-Asp-Asp-Asp-Lys▼ Enterokinase 
Glu-Asn-Leu-Tyr-Phe-Gln▼Gly TEV protease 
Leu-Glu-Val-Leu-Phe-Gln▼Gly-Pro HRV 3C protease 
 
2.6.4 PEG 
 
Considering the influence of PEG polymer on the overall preparation and 
performance of the proposed protein delivery system, it is worthwhile to 
understand the characteristic properties of this polymer, especially the 
structural features.    
 
2.6.4.1 Properties of PEG molecule 
 
PEGs are generally prepared by the ring opening polymerization of 
ethylene oxide (Hill et al. 1958; Bailey and Koleske 1976). Compared to 
its structural analogues, PEG has very good water solubility under 
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ordinary conditions (Kjellander and Florin 1981; Israelachvili 1997) 
(Table 2-4).  
 
Table 2-4: Solubility of PEG and similar polymers in water 
 
Polymer CAS 
No 
Structure Solubility 
 in water 
Poly (methylene 
oxide) 
9002-
81-7 O CH2
n
 
 
Insoluble 
Poly (acetaldehy-
de) 
9002-
91-9 O CH
CH3
n
 
 
Insoluble 
Poly (ethylene 
oxide) 
25322
-68-3 O CH2 CH2
n
 
 
Soluble 
Poly (propylene 
oxide) 
25322
-69-4 O CH2 CH
n
 
CH3
 
Insoluble 
Poly (trimethyle-
ne oxide) 
31714
-45-1 O C3H6
n
 
 
Insoluble 
Poly (tetrahydro-
furan) 
25190
-06-1 O C4H8
n
 
 
Insoluble 
 
The high solubility of PEG in water at ambient temperature can be 
mainly attributed to the conformational behaviour of the ethylene oxide 
fragment of the polymer backbone (Section 2.6.4.2.1). PEG water 
solubility is characterized by a distinctive inverse solubility-temperature 
relationship (Bailey and Koleske 1976); as the temperature increases the 
polymer starts precipitating out from the solution. This is known as the 
clouding effect and the temperature at which the PEG starts precipitating 
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out (cloud point or the lower critical solution temperature (LCST)) 
depends on the molecular weight of PEG, its concentration, the presence 
of any salts and the pH of the solution (Han and Jhun 1984; Armstrong et 
al. 2001; Nozary et al. 2003). Jeon and Chang (1996) correlated this 
behaviour to the intrinsic viscosity of the PEG-water solution. Their 
studies showed that the intrinsic viscosity of the PEG-water solution 
decreases with an increase in temperature, and suggest that this results in 
a decrease in the PEG-water interaction, which contracts the PEG chain 
and thereby induces hydrophobic interactions. 
 
PEG is also soluble in a variety of organic solvents like chlorinated 
hydrocarbons, but insoluble in hexane, diethyl ether and ethylene glycol 
(molecules which resemble PEG). Even though PEG is soluble in both 
organic and aqueous solvents, the partitioning property of PEG will vary 
depending on the nature of the solvent (Harris 1992). In a water-benzene 
system, PEG will partition in favour of water, whereas in a water–
dichloromethane system, it favours dichloromethane. Also by taking 
advantage of the reduced solubility of PEG in aqueous solutions in the 
presence of salts (Armstrong et al. 2001), this favourable partition 
coefficient towards dichloromethane can be used as an effective 
methodology in avoiding the formation of emulsions usually associated 
with extracting PEGs from their aqueous solutions using organic 
solvents. Consequently, PEG derivatives extracted from a saturated NaCl 
solution using dichloromethane were adapted for the workup during their 
synthesis (Section 3.5).  
 
2.6.4.2 PEG Conformations 
 
The conformational behaviour of PEG molecule varies depending on a 
number of factors. If the molecule is in solution, the nature of the 
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medium was found to have a great influence on the conformational 
property of PEG molecules. If the polymer is attached to a matrix 
surface, the conformational behaviour is greatly influenced by surface 
PEG concentrations.  
 
2.6.4.2.1 PEG conformation in solutions 
 
In aqueous solutions, PEG can exist in either trans-gauche-trans (t-g-t) or 
all trans (t-t-t) conformations, as shown in Figure 2-23. 
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Figure 2-23: PEG conformations (Rixman et al. 2003) 
 
In t-g-t conformations, a single water molecule can form hydrogen 
bonding between the two adjacent oxygen atoms in PEG, resulting in the 
formation of bridges that stabilize the dynamic helical configuration. This 
is further favoured by a structural matching between the ethoxide moiety 
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and water, with a comparable distance between the oxygen atoms in -O-
CH2-CH2-O- segments in the gauche conformation and the hydrogen 
atoms within the nearest water molecule (Begum and Matsuura 1997). In 
the t-t-t conformation, the increased distance between oxygen atoms 
(Figure 2-23b) prevents the bridge formation and allows only one 
hydrogen bond between the water molecule and the polymer backbone. 
Consequently, there is an increase in the mobility of the molecule and 
therefore the t-t-t configuration is favoured by an entropic advantage 
(Oesterhelt et al. 1999).  
 
Because the chances of such hydrogen bonding are almost negligible 
with aprotic solvents,   PEG will exist in an all trans conformation in such 
solvents, leading to the formation of random coils, but the presence of a 
small amount of water can favour helical formations. Thus a polymer 
exists predominantly in its random coil form in organic aprotic solvents 
and in helix form in aqueous solutions. Also, at high molecular weights, 
PEG exists as a helix in its solid state and when it is melted, the 
destruction of the helical structure takes place, leading to the formation of 
random coils. Studies on the heat of fusion, ∆Hf, of PEG with a 
molecular weight of 6000 Da in water (74.5 J/g) and organic solvents 
such as chloroform and dichloromethane (239 J/g) (Maron and Filisko 
1972), showed a difference of 164.5 J/g of polymer, confirming the 
difference in conformation of PEG in these solvents and suggesting the 
existence of a helical conformation in water and a random coil 
conformation in organic solvents.  This also suggests that this quantity of 
heat is required to disrupt the dynamic helical configuration, and the high 
∆Hf value for PEG in non-aqueous solvents may be mainly due to the 
increased disorder introduced by the conversion of helix to random coils.  
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2.6.4.2.2 Conformational behaviour of surface-grafted PEG  
 
The conformational behaviour of surface-grafted PEGs, derived from the 
theories initially proposed by Alexander (1977a; 1977b) and de Gennes 
(1980; 1987) and by many others in recent years (Kuhl et al. 1994; 
Vermette and Meagher 2003; Norde 2007; Wattendorf and Merkle 2008; 
Steinmetz and Manchester 2009), suggests the existence of a variety of 
conformations, ranging from mushroom to brush forms with overlapping 
regimes.  
 
 
a) Mushroom b) Brush-mushroom 
intermediate 
c) Brush 
Figure 2-24: Schematic representation of various conformations of 
surface grafted PEGs (Wattendorf and Merkle 2008) 
 
de Gennes, in his theory (1980; 1987), correlated grafting density to 
preferred conformations and suggested that a mushroom conformation 
exists at a low graft density, while a high grafting density will favour a 
brush conformation. With lower grafting densities, the distance between 
grafting terminals of the PEG chains (D) will be greater than the Flory 
radius (RF) of the polymer (D > RF), allowing mushroom conformations. 
As the grafting density increases, the distance between the grafting 
terminals will decrease, causing the polymer chains to stretch away from 
the matrix due to interchain interactions. In this case, D < RF, and the 
polymer will be predominantly in its brush conformation.  
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2.7 PEG grafted solid matrices 
 
PEG grafted matrices are used in a variety of applications, such as solid-
phase peptide synthesis (Felix 1997), enzyme immobilization (Manta et 
al. 2003), anti-fouling surfaces (Malmsten and Muller 1999; Xu et al. 
2008), biosensors (Sharma et al. 2004; De Vos et al. 2009),  molecular 
brushes (Gao and Matyjaszewski 2007; Halperin et al. 2007) and ligand 
spacers (Ham et al. 2009). The improved properties of these modified 
matrices are mainly attributed to the unique nature of PEG molecules 
(Section 2.3). Various methods of preparing these grafted matrices are 
described in following sections.   
 
2.7.1 Physisorption 
 
A variety of PEG-matrices can be prepared by physical adsorption of 
PEG onto surfaces based on electrostatic interactions.  A large number of  
such materials have proved their importance in biomedical and 
chromatographic applications due to their simple method of preparation, 
but were characterized by their non-specificity and lack of permanent 
intact on the surface (Lee et al. 1995).  Examples include the adsorption 
of PEG onto poly(ethylene imine) functionalized silica and mica surfaces 
(Claesson et al. 1996) and through poly(L-lysine) derivatization on a 
negatively charged metal oxide substrate (Pasche et al. 2005).   
 
2.7.2 Block polymerization (“grafting from”) 
 
PEG grafted solid matrices using block polymerization are prepared by 
using PEG as the polymerization macroinitiator, functionalized with an 
initiation group capable of starting the polymerization of a second 
monomer (Borner and Matyjaszewski 2002). Depending on the structure 
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of the monomer units, the polymerized products displayed characteristic 
sequences and polymer chain networks, resulting in the formation of 
mono-block, di-block or multi-block copolymers (Xie and Xie 1999). 
Solid matrices with high grafting density molecular brushes can be 
conveniently prepared by this method (Borner and Matyjaszewski 2002).  
  
A number of examples for preparing PEG grafted matrices using block 
copolymerization are cited in literature (Xu et al. 2006; Durmaz et al. 
2008; Varshney et al. 2008). Ring opening copolymerization of ethylene 
oxide (EO) with ethoxyethyl glycidyl ether (EEGE) in the presence of 
mPEG yielded a linear macroinitiator that initiated the atom transfer 
radical polymerization (ATRP) of styrene. The resulting comb-like 
polymer (mPEG-b-[poly(EO-co-Gly)-g-PS]) is a classic example of a 
PEG-block copolymer prepared by using the graft from polymerization 
strategy  (Sun et al. 2009).  
 
2.7.3 Graft polymerization (“grafting to”) 
 
PEG grafted matrices through graft polymerizations are mainly prepared 
by the utilization of free radicals, peroxides or various high energy 
irradiations (Lee et al. 1995). PEG methacrylate or azide derivatives are 
commonly used for this type of grafting, due to their capability for direct 
insertion into C=C or C-H bonds (Thom et al. 1998).  Consequently this 
methodology offers PEG grafting onto a variety materials, independent of 
the surface composition or chemistry. Examples include the grafting of 
PEG onto gold (Larsson et al. 2007), stainless steel (Zhang et al. 2001), 
polysulfone (Thom et al. 1998), polystyrene (Lazos et al. 2005) and 
poly(vinyl chloride) surfaces (Lee et al. 1995).     
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2.7.4 Covalent grafting 
 
The covalent grafting of a PEG onto a matrix is a type of “grafting to” 
technique that provides the most effective method of creating a 
permanent linkage between the matrix and the polymer. Well defined 
tailor made PEG derivatives capable of forming covalent bonding with 
the available functional groups on the matrix surface and the use of 
ambient reaction conditions, make this technique more attractive than the 
other methods. In the case of matrices without any functional groups, a 
pre-modification of the surface with a suitable functional moiety is 
required before PEG grafting. A detailed insight into this method is given 
in Section 4.2.2.  
 
2.8. Protein interactions with PEG grafted matrices 
 
Proteins can be considered as complex polymers made of various amino 
acids (Branden and Tooze 1991). Consequently, their interaction with 
another polymer grafted matrix surface will result in a variety of 
simultaneous interfacial interactions consisting of many attractive and 
repulsive forces, depending on PEG grafting density, chain length and the 
nature of approaching proteins (Jeon and Andrade 1991; Jeon et al. 1991; 
Leckband and Sivasankar 1999; Vermette and Meagher 2003). The 
overall outcome of these forces in general leads to two types of protein 
adsorption on a PEG grafted solid matrix, namely primary and secondary 
adsorptions (Szleifer 1997; Halperin 1999). A primary adsorption is 
characterized by a primary potential energy minima close to the matrix 
surface, whereas a secondary adsorption occurs at a secondary potential 
energy minima, usually farther away from the surface (Vermette and 
Meagher 2003) (Figure 2-25).  
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              Matrix 
 
 
Figure 2-25: Schematic illustration A) Primary adsorption  and B) 
Secondary adsorption of proteins 
 
A brief survey of various possible interactions that can influence the 
performance of the novel solid-phase PEGylation system are summarized 
below.  
 
2.8.1 Attractive interactions 
 
In aqueous solutions PEG chains can undergo partial oxidations, resulting 
in the development of small negative charges along the polymer chain, 
and proteins can be positively charged at physiological pH. This can 
contribute towards the formation of an attractive electrical double layer 
interaction between the PEG molecules and the approaching protein 
(Vermette and Meagher 2003). If the PEG grafting density is low and the 
underlying matrix surface is characterised by negatively charged 
functional groups, these attractive interactions can lead to the formation 
of mainly primary adsorptions on the matrix surface. Similarly some 
other short range attractive forces, including hydrogen bonding and van 
der Waals interactions (Rixman et al. 2003), may also be exerted between 
the matrix surface and the approaching protein during conjugation.    
A B 
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2.8.2 Repulsive interactions 
 
According to de Gennes (1987), surface grafted PEG molecules in their 
brush conformation can be treated as a polymer solution whose 
concentration will increase with an increase in grafting density. An 
increase in the concentration of this solution will result in an apparent 
increase in osmotic pressure between the chains, due to an increase in 
polymer chain segment concentration with a decrease in the elastic 
restoring force arising from the configurational entropy (Jeon et al. 1991; 
Rixman et al. 2003). When a protein approaches such a highly 
concentrated solution, there will be an increased repulsive force (F) 
contributed by both osmotic pressure and elastic restoring forces as in 
Equation   2-1 (de Gennes 1987) 
 
 F ≈ 3D
kT
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where k is the Boltzmann constant, T is the absolute temperature, D is the 
distance between the grafted polymer chains, t is the thickness of the 
PEG layer and h is the average distance between protein and polymer 
grafted matrix. The first term in Equation 2-1 outside the bracket 
represents the osmotic term, while the second one is the elastic term. This 
indicates a complete domination of the osmotic factor, resulting from 
compressions occurring due to approaching proteins for conjugation. 
Simultaneously, these compressions and the resultant outward osmotic 
pressure tends to remove water molecules out from the PEG hydrated 
shells. This results in thermodynamically unfavourable conditions 
causing increased steric repulsions, and finally contributes towards an 
inertness to PEG molecules (Ostuni et al. 2001).  
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2.8.3 Impact of various surface force interactions on expected results 
 
Considering all these cumulative surface force interactions, the 
magnitude and range of repulsive interactions are much higher than those 
of attractive interactions and will increase with an increase in PEG 
grafting densities. Consequently with a higher grafting density, where the 
grafted PEG molecules will predominantly be in their brush 
conformations, a localised higher concentration of protein can be 
expected near the terminal end of the PEG molecules, due to secondary 
potential energy minima. Therefore, this will result in the conjugation of 
activated PEG terminals with proteins accumulated on the secondary 
potential energy minima zone nearer to the PEG terminals (Figure 2-26). 
Taking advantage of the high mobility of the PEG end terminal as well 
the repulsive interactions between the hydrated PEG chains, this keeps 
the polymer chains apart from each other; a predominant mono-
PEGylation is anticipated as an outcome of the resulting conjugation.  
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Figure 2-26: Influence of surface interactive forces on solid-phase 
protein PEGylation 
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2.9 Conclusions 
 
Improved pharmacological advantages and the commercial acceptance of 
various PEGylated products catalyzed a substantial improvement in their 
chemistry and process. Even though the introduction of various site 
specific conjugation techniques and process variations can improve the 
product profile and yield of PEGylation, there are very good possibilities 
for further improving this technology to overcome the existing challenges 
and to meet commercially acceptable norms.  
 
After going through a detailed insight into various conjugation strategies 
and process considerations and evaluating the present limitations and 
drawbacks, the requirement for an improved technique is ascertained in 
this chapter. The proposed methodology, solid-phase protein PEGylation, 
utilizes the concept of surface force interactions between the grafted PEG 
molecules and the approaching protein, and is anticipated to provide an 
improved product profile compared with other methods by reducing the 
product heterogeneity and variation between the batches.  
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3 Synthesis of heterobifunctional PEG 
derivatives  
 
3.1 Introduction 
 
This chapter describes the various methodologies used for synthesizing 
suitable PEG derivatives for surface grafting, protein conjugation and 
hydrolysis kinetic studies. Solution-phase protein PEGylation using 
prepared PEG derivatives is also described to compare the selectivity of 
the conjugation and nature of product profile with its solid-phase 
analogue.  
 
The development and optimization of a suitable synthetic scheme for a 
heterobifunctional PEG derivative which suits the requirements of the 
current project objectives was not straightforward due to the lack of 
literature and reported methodologies. The synthetic schemes for PEG 
modifications were finalized based on similar functional group 
transformations and from the results of various experiments with a 
number of reaction schemes, chosen for their compatibility with the 
different functional moieties present on either side of the PEG molecule 
during their preparation and modifications.   
 
3.2 Synthesis strategy development 
3.2.1 PEG derivative for solid-phase protein conjugation 
 
One of the main objectives of the project was to develop a suitable PEG 
derivative with a functional group capable of forming a cleavable linkage 
with a functionalized solid matrix at one terminus and the other end of 
the PEG chain incorporating a functional moiety capable of forming a 
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stable linkage with a suitable functional group on a protein under mild 
conditions. Once the PEG derivative was grafted onto the matrix, the 
other terminal would conjugate to the protein and the PEG-protein 
conjugate would finally cleave off the matrix to yield a PEGylated 
protein with a desired degree of PEGylation.  
 
3.2.1.1 Choice of a suitable cleavable linkage 
 
Cleavable linkers are commonly used with solid-phase synthetic 
strategies and their choice depends on the reaction parameters and nature 
of the product required. A brief summary of the various labile linkages 
used in organic preparations with a special emphasis on solid-phase 
synthesis is summarised in Table 3-1. 
 
In the majority of reported cases, very harsh reaction conditions and 
chemicals were utilized for cleaving the linkage and the resulting 
hydrolysed product ends up with a residual terminal functional group 
from the cleaved linkage. The ultimate goal of this project was to produce 
PEGylated proteins and this, along with the presence of protein in the 
reaction media during the cleaving process, necessitates the use of very 
mild cleavage conditions and reagents to prevent denaturing of the 
protein. Also, any resulting PEGylated product with a residual reactive 
terminal functional group can induce toxicity in vivo and hence will not 
be approved as a drug component by the drug regulation authorities. 
Considering all these limitations and requirements, an ester linkage was 
selected, because the cleavage of an ester will result in a less reactive 
hydroxy terminated PEG derivative and it was anticipated that this could 
be performed under very mild conditions with low toxicity chemicals.  
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Table 3-1: Labile linkages  
 
Linkage  Nature  References 
Acetal 
R-CH-(OR')2 
Acid labile (Cordes and Bull 1974; Furman et 
al. 1999; Rozema and Wakefield 
2005; Trubetskoy et al. 2005) 
Carbamate 
(urethane) 
R2-N-CO-O- 
Labile, nature 
varies with 
substituents 
(Letsinger et al. 1964; Dressman et 
al. 1996) 
Diazo 
-N=N- 
Cleavage by 
dithionite 
(Jaffe et al. 1980; Hermanson 
1996) 
Disulfide 
-S-S- 
Cleavage via 
reduction 
(Hermanson 1996; Salo et al. 
1998; Lack et al. 2002) 
Enamine 
R2C=CR-NR2 
Acid labile (Hird et al. 1997; Dorwald 2003) 
Enol ether 
R2C=CR-O-R 
Acid labile, 
cleavable by 
oxidising agents 
(eg. dimethyl 
dioxirane) 
(Dorwald 2003; Roberts and 
Hartley 2004) 
Esters 
-CO-O- 
Acid and base 
labile 
(Greenwald et al. 1996; Dorwald 
2003) 
Imine 
-N=C- 
Acid labile (Baker et al. 1996; Kim et al. 
2005) 
Ketals 
R2-C-(OR')2 
Acid labile (Cordes and Bull 1974; Olsen et al. 
1985) 
Orthoester 
RC(OR')3 
Acid labile (Cordes and Bull 1974) 
Silyl ether 
-O-SiR2- 
Acid labile (Boehm and Showalter 1996; Ishii 
et al. 2000; Wang et al. 2001) 
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Table 3-1 continued 
β-thiopropionate 
-O-CO-CH2-
CH2-S- 
Acid labile (Oishi et al. 2005) 
 
3.2.1.2 Succinyl ester as a cleavable linker 
 
Succinyl ester is a useful cleavable linker for attaching drugs to many 
polymeric delivery systems due to the ability to hydrolyse it under very 
mild conditions (Zalipsky et al. 1983; Douglas et al. 1991; Plourde et al. 
1995; Braunova et al. 2004). Introduction of a succinyl ester between the 
functionalised solid matrix and one terminal of PEG was thus considered 
to be a good option to meet and overcome many of the project 
requirements and constraints, respectively.  
 
Detailed synthetic methods and results are attached in Appendix A. In 
brief, one terminal of the PEG was first functionalized with a carboxy 
derivative, followed by protecting it with a suitable functional group to 
make it available for further activation and conjugation with protein. The 
unmodified hydroxyl terminal was then esterified with succinic 
anhydride and grafted onto Sephadex under anhydrous conditions. The 
carboxy terminal of the PEG was regenerated by deprotection and then 
conjugated with protein after NHS activation. Finally, the objective was 
to cleave off the PEGylated protein by hydrolysing the succinyl ester 
linkage under very mild reaction conditions. The hydrolysed fractions 
were analysed using SEC chromatography but the results were negative - 
no PEGylated protein was detected in the hydrolysed fractions. 
Experiments were repeated with various protection-deprotection methods 
and various PEG grafting and hydrolysis conditions but none of them 
gave a positive result.  
  
3-5 
The solid-phase deprotection strategy adopted in this synthetic scheme 
resulted in complexity that caused difficulty in understanding the reaction 
mechanism and kinetics such as the actual molar ratio of reagents, extent 
of deprotection and complete removal of the reagents and side products. 
Use of a PEG derivative without protecting its ω-carboxy terminal with 
this scheme was not viable, as it could lead to further complexity in the 
reaction due to a competing reaction between the two similar functional 
groups at the two terminals.  
 
3.2.1.3 β-alanine ester as a cleavable linker  
 
In seeking a new synthetic strategy using a deprotected ω-carboxy 
terminated PEG derivative before grafting onto a solid matrix, the 
hydrolysable nature of the β-alanine ester was noted (Wilchek and Miron 
1987). Tateyama (1999) reported the release of Heyns rearranged sugar 
analogs (acetol and ribulose) from their PEG support by the alkaline 
hydrolysis of β-alanine ester linkage and it is now receiving more 
attention as a useful cleavable linker for controlled drug delivery systems 
(Pasut et al. 2008).   
 
A detailed kinetic study of the hydrolysis of β-alanine ester linkage using 
PEG-acyclovir conjugate (Zacchigna et al. 2002) showed nearly 65% 
hydrolysis at pH 1.2,  9% at pH 7.4 and it remained almost stable  at pH 
5.5 at 37°C after 7 hour. The detailed kinetic profiles of hydrolysis at 
various pH values are given in Figure 3-1. 
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Figure 3-1: Release of acyclovir by hydrolysis of β-alanine ester linkage 
at 37°C from PEG-acyclovire2. ♦- pH 1.2, 0.2 M (HCl, NaCl and 
glycine), ▲- pH 7.4, 0.1 M phosphate and ■- pH 5.5, 0.2 M, 
phosphate/citrate (Zacchigna et al. 2002).  
 
These observations regarding the labile nature of β-alanine ester group, 
along with the availability of different functional groups at the two 
terminals (NH2 group at the β-alanine terminal and COOH group at the 
far end of PEG), became the central basis of the new synthetic 
methodology  for the proposed solid-phase PEGylation system.  
 
3.2.1.4 Preparation of ω-carboxy PEG derivative  
 
Selective monocarboxylation of PEG was very challenging, as it was 
very difficult to control the extent of carboxylation due to the availability 
of the reactive hydroxyl terminus at each end of the PEG.  Efficient 
monocarboxylation of PEG was first reported by Harris and Kozlowski 
(1997), in which they first converted the PEG to a mono-nitrile derivative 
by treating with a stoichiometric molar amount of acrylonitrile under 
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alkaline conditions, followed by hydrolysing with excess sulphuric acid 
to its carboxyl analogue. Even though various other methodologies were 
reported, such as use of ethyl bromoacetate (Zalipsky and Barany 1990; 
Kao et al. 2005), ethyl isocyanoacetate (Zalipsky et al. 2001) and 
chloroacetic acid (Brock et al. 2004), the method by Harris and 
Kozlowski is more reliable and reproducible and it was adopted for the 
preparation of α- hydroxy-ω-carboxy PEG derivative.     
 
3.2.1.5 Protection of the monocarboxy PEG terminal  
 
The ω-carboxyl terminal prepared should be protected from other, 
unwanted cross reactions while modifying the α-terminal and ensure its 
availability during protein conjugation. Various available common 
carboxylic protection methodologies include conversion into esters, 
orthoesters, oxazoles, amides or hydrazides (Greene and Wuts 1991).  
However, the protection of carboxylic group through esterification was a 
preferable choice, as both the esterification and its deprotection can be 
performed under moderate conditions without affecting other 
functionalities present at the further end of the PEG derivative.  
 
Esterification using lower aliphatic alcohols such as methanol and 
ethanol was not viable in this case, as their removal by aqueous acidic or 
alkaline hydrolysis could result in a substantial cleavage of the β-alanine 
ester linkage at the other terminal (Figure 3-1) and this emphasized the 
requirement for an anhydrous deprotection method. 
 
Mainly two different protection-deprotection methodologies, allyl and 
benzyl methods, were developed, each characterised by particular 
advantages and disadvantages. The allyl method involves utilizing a 
soluble palladium catalyst for deprotection, with the advantage of 
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extending this to both solution-phase and solid-phase reactions, whereas 
the benzyl method involves deprotection using an insoluble palladium 
catalyst which can be applied only to solution-phase reactions.  
 
3.2.1.6. Allyl protection and deprotection 
 
Allyl protection of carboxyl group is a very efficient and frequently used 
method due to the stability of allyl esters under strongly acidic and basic 
conditions and the availability of very specific deprotection methods 
(Kunz and Waldmann 1984; Schelhaas and Waldmann 1996; Yu et al. 
1998).  
 
The well-established dicyclohexyl carbodiimide (DCC)-dimethylamino 
pyridine (DMAP) mediated esterification (Steglich esterification) method 
was adopted for the esterification of carboxylated PEG with allyl alcohol 
(Neises and Steglich 1978; Balas et al. 1989; Jarowicki and Kocienski 
2001). Due to the very high efficiency and yield of this reaction, the same 
method was followed for all types of esterifications used in the current 
research.  
 
The mechanism of the DCC-DMAP catalysed esterification (Smith et al. 
1958; Smith and March 2000), illustrated in Figure 3-2, involves the 
formation of a pseudo-anhydride like N-acylurea intermediate (Step1) 
between the carboxylic acid and DCC. This intermediate reacts readily 
with the alcohol to form the ester, along with dicyclohexylurea (DHU) as 
a by-product (Step 2).  Presence of a tertiary base like DMAP acts as an 
acyl transfer agent (Step 3), by forming an active amide intermediate 
with the displacement of DHU, which reacts readily with alcohol and 
accelerates the formation of the ester.     
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Step 1 
 
 
 
Step 2 
 
 
Step 3 
 
Figure 3-2: Mechanism of esterification catalysed by DCC and DMAP 
(Smith et al. 1958)  
 
The most commonly used allyl deprotection method involves the 
catalytic transfer of allyl entity to a suitable nucleophilic scavenger by a 
zerovalent co-ordinately saturated palladium complex, preferably tetrakis 
(triphenylphosphine) palladium(0) (Pd(PPh3)4). The mechanism of allyl 
deprotection involves an in situ ligand dissociation from the palladium 
complex (Step 1, Figure 3-3) followed by the formation of a  π-allyl 
palladium complex by cleaving off from the carboxyl group, with an 
increase in the oxidation state of palladium from zero to two. The 
nucleophilic allylic scavengers present in the reaction media react 
directly at the allylic carbon, resulting in the reductive elimination of the 
allyl group and the restoration of the palladium fragment to its initial 
zerovalent oxidation state (Step 2, Figure 3-3) (Guibe 1998). 
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Pd0L4 
-L
+L
Pd0L3 
-L
+L
Pd0L2 
 
Step 1. Ligand dissociation 
 
Step 2. Formation of π-allyl palladium complex and subsequent allyl 
removal 
 
Figure 3-3: Mechanism of allyl deprotection through catalytic palladium 
π-allyl methodology (Y = PEGCOO) (Guibe 1998).  
 
 
A large variety of nucleophilic species, such as oxygen (potassium 2-
ethylhexanoate), nitrogen (N-methyl aniline), carbon (dimedone, N,N-
dimethyl barbituric acid), sulphur (2-thiobenzoic acid) and silanated 
(trimethylsilylazide) nucleophiles were cited as allyl scavengers. A brief 
summary of nucleophiles which were specifically used in this project are 
summarised in Table 3-2.  
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Table 3-2: Various nucleophiles used for the deallylation of ω-allyl PEG 
derivative 
 
Nucleophile Nature Reference 
Phenylsilane Silanated, 
neutral 
(Dessolin et al. 1995; 
Thieriet et al. 1997; Thieriet 
et al. 2000; Tulla-Puche and 
Barany 2004; Brunsveld et 
al. 2006) 
N-methyl morpholine  Nitrogen, basic (Albericio and Kates 1994; 
Lee et al. 1996; Flouzat et al. 
1997; Lohse and Felber 
1998; Napolitano et al. 
2001; Zhang et al. 2007) 
Pyrrolidine Nitrogen, basic (Juteau et al. 1997; Curt A. 
Dvorak 2000; Lienard et al. 
2007) 
 
The reaction requires very strict anhydrous conditions, as the palladium 
catalyst and the π-allyl palladium complex are highly susceptible to 
atmospheric moisture and can lead to the formation of undesired side 
products. 
 
3.2.1.7 Benzyl protection and deprotection 
 
Benzyl protection for the PEG carboxyl derivative was formulated as an 
alternative to allyl protection, which is characterised by the use of a non-
soluble palladium catalyst for deprotection. Benzyl esters and their 
substituents are important protecting functional groups for carboxylic 
acids, due to their ease of esterification and relative stability under acidic 
and basic conditions. The benzyl protecting group can be quantitatively 
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cleaved by catalytic hydrogenolysis using a palladium on charcoal 
catalyst under very mild reaction conditions (Anantharamaiah and 
Sivanandaiah 1977; Greene and Wuts 1991). Characteristic properties of 
the benzyl group, such as state of hybridization, high reactivity of the 
benzyl carbon and the electronic interaction of the neighbouring phenyl 
group result in the formation of a π-benzyl intermediate with palladium, 
which is favoured by the electronegative carboxyl leaving group. 
Hydrogen acts as the primary displacing agent to facilitate the leaving of 
the carboxyl nucleophile from this π-benzyl intermediate, resulting in the 
formation of free carboxylic acids (Khan et al. 1967).  
 
3.2.1.8 β-alanine esterification of the PEG derivative 
 
The choice and requirements of β-alanine ester as the cleavable linker 
were explained previously in Section 3.2.1.3. As mentioned in Section 
3.2.1.6, DCC-DMAP catalysed esterification was a suitable technique to 
link Boc-β-alanine on the hydroxy terminal of the carboxy protected PEG 
derivative. However, a very careful selection of the Boc deprotection 
method was necessary due to the presence of a labile ester linkage within 
the molecule. Various deprotection methods were available, such as 
TFA/H2O/DCM (Park et al. 1996; Ripka et al. 1998), TFA/DCM (Kim et 
al. 1996; Paranjpe et al. 2004), concentrated H2SO4/DCM (Strazzolini et 
al. 2005), 10% H2SO4/Dioxane (Houghten et al. 1986) and 4 M 
HCl/Dioxane (Schneider and Kazmaier 1998; Atiq ur et al. 1999; Kono et 
al. 2000). Selection of a suitable deprotection reagent was achieved based 
on experimental results depending on the relative stability of the alanine 
ester linkage in the PEG derivative.  
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3.2.2 PEG derivative for hydrolysis kinetic studies 
 
The overall objectives of the proposed solid-phase protein PEGylation 
method include the grafting of a functionally modified PEG derivative 
onto a suitable solid matrix, followed by cleaving off the conjugated 
PEG-protein derivative under mild conditions without denaturing the 
protein in a commercially acceptable quantity and quality. Due to the 
very high cost of protein, associated with its high probability of 
contamination and degradation, optimization of these parameters were 
planned using similar conditions but in the absence of protein.  
 
Accurate and reproducible quantification of PEG on the solid matrix 
before and after hydrolysis was a significant challenge throughout the 
process development and there is still a very good scope for improvement 
in establishing a suitable methodology for this. Even though the gain in 
weight of the solid matrix after PEG conjugation provides an 
approximate estimation of the amount of PEG for establishing grafting 
parameters, a method to quantify the amount of PEG cleaved off the 
matrix is necessary to establish an optimised hydrolysis condition.  
 
Quantification of PEG using UV estimation by complexing with 
ammonium ferrothiocyanate (Nag et al. 1996; Li et al. 2003; Gong et al. 
2007), barium chloride-iodine (Childs 1975; Sims and Snape 1980; Gong 
et al. 2007) and Nessler’s reagent (Ingham and Ling 1978; Harris et al. 
1984) were tried. Even though very accurate and reproducible standard 
curves could be generated by PEG standard solutions alone, all of these 
procedures failed to produce a consistent, reproducible result in a 
heterogeneous system with PEG, NHS, protein and hydrolysing buffers, 
which constitute the actual reaction conditions, due to the interference in 
the UV estimation arising from their individual absorptions.   
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Use of a suitable chromatographic method such as SEC to separate the 
PEG from this heterogeneous reaction mixture and its quantification was 
a choice but was constrained by the lack of absorption of pure PEG in the 
UV region (Devineni et al. 2002). The optical activity of benzyl 
chromophores (Nomori et al. 1975) is well known and introduction of 
this chromophores into PEG provides a useful tool for monitoring the 
molecule by UV absorption and thereby its quantification using SEC.  
 
3.2.3 PEG derivative for solution-phase protein conjugation 
 
Solution-phase protein conjugation of the synthetic PEG derivative was a 
requirement for comparing the performance between the two phase 
conjugation methodologies and to help with the interpretation of 
experimental results and hypothesis. A monocarboxy-PEG derivative was 
conjugated to a selective functional group of protein with a specific 
bioconjugate technique and was characterised by using SEC and SDS–
PAGE gel electrophoresis.  
 
NHS ester is the most commonly used amine reactive species used in 
conjugation chemistry. This preferentially reacts with the primary amine 
group (N-based nucleophiles) present in the N-terminus and side chains 
of lysine residues in protein and peptides (Hermanson 1996). Because the 
present research utilizes Cytochrome c as a model protein (Section 2.6.1), 
protein conjugation with NHS activated PEG derivative was selected as 
the main bioconjugation technique and was adopted for both solution-
phase and solid-phase protein conjugations.  
 
The proposed synthetic scheme for solution-phase protein PEGylation 
involves the preparation of NHS ester of the PEG carboxyl derivative 
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under anhydrous conditions (Harris and Kozlowski 1997) followed by its 
conjugation with Cytochrome c in PBS buffer (Fee 2007).  
 
3.3 Materials  
 
PEGs with molecular weights 2000 and 4000 Da (Sigma-Aldrich, St. 
Louis, MO, USA) were used for modifications. Cytochrome c from 
bovine heart (Sigma-Aldrich) was used as the model protein for protein 
conjugation. Other reagents used for preparing heterobifunctional PEGs 
are summarised in Table 3-3. 
 
Table 3-3: List of reagents used for preparing PEG derivatives 
 
Chemical Abbreviation Manufacturer/ 
Supplier 
Acetic acid AcOH Ajax Finechem Ltd, 
Auckland, New Zealand 
Acrylonitrile  Sigma-Aldrich 
Allyl alcohol  Sigma-Aldrich 
Benzyl alcohol  Sigma-Aldrich 
Benzylamine  Sigma-Aldrich 
Boc-β-alanine Boc-β-Ala-
OH 
Sigma-Aldrich 
Celite  Ajax Finechem Ltd 
Conc. Sulphuric acid H2SO4 Ajax Finechem Ltd 
4-(Dimethylamino)pyridine DMAP Sigma-Aldrich 
Hydrochloric acid HCl Ajax Finechem Ltd 
N,N′-
Dicyclohexylcarbodiimide 
DCC Sigma-Aldrich 
N,N-Diisopropylethylamine DIEA Sigma-Aldrich 
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Table 3-3 continued 
N-Methylmorpholine NMM Sigma-Aldrich 
10 % Palladium on charcoal Pd/C Johnson Matthey, 
London, UK 
Potassium hydroxide KOH Merck, Darmstadt, 
Germany 
Tetrakis(triphenylphosphine) 
palladium(0) 
Pd(PPh3)4 Sigma-Aldrich 
 
Various solvents used and their drying conditions are given in Table 3-4. 
 
Table 3-4: Solvents used and their drying conditions 
 
Solvent 
(Abbreviation) 
Manufacturer/ 
Supplier 
Drying and storage 
conditions 
Dichloromethane 
(DCM) 
Merck Refluxed over calcium hydride 
and constant  boiling fractions 
were collected. Stored over 4 
Ǻ molecular sieves under N2. 
Diethyl ether Ajax Finechem Ltd Anhydrous diethyl ether 
directly procured from the 
supplier and used as such. 
Dimethyl 
formamide 
(DMF) 
Sigma-Aldrich Anhydrous DMF procured 
from Sigma-Aldrich and stored 
over 4 Ǻ molecular sieves 
under N2. 
Dimethyl 
sulphoxide 
(DMSO) 
Sigma-Aldrich Anhydrous DMSO procured 
from Sigma-Aldrich and stored 
over 4 Ǻ molecular sieves 
under N2. 
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Table 3-4 continued 
1, 4-Dioxane Sigma-Aldrich Anhydrous 1,4-Dioxane 
procured from Sigma-Aldrich 
and stored over 4 Ǻ molecular 
sieves under N2. 
Ethanol 
(EtOH) 
Ajax Finechem Ltd Used as received 
Methanol 
(MeOH) 
Ajax Finechem Ltd Double distilled from 
magnesium metal. Constant 
boiling fraction were collected 
and stored over 4 Ǻ molecular 
sieves. 
 
10 mM PBS buffer was used for PEG protein conjugation and also for 
SEC analysis. PBS buffer was prepared by dissolving 8 g  NaCl, 0.2 g  
KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4 in 800 mL ultrapure water, 
adjusted the pH to 7.4 with HCl and finally added extra  ultrapure water 
to make up to the 1 L (Zhang et al. 2006).  
 
 
3.4 Analytical methods 
3.4.1 1H NMR 
 
1H NMR spectra were used for the characterization of all PEG 
intermediates and for reaction monitoring in some cases. NMR spectra 
were recorded at 23°C on a Varian Unity INOVA-500 spectrometer 
operating at 500 MHz. Chemical shifts in this thesis are described in parts 
per million (ppm) on the δ scale and CDCl3 was used as the solvent 
(referenced to CHCl3 at δH  approximately 7.26 ppm).  
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3.4.2 Ninhydrin test detection of primary amine on PEG-alanine 
derivative 
 
The ninhydrin test was performed to confirm the primary amine terminal 
(Kaiser et al. 1970) obtained by deprotection of Boc-β-alanine PEG 
derivative. A stock solution was prepared by dissolving 0.2 g of 
Ninhydrin in 50 mL DI water under stirring. About 2 mg of sample (or a 
small drop if for the samples was in solution) was added to 1 mL of the 
above prepared solution and heated to boil for about 30 seconds. A blue 
or blue violet colouration confirmed the presence of α–amino groups.  
 
3.4.3 AKTA Explorer  
 
SEC was used extensively to monitor the PEG-protein conjugation as 
well as the kinetic studies of grafted PEG from the solid matrix. Samples 
were analysed using a Superdex 200 HR 10/30 size exclusion column 
(GE Healthcare Technologies, formerly Amersham Biosciences, Uppsala, 
Sweden) connected to an AKTAexplorer 10XT (GE Healthcare 
Technologies). 10 mM PBS buffer was used as the running buffer for 
PEGylated protein samples and the column was first equilibrated with the 
running buffer before introduction of the sample. Various components 
present in the samples were separated based on their molecular sizes and 
their elution profiles were monitored by following UV absorbances at 
215 and 280 nm.  
For quantification of the hydrolysed PEG during the kinetics studies, 
10% methanol in ultrapure water was used as the running buffer to avoid 
the clogging of column while keeping all other parameters constant.  
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3.4.4 SDS-PAGE gel electrophoresis 
 
The sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
(PAGE) method is a commonly used analytical technique to separate 
proteins according to their molecular weights. This analytical tool was 
used as a supplementary method to characterise the PEGylated protein 
species and to determine their degree of PEG conjugation.  
 
1–10 µL of each samples were mixed with 5 µL of 4X NuPAGE® LDS 
sample buffer and 2 µL of NuPAGE® sample reducing agent and heat 
denatured at 95–100°C for 5 minutes. Samples were run through a 12% 
gradient Bis-Tris NuPAGE® polyacrylamide gel and after the completion 
of the run the gel was stained for 30–60 minutes in staining solution 
(0.125% Coomassie Brilliant blue, 10% acetic acid and 50% methanol), 
then destained overnight with 10% acetic acid and 50% methanol. The 
gels were scanned using Stratagene Cheme Genius 2. 
 
3.5 Synthetic procedures and characterizations 
 
PEGs with two different molecular weights 2000 and 4000 Da were used 
for modifications, following the same synthetic schemes with the same 
molar ratios and reaction parameters. All synthetic strategies were 
adopted based on similar functional transformations or preparation of 
similar PEG derivatives as reviewed in Section 3.2, with some changes in 
the parameters and molar ratios where necessary.  
 
3.5.1 PEG derivative for solid-phase protein conjugation 
 
The heterobifunctional PEG derivative, α-(β-alanine)-ω-carboxy PEG 
derivative (6) was prepared by following two different schemes, namely 
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Scheme-1 (Figure 3-4), following the allyl protection-deprotection, and 
Scheme-2 (Figure 3-5), following the benzyl protection-deprotection 
methods. All experimental procedures were explained based on PEG 
4000 Da for better understanding of reagent quantities and the same 
molar ratios and parameters were followed for PEG 2000 Da 
derivatization.  
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Figure 3-4: Scheme-1 Using allyl protection 
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Figure 3-5: Scheme-2 Using benzyl protection 
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3.5.1.1 Preparation of α-hydroxy-ω-carboxy PEG (4000) derivative 
(1) 
 
PEG (average MW 4000 Da, 20.0 g, 5 mmol) and KOH (0.37 g, 5.75 
mmol, 1.15 molar eq.) were dissolved in DI water (25 mL) and cooled to 
0°C under stirring. Acrylonitrile (0.34 g, 6.25 mmol, 1.25 molar eq.) was 
charged slowly over a period of half an hour and stirring was continued 
for 4 hour. Concentrated sulphuric acid (26.2 g, 262 mmol, 52.4 molar 
eq.) was added and the mixture was maintained at 95–100°C for 5 hour. 
After cooling to room temperature, the reaction mixture was quenched 
into saturated sodium chloride solution (200 mL) and the product was 
extracted using DCM (4 x 100 mL). The pooled DCM extracts were 
dehydrated using anhydrous sodium sulphate and concentrated under 
vacuum to isolate the crude product.  
 
The crude product was then redissolved in DCM (20 mL, 1 vol.) and 
diethyl ether (400 mL, 20 vol.) was charged to precipitate the PEG 
derivative. After stirring for one hour to ensure the complete 
precipitation, the product was filtered and washed with diethyl ether (2 x 
20 mL, 2 x 1 vol.).  Dried the product under vacuum at 25°C (isolated 
quantity 17.8 g) and was confirmed from its NMR spectra.  1H NMR 
(CDCl3): -O-CH2-CH2-COOH (t, δ 2.553 ppm),  -O-CH2-CH2-COOH (t, 
δ 4.186 ppm) and PEG back bone (-CH2CH2-O-)n-) (δ  3.648 ppm). 
 
3.5.1.2 Preparation of α-hydroxy-ω-allyl PEG (4000) derivative (2) 
 
To a clear solution of intermediate 1 (17.0 g, 4.25 mmol) in anhydrous 
DCM (136 mL), allyl alcohol (0.37 g, 6.37 mmol, 1.5 molar eq.) was 
charged under N2 atmosphere and the mixture was cooled to 0°C under 
stirring. A solution of DCC (2.21 g, 10.62 mmol, 2.5 molar eq.) and 
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DMAP (0.13 g, 1.06 mmol, 0.25 molar eq.) was prepared in DCM (34 
mL) and added to the reaction mass over a period of half an hour. 
Cooling was removed after one hour and continued the stirring overnight 
at room temperature. The dicyclohexylurea by-product was removed by 
filtration and the clear filtrate concentrated under vacuum in rotary 
evaporator to get the crude product. The product was crystallized using 
DCM (17 mL)-diethyl ether (340 mL) mixture, as mentioned in the 
previous step and dried under vacuum at 25°C.   
 
Isolated yield 16.4 g. 1H NMR (CDCl3): H2C=CH-CH2- (dd, δ 5.163, 
5.184 and 5.243, 5.277 ppm), H2C=CH-CH2- (m, δ 5.849 ppm), 
H2C=CH-CH2- (d, δ 4.533, 4.545 ppm), -CH2-COO-  (t, δ  2.556 ppm) 
and PEG back bone (δ 3.586 ppm).   
 
3.5.1.3 Preparation of α-(Boc-β-alanine)-ω-allyl PEG (4000) 
derivative (3) 
 
Intermediate 2 obtained from the previous step (16.2 g, 4.05 mmol) and 
Boc-β-alanine (0.97 g, 5.06 mmol, 1.25 molar eq.) were mixed together 
in anhydrous DCM (130 mL) under N2 and stirred to get a clear solution. 
After cooling the reaction mass to 0°C, slowly charged a solution of DCC 
(2.11 g, 10.12 mmol, 2.5 molar eq.) and DMAP (0.12 g, 1.01 mmol, 0.25 
molar eq.) in DCM (32 mL) over a period of half an hour. Cooling was 
removed after one hour and continued the stirring overnight. The DCC-
urea by-product was filtered off and the clear filtrate was concentrated 
under vacuum in a rotary evaporator. Crude product was then crystallized 
using DCM (16 mL)-diethyl ether (320 mL) mixture, as in Section 
3.5.1.2 and was characterised using 1H NMR spectrum.  
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Isolated yield 16.24 g. 1H NMR (CDCl3) (Figure 3-6): (CH3)3C-O-CO- 
(s, δ 1.399 ppm), -NH-CH2-CH2-CO-O- (t,  δ 3.355 ppm), -NH-CH2-
CH2-CO-O- (t,  δ 2.519 ppm), -CO-O-CH2-CH2-O- (t, δ  4.233 ppm), -
CO-O-CH2-CH2-O- (t, δ 3.467 ppm), -O-CH2-CH2-CO-O- (t, δ  2.596 
ppm), -O-CH2-CH=CH2 (d, δ 4.558, 4.570 ppm), -O-CH2-CH=CH2 (m, δ 
5.886 ppm ), -O-CH2-CH=CH2 (dd, δ 5.187, 5.208 and 5.269, 5.302 
ppm) and PEG back bone (δ 3.611 ppm). 
 
 
Figure 3-6: 1H NMR of α-(Boc-β-alanine)-ω-allyl PEG (4000) derivative 
(3) 
 
3.5.1.4 Deallylation and preparation of α-(Boc-β-alanine)-ω-carboxy 
PEG (4000) derivative (4) 
 
Deallylation was performed with Pd(PPh3)4. Experiments were conducted 
using various allyl scavengers such as phenylsilane, N-methylmorpholine 
(NMM) and pyrrolidine and all these methods resulted in specific 
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removal of the allyl protection very efficiently and quantitatively, without 
cleaving the other terminal ester linkage.  
 
In order to confirm the specificity of this deprotection and compatibility 
with the ester group at the α terminal of the bifunctional PEG derivative, 
a kinetic study of the allylic deprotection was performed with Pd(PPh3)4 
and NMM and phenylsilane as allyl scavengers. For this, a PEG 
derivative was prepared with 2-butyl ester group one terminus and allyl 
group at the other end (intermediate 10) following the Scheme-3 (Figure 
3-7).  
O
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Figure 3-7: Scheme-3 Preparation of 2-butyl ester for deallylation 
reaction monitoring 
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α-hydroxy-ω-allyl PEG derivative (intermediate 2, Section 3.5.1.2) was 
converted into its α-succinyl derivative (9) by treating with succinic 
anhydride (5 molar eq.) in presence of DMAP (0.5 molar eq.) in 
anhydrous pyridine (1.5 vol.)  (Krepinsky et al. 1994). The product was 
crystallized using DCM-diethyl ether mixture and characterised as the 
DMAP salt of the succinic acid PEG derivative from its NMR spectrum. 
 
 
1H NMR in CDCl3 : H2C=CH-CH2- (dd, δ 5.163, 5.184 and 5.240, 5.274 
ppm), H2C=CH-CH2- (m, δ 5.847 ppm), H2C=CH-CH2- (d, δ 4.532, 
4.543 ppm), -O-CO-CH2-CH2-O- (t, δ 4.191 ppm), -CO-CH2CH2-CO- 
(succinyl) and O-CH2-CH2-CO- (m, δ 2.570 ppm), PEG backbone (δ 
3.585 ppm), pyridine Hs from DMAP (d, δ 6.627, 6.642 and 8.155, 
8.168) and –N(CH3)2 (s,  δ 3.137 ppm). 
   
Intermediate 9 was esterified with 2-butanol following the same 
esterification method using DCC and DMAP as mentioned in sections 
3.5.1.2 and 3.5.1.3. to get the α-(2-butyl)-ω-allyl PEG derivative (10).  1H 
NMR (CDCl3):  CH3-CHO-CH2-CH3 (d, δ 1.139, 1.152 ppm), CH3-
CHO-CH2-CH3 (m, δ 4.802 ppm), CH3-CHO-CH2-CH3 (m, δ 1.527 
ppm), CH3-CHO-CH2-CH3 (t, δ 0.835 ppm), H2C=CH-CH2- (dd, δ 5.166, 
5.188 and 5.244, 5.278 ppm), H2C=CH-CH2- (m, δ 5.865 ppm), 
H2C=CH-CH2- (d, δ 4.536, 4.548 ppm), -CO-O-CH2-CH2-O- (t, δ 4.180 
ppm), -CO-CH2CH2-CO- (succinyl) (m, δ 2.587 ppm), O-CH2-CH2-CO- 
(t, δ 2.487 ppm) and PEG backbone (δ 3.590 ppm). 
 
3.5.1.4.1 Deallylation using phenylsilane as allyl scavenger 
 
Deallylation with phenylsilane was performed by treating intermediate 10 
with 1.2 equivalents of Pd(PPH3)4 and 24 equivalents of  phenylsilane 
under N2 atmosphere. Samples were withdrawn periodically after 1, 2, 4 
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and 12 hour and were immediately crystallised from DCM / diethyl ether 
mixture. The 1H NMR spectra of these samples shows the completion of 
deallylation within 1 hour (Figure 3-8A) and butyl group remained intact 
with the molecule even after 12 hour (Figure 3-8B) indicating the very 
specificity of the reagents.  
 
A) After 1 Hr B) After 12 Hr 
Figure 3-8: 1H NMR of deallylated PEG derivative using Pd(PPH3)4 and 
phenylsilane 
 
3.5.1.4.2 Deallylation using NMM as allyl scavenger 
 
Intermediate 10 was treated with 1.2 equivalents of Pd(PPH3)4 in a 
mixture of  chloroform-acetic acid-NMM (37:2:1, 13 vol.) under N2. As 
in the case with phenylsilane, samples were withdrawn periodically after 
1, 2, 4 and 12 hour and the crystallised samples were analysed by 1H 
NMR.  The selectivity and specificity of the deallylation was exactly 
similar to the previous method and also the reaction was completed 
within 1 hour. (Figure 3-9A for 1 hour and Figure 3-9B for 12 hour 
sample).  
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A) After 1 Hr B) After 12 Hr 
Figure 3-9: 1H NMR of deallylated PEG derivative using Pd(PPH3)4 and 
chloroform-acetic acid-NMM 
 
1H NMR spectra of the deprotected products using Pd(PPH3)4 and 
chloroform-acetic acid-NMM shows presence of multiplets at δ values 
7.1 to 7.5 ppm indicating the presence of triphenylphosphine impurity 
along with the deprotected PEG derivative. The probable reason for this 
is due to the oxidative coupling of chloroform with Pd(PPH3)4 resulting  
in formation of the complex Pd(PPh3)2CHCl3, with displacement of two 
molecules of triphenylphosphine ligand (Kaliya et al. 1969). This 
complex is insoluble in diethyl ether and crystallized out along with the 
PEG derivative, imparting an yellow colouration to the product.  
 
Based on these observations and product profile, phenylsilane was 
selected as the suitable allyl scavenger for further experimentation. 
Optimization of the process leads to a complete removal of the allyl 
group with 0.25 molar equivalents of Pd(PPH3)4 within 4 hour and  the 
deallylation process was finalized as below.  
 
Very strict moisture control was taken care during allyl deprotection and 
all glasswares were cleaned and dried overnight at 100°C and flushed 
with enough N2 before raw material charging. α-(Boc-β-alanine)-ω-allyl 
PEG derivative (3) (15.0 g, 3.75 mmol) and Pd(PPh3)4 (1.12 g, 0.94 
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mmol, 0.25 eq.) were mixed in dry freshly distilled DCM (120 mL) under 
N2 and stirred to get a clear solution. Prepared a solution of phenylsilane 
(10.0 g, 90 mmol, 24 eq.) in dry DCM (30 mL) and charged into the 
reaction mass within 15 minutes and stirred for 4 hour under N2 
atmosphere.  Quenched the mass slowly under stirring into diethyl ether 
(1 L) and stirred for 1 hour to allow the complete precipitation. Filtered 
the mass under vacuum and washed thoroughly with diethyl ether (4 x 50 
mL). Recrystallized the product second time with DCM (34 mL)-diethyl 
ether (340 mL) mixture.  Isolated yield 13.5 g  
 
3.5.1.5 Boc removal and preparation of α-(β-alanine)-ω-carboxy PEG 
(4000) derivative (6) 
 
Removal of the Boc protecting group at the N terminal of alanine with 
TFA (50 molar eq.) was tried but only partial deprotection was achieved 
with about 55% Boc group left behind with the PEG and further 
reprocessing of the material was necessary to get the complete removal of 
the protecting group. Due to the high cost of TFA along with 
reprocessing of the PEG derivative to achieve complete deprotection 
necessitates the requirement of an easy and cost effective alternate 
methodology.  
 
Use of HCl-Dioxane mixture was promising with the easy preparation of 
HCl gas from commercially available NaCl and conc. H2SO4. HCl gas 
thus prepared was absorbed in a known volume of dioxane and was used 
for Boc deprotection. Use of 4 M HCl/dioxane (30 molar eq.) resulted in 
removing 80% of the Boc protection within 3 hour (Figure 3-10). 1H 
NMR (CDCl3) : -NH3+ (HCl salt) (s, δ 7.930 ppm), -NH-CH2-CH2-CO- 
(t, δ 3.292 ppm), -NH-CH2-CH2-CO- (t, δ 2.581 ppm), -CO-O-CH2-CH2- 
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(t, δ 4.288 ppm), -CO-O-CH2-CH2- (t, δ 3.477 ppm), -O-CH2-CH2-CO-
O- (t, δ 2.924 ppm) and PEG back bone (δ 3.621 ppm).  
 
 
Figure 3-10: 1H NMR of PEG derivative after deprotection using 30 eq. 
HCl (4 M HCl/dioxane)  
 
Complete Boc removal was observed when deprotection was done with 
40 eq. HCl and this molar ratio was adopted for further deprotection 
experiments and the process was finalised as below for the preparation of 
intermediate 5.   
 
α-(Boc-β-alanine)-ω-carboxy PEG derivative (4) (13.2 g, 3.3 mmol) was 
dissolved in DCM (132 mL) and cooled to 0°C. Slowly charged 4 M 
HCl/dioxane mixture (37.8 g, 132 mmol, 40 molar eq.) over a period of 
half an hour and maintained at that temperature for 4 hour. N2 was 
carefully bubbled through the reaction mass to vent out the excess HCl 
gas and then concentrated the product under vacuum. The product was 
recrystallized using DCM (13 mL)-diethyl ether (264 mL) mixture.  
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Isolated yield 12.89 g.1H NMR (CDCl3): -NH3+ (HCl salt) (s, δ 7.853 
ppm), -NH-CH2-CH2-CO- (t, δ 3.266 ppm), -NH-CH2-CH2-CO- (t, δ 
2.548 ppm), -CO-O-CH2-CH2- (t, δ 4.253 ppm), -CO-O-CH2-CH2- (t, δ 
3.452 ppm), -O-CH2-CH2-CO-O- (t, δ 2.892 ppm) and PEG back bone (δ 
3.597 ppm).  
 
HCl salt of the alanine-PEG derivative (5) (12.5 g, 3.12 mmol) was then 
dissolved in dry methanol ( 250 mL) and 10% DIEA in methanol was 
added drop wise till the pH is slightly basic to about pH 8.0. Stirred the 
mass for one hour maintaining the pH with addition of DIEA, if required, 
with continuous monitoring by Ninhydrin test (Section 3.4.2), till the test 
give persistent violet colour. The product was concentrated under 
vacuum to remove the methanol and product was crystallized using DCM 
(12.5 mL)-diethyl ether (250 mL) to get the free base (intermediate 6).  
Isolated yield 11.6 g. 
 
3.5.1.6 Preparation of α-hydroxy-ω-benzyl PEG (4000) derivative (7) 
 
To a clear solution of α-hydroxy-ω-carboxy polyethylene glycol (1) (15.0 
g, 3.75 mmol) in anhydrous DCM (120 mL), benzyl alcohol (0.61 g, 5.63 
mmol, 1.5 molar eq.) was charged under N2 atmosphere and the mixture 
was cooled to 0°C under stirring. A solution of DCC (1.95 g, 9.38 mmol, 
2.5 molar eq.) and DMAP (0.12 g, 0.94 mmol, 0.25 molar eq.) in DCM 
(30 mL) was prepared and charged in to the reaction mass over a period 
of half an hour. Cooling was removed after one hour and continued the 
stirring overnight at room temperature.  
 
Dicyclohexylurea by-product formed during the reaction was removed by 
filtering the mass over Buchner funnel and the clear filtrate was 
concentrated under vacuum in rotary evaporator to get the crude product. 
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The crude product was crystallised using DCM (30 mL)-diethyl ether 
(300 mL) mixture and was characterised from its 1H NMR spectrum. 
Isolated yield 14.22 g. 
 
1H NMR (CDCl3): Benzyl Ar Hs (m, δ 7.260 ppm) and C6H5-CH2- (s, δ 
5.045 ppm), -O-CH2-CH2-CO-O- (t, δ  2.558 ppm) and PEG back bone 
(δ 3.553 ppm). 
 
3.5.1.7 Preparation of α-(Boc-β-alanine)-ω-benzyl PEG (4000) 
derivative (8) 
 
Benzyl protected polyethylene glycol (7) (14 g, 3.5 mmol) was converted 
into its Boc-β-alanine ester derivative (8) by following the same 
procedure described in Section 3.5.1.3.  Isolated product quantity 12.45 
g. 
 
1H NMR (CDCl3) (Figure 3-11): (CH3)3C-O-CO- (s, δ 1.407 ppm), -NH-
CH2-CH2-CO-O- (t,  δ 3.363 ppm), -NH-CH2-CH2-CO-O- (t,  δ 2.624 
ppm), -CO-O-CH2-CH2-O- (t, δ  4.231 ppm), -CO-O-CH2-CH2-O- (t, δ 
3.474 ppm), -O-CH2-CH2-CO-O- (t, δ  2.526 ppm) PEG back bone (δ 
3.618 ppm), Benzyl Ar Hs (m, δ 7.326 ppm) and C6H5-CH2- (s, δ 5.111 
ppm). 
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Figure 3-11: 1H NMR of α-(Boc-β-alanine)-ω-benzyl PEG (4000) 
 
3.5.1.8 Preparation of α-(Boc-β-alanine)-ω-carboxy PEG (4000) 
derivative (4) by debenzylation of (8) 
 
A solution of benzyl protected PEG derivative (8) (12.0 g, 3 mmol) in dry 
methanol (120 mL) was prepared and charged 10% Pd/C (1.2 g, 10% 
w/w). The reaction flask was filled with hydrogen and stirred vigorously 
for 24 hour at room temperature. Spent catalyst was filtered off over 
celite and washed with methanol (2 x 12 mL). The product was 
concentrated under vacuum and crystallized using DCM (12 mL)-diethyl 
ether (240 mL) mixture. Isolated yield 10.4 g. 
 
1H NMR (CDCl3): (CH3)3C-O-CO- (s, δ 1.380 ppm), -NH-CH2-CH2-CO-
O- (t,  δ 3.341 ppm), -NH-CH2-CH2-CO-O- (t,  δ 2.500 ppm), -CO-O-
CH2-CH2-O- (t, δ  4.203 ppm), -CO-O-CH2-CH2-O- (t, δ 3.379 ppm), -O-
CH2-CH2-CO-O- (t, δ  2.540 ppm) and PEG back bone (δ 3.594 ppm). 
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3.5.2 Preparation of α-(β-alanine)-ω-benzyl amide PEG (4000) 
derivative for hydrolysis kinetic studies 
 
α-(β-alanine)-ω-benzyl amide PEG derivative with molecular weight 
4000 Da was used for the hydrolysis kinetic studies and Scheme-4 
(Figure 3-12) illustrates the reaction sequence used for their preparation.    
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Figure 3-12: Scheme-4 Preparation of α-(β-alanine)-ω-benzyl amide 
PEG derivative 
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α-hydroxy-ω-carboxy polyethylene glycol (1) was converted into its 
benzyl amide (11) by reacting with benzyl amine (1.5 molar eq.) in 
presence of DCC (2.5 molar eq.) and DMAP (0.25 molar eq.) in 
anhydrous DCM (10 vol.) under N2 atmosphere. Intermediate 11 was 
then esterified with Boc-β-alanine at the α-hydroxyl terminal (12) (refer 
section 3.5.1.3), the Boc group deprotected with 4 M HCl/dioxane 
(Section 3.5.1.5) and finally neutralized with DIEA in anhydrous 
methanol to produce   α-(β-alanine)-ω-benzyl amide PEG derivative (14).  
 
1H NMR of intermediate 14 (CDCl3): NH2-CH2-CH2-CO- (t, δ 3.084 
ppm), NH2-CH2-CH2-CO- (t, δ 2.933 ppm), -CO-O-CH2-CH2- (t, δ 4.248 
ppm), -CO-O-CH2-CH2- (t, δ 3.477 ppm), -O-CH2-CH2-CO-O- (t, δ 
2.524 ppm), PEG back bone (δ 3.534 ppm), -CO-NH-CH2- (s, δ 2.524 
ppm) and benzyl Ar Hs (m, δ 7.221 to 7.293 ppm). 
 
3.5.3 Solution-phase protein conjugation using PEG-N-
hydroxysuccinimide (PEG-NHS) ester 
 
As mentioned in Section 3.2.3 monocarboxy PEG was first converted 
into its NHS ester and then selectively conjugated through N terminal 
amine group present in the protein. The chemistry is illustrated in 
Scheme-5 (Figure 3-13) and Cytochrome c was used as the model protein 
for protein conjugation.  
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Figure 3-13: Scheme-5 Preparation of PEG-NHS and solution-phase 
protein conjugation 
 
3.5.3.1 Preparation of PEG-NHS derivative (15) 
 
To a clear solution of α-hydroxy-ω-carboxy polyethylene glycol (1) (1.0 
g, 0.25 mmol) in anhydrous DCM (8 mL), charged NHS (0.06 g, 0.525 
mmol, 2.1 molar eq.) under N2 and cooled the mass to 0°C under stirring. 
To this, a solution of DCC (0.11 g, 0.525 mmol, 2.1 molar eq.) in DCM 
(2 mL) was added slowly and stirred the mass for 12 hour at 20°C. 
Precipitated urea by-product was filtered off and the clear filtrate was 
concentrated under vacuum. The crude product was crystallized using 
DCM (1 mL)-diethyl ether (20 mL) and was stored under N2 at 4°C.  
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1H NMR (CDCl3): NHS Hs (s, δ 2.821 ppm), -O-CH2-CH2-CO-O- (t, δ 
2.573 ppm) and PEG back bone (δ 3.618 ppm). 
 
3.5.3.2 Cytochrome c conjugation with PEG-NHS ester 
 
Stock solutions of 20 mg/mL PEG-NHS ester (15) and 20 mg/mL 
Cytochrome c were prepared with 10 mM PBS buffer at pH 7.4. 5 mL of 
these solutions were mixed together in a 25 mL conical flask and stirred 
for 1 hour at 20°C. Reaction was terminated by adding a drop of 0.1 M 
HCl and 500 µL sample was then analysed by SEC following the method 
given in Section 3.4.3.  
 
3.6 Results and discussions 
3.6.1 Heterobifunctional PEG derivatives 
 
Various heterofunctional PEG derivatives relevant to the project were 
synthesised and were characterized from their NMR spectra. The PEG 
precursor for solid-phase PEGylation, α-(β-alanine)-ω-carboxy PEG 
derivative (6), prepared following two different methods (Scheme-1 and 
2, Figure 3-4 and 3-5) resulted in almost similar quality products. Highly 
selective and fast deallylation deprotection strategy using soluble 
Pd(PPH3)4 and relatively slow but selective debenzylation methodology 
using heterogeneous Pd/C were also provided very useful and promising 
synthetic strategies for preparing various PEG derivatives.  
 
An inherent disadvantage of UV estimation arises due to lack of any UV 
absorbing chromophore group available with the PEG chain was 
overcame by derivatizing with a  benzyl amide functional group 
(Scheme-4, Figure 3-12). This method proved very useful in 
quantification of PEG derivatives and was used as a useful tool in 
  
3-39 
quantifying the hydrolysed PEGs obtained from various PEG grafted 
solid matrices (Section 4.6.4) 
 
3.6.2 Solution-phase protein PEGylation 
 
The molecular weight profiles of the PEGylated Cytochrome c and other 
by-products were monitored by following their UV absorbances at 280 
and 215 nm and are plotted in Figure 3-14 (of PEG 4000 Da) and 3-15 
(of PEG 2000 Da).   
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Figure 3-14: PEGylated Cytochrome c with 4000 Da PEG  
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Figure 3-15: PEGylated Cytochrome c with 2000 Da PEG  
 
The low resolution between the peaks of PEGylated products in these 
chromatographs are mainly due to the limitation with the efficiency of 
SEC to separate species with small difference in the molecular sizes. A 
better separation can be achieved, if these species differed in their 
molecular weights by about 100% (Fee and Van Alstine 2006).  
 
The hydrodynamic radii (Rh, PEGprot) of the PEGylated Cytochrome c were 
calculated using Equation 3-1, formulated by Fee and Van Alstine (2004)   
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where Rh, prot is the viscosity radius (Å)  of Cytochrome c, calculated 
using Equation 3-2 and Mr, prot is its molecular weight 12,130 Da 
(Flatmark 1967).  Rh,PEG, the viscosity radius of the PEG used with a 
molecular weight Mr,PEG and was calculated using Equation 3-3 (Fee and 
VanAlstine 2004). 
                  
3
1
,,
)02.082.0( protrproth MR ±≈           (3-2) 
                             
                  
559.0
,,
1912.0 PEGrPEGh MR =  (3-3) 
 
Calculated viscosity radius of Cytochrome c, PEGs and their PEGylated 
products are summarised in Table 3-5. The difference between the 
hydrodynamic radii of various PEGylated Cytochrome c species with 
2000 Da PEG is very small, comparing with that of 4000 Da MW. This 
resulted in almost no separation of the products during their 
chromatographic elution in Figure 3-15.   
 
Table 3-5: Size comparison between Cytochrome c and its various 
PEGylated products 
 
MW of PEG 
used Da 
Species Degree of 
PEGylation N 
Viscosity 
radius in Å 
Cytochrome c  18.83 
PEG  19.73 
mono-PEGylated 1 28.13 
di-PEGylated 2 34.62 
 
 
4000 
tri-PEGylated 3 40.52 
PEG  13.39 
mono-PEGylated 1 24.52 
di-PEGylated 2 28.13 
 
2000 
tri-PEGylated 3 31.48 
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The various column fractions corresponding to PEGylated species were 
analyzed by SDS-PAGE (12% gel, Coomassie-staining) (Section 3.4.4) 
and confirmed the presence of multi-PEGylated products with both 4000 
Da (Figure 3-16) and 2000 Da (Figure 3-17) PEG derivatives.  
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  
 
Figure 3-16: SDS-PAGE analysis of PEGylated Cytochrome c (4000 Da 
PEG). Line 1 & 19: Molecular weight ladder, L2: Crude PEGylated 
Cytochrome c (before SEC), L5 to 9: multi-PEGylated products, L10 
&11: di-PEGylated product, L 13 to 15 mono-PEGylated products and L 
18: Cytochrome c. 
 
 
 
 
 
 
 
10kDa 
15kDa 
25kDa 
37kDa 
75kDa 
100kDa 
150kDa 
200kDa 
50kDa 
  
3-43 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
 
Figure 3-17: SDS-PAGE analysis of PEGylated Cytochrome c (2000 Da 
PEG). Line 1-2 & 15: Molecular weight ladder, L3 to 6: multi-PEGylated 
products, L7 to 9: di-PEGylated product, L 10 & 11: mono-PEGylated 
products and L 13: Cytochrome c. 
 
 
Even though SDS-PAGE proved to be a very efficient and simple 
characterization technique for proteins, the separation was not good for 
PEGylated products. This phenomenon of band broadening and smearing 
of PEGylated products has been observed with many proteins during 
their SDS-PAGE analysis (Zheng et al. 2007). This is probably due to the 
formation of a complex between PEG and SDS, in which the polymeric 
PEG chains assumes a strained conformation in order to bind to the small 
SDS micellar cluster (Bernazzani et al. 2004). The influence of SDS 
concentration on this smearing effect (Odom et al. 1997) provides 
valuable support for this hypothesis, with a decreasing effect with a 
reduction in the SDS concentration.  
 
3.7 Conclusions 
 
Various methods were developed and optimised for the preparation 
heterobifunctional PEG derivatives for surface grafting, protein 
3.5kDa 
10kDa 
15kDa 
30kDa 
40kDa 
60kDa 
160kDa 
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conjugation and hydrolysis studies. A suitable tether for the solid-phase 
protein PEGylation, α-(β-alanine)-ω-carboxy PEG derivative (6) was 
synthesised and characterized. 
 
Solution-phase protein PEGylation was performed using PEG-NHS 
derivative and the various PEGylated products were characterised using 
SEC and SDS gel electrophoresis. Hydrodynamic radii of products with 
various degrees of PEGylation were calculated and their elution profiles 
were explained based on these results.   
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4 Surface grafting, hydrolysis and solid-
phase protein PEGylation 
 
4.1 Introduction 
 
This chapter provides a detailed description of the PEG grafting profile 
onto various modified solid matrices, as well as studies of its hydrolysis 
kinetics. A method for preparing the solid-phase PEGylation matrix is the 
main focus of this chapter and the characterization of the PEGylated 
protein prepared using this novel matrix is also described.  
 
4.2 Strategy development  
 
The choice of β-alanine ester as the cleavable linker was described 
earlier, in Section 3.2.1.3. The amine terminal of this derivative can be 
covalently grafted onto a matrix surface through a relatively stable amide 
linkage, if it is provided with carboxyl functional groups on the surface 
matrix. Due to the relatively stable nature of amide linkages in both 
acidic and alkaline conditions compared to ester linkages, these bonds 
will remain intact during hydrolytic cleaving of the alanine ester bond 
and thus will not interfere with the cleaved product. Keeping this in 
mind, carboxy modified matrices were selected as the base matrix for 
developing solid-phase protein PEGylation system.  
 
4.2.1 Carboxylated solid matrices for PEG grafting  
 
As mentioned in Section 2.6.2,  two different types of matrices were used 
to study their influence on the properties of the solid-phase system, 
namely hydrophilic Sephadex derivatives such as carboxymethyl 
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Sephadex (CM Sephadex) and carboxypentyl Sephadex (CP Sephadex) 
and hydrophobic polystyrene derivative. Carboxylated polystyrene 
((Succinylaminoethyl) polystyrene, Polystyrene AM COOH) was 
procured directly from Sigma-Aldrich whereas the Sephadex G 25 coarse 
(obtained from GE healthcare Ltd., Uppsala, Sweden) was carboxylated 
with a suitable linker for further modifications.  
 
Carboxylated Sephadex derivatives prepared for grafting studies were 
characterized by the difference in their carboxyl tether lengths. In one 
modification, CM Sephadex was prepared with a single carbon carboxy 
tether, whereas in another modification CP Sephadex was prepared with a 
five-carbon tether. These differences in the carbon chain length were 
used as a measure to study the influence of tether length on the PEG 
grafting as well as to study the steric repulsive interactions due to 
crowding at the reaction site during grafting.  
 
4.2.1.1 CM Sephadex 
 
Carboxymethylation of Sephadex using monochloroacetic acid has been 
extensively reported (Flodin 1962; Fujita et al. 1981; Mauzac et al. 1982; 
Carreno et al. 1988) due to applications in gel filtration and ion exchange 
chromatography. All this literature followed methodologies similar to 
that initially reported by Flodin (1962) using benzene as the reaction 
media. The very high carcinogenicity associated with benzene and the 
heterogeneous reaction mixture which occurs when it is mixed with 
aqueous alkaline media necessitates the requirement of a safer and a 
water soluble protic solvent for Sephadex modifications.   
 
The carboxymethylation of Sephadex structural analogues such as 
dextran (Hattori et al. 1994; Nogusa et al. 1994; Tsujihara et al. 1997; 
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Huynh et al. 1998), chitin (Wan et al. 1996; Hjerde et al. 1997; Sakairi et 
al. 1998) and chitosan (Liu et al. 2001; Chen and Park 2003; Liang and 
Zhang 2007) was extensively studied and the influence of solvent 
composition on the reaction as well as product profile was also well 
documented (Chen and Park 2003). A method for the modification of 
Sephadex which incorporated the optimised reaction parameters reported 
for the carboxymethylation of chitosan by Chen and Park resulted in a 
better carboxyl content and product profile than those following Flodin’s 
method and was thus adopted throughout the project.  
 
4.2.1.2 CP Sephadex 
 
In search of a relatively longer tether to study its influence on the PEG 
grafting profile, a carboxypentyl derivative having a five carbon spacer 
was chosen for modification. Experiments were performed by following 
the same optimized process for the preparation of CM Sephadex using 6-
bromohexanoic acid in place of monochloro acetic acid. 
  
4.2.2 PEG grafting  
 
PEGs can be grafted onto various surfaces using a variety of methods 
which were reviewed in Section 2.7. In view of the requirement for a 
cleavable linkage between grafted PEG and the solid matrix, covalent 
grafting of PEG onto the matrix was chosen. Covalent grafting of PEG 
onto solid surfaces can be performed under either aqueous conditions or 
non-aqueous conditions.  
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4.2.2.1 Aqueous PEG grafting  
 
Covalent coupling of PEG derivatives such as amines, aldehydes and 
carboxylic acids can be successfully performed with various 
functionalized solid matrices under aqueous conditions and this is one of 
the most frequently used grafting methods for preparing PEG modified 
surfaces. Commonly reported aqueous-phase coupling methods for PEG 
amines include grafting through amide bonding onto carboxylated 
surfaces such as polystyrene (Zalipsky et al. 1994; Van Delden et al. 
1996; Meng et al. 2004a; Meng et al. 2004b), silicon wafers (Andruzzi et 
al. 2007), nanoparticles (Popielarski et al. 2005; Cheng et al. 2007; Pan 
and Feng 2008) and gold (Feng et al. 2005), and sodium 
cyanoborohydride mediated coupling with aldehyde functionalized 
surfaces like glass (Schlapak et al. 2006). In a similar way, carboxy 
functionalized PEGs can be attached to amine functionalized surfaces 
following the carbodiimide chemistry (Wazawa et al. 2006; Hong et al. 
2007; Thierry et al. 2008; Barrera et al. 2009), as well as a PEG aldehyde 
derivative onto an amine modified surface catalysed by sodium 
cyanoborohydride (Saneinejad and Shoichet 1998; Kingshott et al. 2002; 
Kingshott et al. 2002; Cole et al. 2007).  
 
Covalent coupling of PEG amine with a carboxyl group can be performed 
in two different ways. In one method the carboxyl terminal of the surface 
can be preactivated using a suitable functional group, followed by 
reacting with the amine functionalized PEG, whereas in the second 
method, which is a single-pot method, the activation and coupling will be 
carried out simultaneously in a single solution. These two methods are 
general methods for amine coupling and are applicable irrespective of 
whether the reactions are being carried out in aqueous or non-aqueous 
conditions. In aqueous-phase reactions, normally the two step coupling 
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process involves the carboxyl activation being catalysed by a water 
soluble carbodiimide, usually 1-ethyl-3-(3-dimethylamino) propyl 
carbodiimide (EDC), followed by coupling with the amino PEG (Van 
Delden et al. 1996; Meng et al. 2004a; Meng et al. 2004b; Andruzzi et al. 
2007). In the case of the single-pot coupling method, the amine 
derivative, EDC and the activating agent are mixed together with the 
carboxylated surface in a suitable buffer to achieve the coupling 
(Popielarski et al. 2005). The most specific and commonly used 
activating agents for amine coupling are N-hydroxysuccinimide (NHS), 
N-hydroxysulfosuccinimide (sulfo-NHS) and N-hydroxybenzotriazole 
(HOBt) (Hermanson 1996).   
 
Van Delden et al (1996) reported almost double the surface concentration 
of PEG on carboxylated polystyrene beads when it was grafted through 
the single-pot coupling method compared with following the two step 
pre-activation method using a 1000 Da PEG amine (Figure 4-1). 
However, the application of this single-pot method for grafting the 
heterobifunctional PEG derivative, in this present context with an amine 
terminal at one end and a carboxyl terminal at the other end, can create 
complexity and non-specificity if both catalyst and activating agents are 
present along with this PEG derivative.  Hence pre-activation of surface 
carboxyl groups, followed by reaction with PEG amine was selected for 
aqueous-phase PEG grafting.  
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Figure 4-1: PEG surface concentration as measured as concentration of 
amino groups obtained from diamino-PEG derivative (1000 Da)(Van 
Delden et al. 1996).  
 
A detailed study of PEG amine grafting onto carboxylated polystyrene 
matrices was conducted by Meng et al. (2004a; 2004b) and Van Delden 
et al (1996). They suggested that grafting kinetics were greatly influenced 
by a number of parameters such as the pH of the reaction medium, 
coupling time and the relative molar equivalents of the carbodiimide 
catalyst and surface COOH concentrations.  The influence of pH on 
carboxyl activation and PEG coupling is illustrated in Figure 4-2, in 
which zeta (ζ) potential correlates to the surface PEG concentration, 
while an increase in concentration leads to a less negative ζ-potential. 
The results suggest that a slightly acidic pH between 5.5 and 6 favours 
the carboxyl activation (pKa of surface COOH groups) whereas a slight 
alkaline pH between 8.5 and 9.5 (close to the pKa of PEG amine) favour 
the PEG coupling. 
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Figure 4-2: Influence of pH on activation and PEG amine coupling 
(Meng et al. 2004a) 
 
 
Figure 4-3: Influence of coupling time on PEG concentration (Meng et 
al. 2004a) 
 
Figure 4-3 illustrates the influence of coupling time on PEG grafting, and 
shows an initial lower concentration which increases with reaction time. 
After a period of time, stagnancy in reaction was observed with no 
further increase in PEG surface concentration even after prolonged 
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immobilization. This indicates a saturation condition due to increased 
steric repulsions between grafted and approaching PEG molecules, 
thereby preventing further conjugations.  PEG surface concentrations also 
depend on the molar equivalent of the catalyst used and were found to 
increase with increasing catalyst concentrations. The optimization of 
molar equivalents by Meng et al suggests that the molar ratio of 
carbodiimide-COOH should be around 5 to 6 to get an optimal maximum 
PEG coupling on the surface.  
 
In addition to the above mentioned parameters which were specific to 
amine coupling, the following important factors may also influence the 
grafting profiles which are related to the inherent properties of PEG 
chains. PEG graftings are greatly influenced by the interchain repulsive 
interactions between grafting and grafted PEG molecules. Studies 
showed that the presence of higher salt concentrations and elevated 
temperatures enhances higher grating densities due to reduced interchain 
repulsive forces resulting from the disruption of hydrated shells 
surrounding the PEG chains (Emoto et al. 1996; Kingshott et al. 2002; 
Kingshott et al. 2002). Another important factor which influences the 
PEG grafting profile, irrespective of the reaction media, is its molecular 
weight, and grafting will become increasingly difficult as the molecular 
weight increases. As shown in the data presented by Lu and Felix (1994) 
(Figure 4-4),  an almost quantitative coupling yield was achieved within 
5 hour with a low molecular weight PEG (750 Da), while only about 50% 
yield was achieved with a high molecular weight PEGs (5000 and 10000 
Da) even after continuing the reaction for 72 hours.    
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Figure 4-4: Influence of PEG molecular weight on coupling (Lu and 
Felix 1994) 
 
Summarizing the optimized parameters for aqueous-phase PEG grafting, 
a prolonged coupling time and alkaline conditions are required to get a 
reasonable grafting profile. But the labile nature of the β-alanine ester 
linkage associated with the PEG derivative will result in a parallel 
hydrolysis of PEG, both grafted as well as reacting, and cause a net loss 
of surface PEG concentration. Hence the use of aqueous PEG coupling 
may not be a viable grafting methodology due to the specific nature of 
PEG in use.   
 
4.2.2.2 Non-aqueous PEG grafting  
 
Compared to aqueous-phase grafting, non-aqueous covalent grafting of 
PEG onto various matrices has not often been cited but it can also be 
performed either in a single-pot method or by following the preactivation 
methodology as in the previous case. In the single-pot methodology PEG 
amine was treated with the carboxy functionalized surface in the presence 
of a carbodiimide (Ploehn and Goodwin 1990; Chattopadhyay et al. 
2006), whereas in the latter method carboxyl groups were preactivated 
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with a suitable activating agent in the presence of a catalyst followed by 
reacting with the PEG amine derivative in the presence of a base (Riener 
et al. 2003; Halpin and Harbury 2004).  
 
Due to the specificity and selectivity of the preactivated method for 
amine coupling in the presence of other functional groups, this 
methodology was preferred over the single-pot one and followed for 
grafting β-alanine PEG derivatives in this project. This non-aqueous 
preactivation method was used as a useful conjugation methodology for 
PEG amine derivatives in solution-phase coupling reactions and was 
followed for the preparation of many drug delivery applications (Cho et 
al. 2005; Kim et al. 2005; Paranjpe et al. 2005).  
 
4.2.3 Hydrolysis of the grafted PEG 
 
The hydrolysis profile of a β-alanine ester linkage under homogenous 
solution conditions was described in Section 3.2.1.3. Even though we can 
anticipate a reasonable difference in hydrolysis nature for a 
heterogeneous surface bound alanine ester, a quite similar hydrolysis 
yield of about 85% was reported for the hydrolysis of an alanine ester 
linkage attached to a Sepharose derivative using 0.3 M NaOH solution 
after 15 minutes (Wilchek and Miron 1987). The compilation of these 
results regarding the labile nature of β-alanine ester linkages provided a 
very promising synthetic strategy and become the major backbone of the 
proposed solid-phase PEGylation approach.   
 
In the absence of any UV absorbance by the PEG molecule alone, a UV 
active chromophore modified PEG derivative was a better choice for the 
quantitative estimation of the hydrolysed PEG from the matrix (Section 
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3.2.2).  Based on these, an α-(β-alanine)-ω-benzyl amide PEG derivative 
(14) was prepared (Section 3.5.2) for hydrolysis kinetic studies.  
 
4.2.4 Solid-phase protein PEGylation  
 
As illustrated Figure 2-19, the solid-phase PEGylation system consists of 
a covalently grafted PEG derivative onto a functionalized solid matrix 
through a cleavable linker, with the free end terminal available for protein 
conjugation.  Activation of the carboxyl PEG terminal with NHS ester 
was preferred for further protein conjugation, as followed in the case of 
solution-phase PEGylation (Section 3.2.3). Protein conjugated PEG 
derivatives were then cleaved off from the matrix under mild conditions 
and were characterized using SEC. 
 
4.3 Materials 
4.3.1 Reagents and solvents 
 
All PEG derivatives were prepared following relevant methodologies 
described in Chapter 3. In addition to those chemicals and solvents 
mentioned in Section 3.3 (Table 3-3 and 3-4); ethanolamine, glycine, 
hydroxylamine hydrochloride, monochloroacetic acid (MCA), 1-ethyl-3-
(3-dimethylamino)propyl carbodiimide hydrochloride (EDC.HCl) (all 
were purchased from Sigma-Aldrich), isopropanol (IPA), sodium 
hydroxide (NaOH) (from Merck, Darmstadt, Germany), 6-
bromohexanoic acid (from Fluka, Buchs, Switzerland) and sodium 
chloride (NaCl) (from Ajax Finechem Ltd.) were used in surface 
modifications and PEG graftings. Sephadex G 25 coarse was purchased 
from GE healthcare Ltd., and polystyrene AMCOOH was from Sigma-
Aldrich.  
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4.3.2 Buffers 
 
10mM PBS was prepared by following the method given in Section 3.3. 
Other buffers were prepared by using methods given below.  
  
4.3.2.1 Glycine-NaOH 
 
Stock solutions of 0.2 M glycine and 0.2 M NaOH were prepared in 
Millipore water. The pH of the glycine solution was adjusted to pH 8.5 
with dropwise addition of NaOH stock solution under stirring. It was then 
stored at 4°C.  
 
4.3.2.2 Hydroxylamine-NaOH 
 
Stock solutions of 0.2 M hydroxylamine hydrochloride and 0.2 M NaOH 
were prepared and pH of the hydroxylamine solution was adjusted with 
NaOH solution to 8.5 and immediately used without any further storage. 
 
4.4 Analytical methods 
4.4.1 FTIR 
 
IR spectra using KBr disk were recorded on a Perkin-Elmer System 2000 
FTIR spectrophotometer (PerkinElmer, Massachusetts, USA). Typically 
64 scans per spectrum were recorded at 4 cm-1 resolution.  
 
4.4.2 AKTA Explorer 
 
A detailed description of AKTA explorer is given in Section 3.4.3. For 
analysis of α-hydroxy-ω-benzyl PEG derivative (11) and monitoring of 
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the hydrolysis kinetic studies 10% methanol (in DI water) was chosen as 
the elution medium instead of PBS buffer.  
 
4.4.3 UV spectrophotometer 
 
UV absorbances were measured by using an Ultraspec 2100 pro 
UV/Visible spectrometer (GE Healthcare Ltd., Uppsala, Sweden). 
Measurements were carried out at 280 nm for Cytochrome c solutions 
and a calibration curve was plotted with known concentrations against 
their absorptions. The concentration of unknown solutions was calculated 
by comparing their absorption with the calibration curve using the same 
buffer solution.   
 
4.4.4 Optical microscope 
 
Diameters of Sephadex and polystyrene matrices before and after PEG 
grafting under both dry and wet conditions were measured with an 
Olympus BX60 optical microscope (Olympus Optical Co., Ltd, Tokyo, 
Japan) using an UMPlanFI 10x / 0.30 BD lens. Diameters of a number of 
particles were measured in pixels which were further calibrated with a 
graduated optical scale under the same focal plane and length and 
converted into micrometres.    
 
4.4.5 Acidimetric estimation of the carboxyl content of Sephadex 
derivatives 
 
0.25 g Carboxylated Sephadex was stirred with 0.05 M sodium 
bicarbonate solution (25 mL) for 48 hour at room temperature. The mass 
was filtered and the clear filtrate was titrated against 0.05 M HCl solution 
using methyl red indicator to estimate the amount of sodium bicarbonate 
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consumed by the resin. A blank experiment was performed with 
unmodified Sephadex by exactly following the same conditions. From 
this the acid content (moles per g) of the modified matrix was calculated.     
 
4.5 Experimental methods 
 
The overall experimental methods for preparing the solid-phase 
PEGylation system can be broadly classified into the preparation of a 
carboxyl modified matrix (except polystyrene), its NHS activation, 
selective covalent coupling between the NHS activated carboxylated 
surface and the NH2 terminal of alanine modified PEG, blocking of the 
unreacted NHS activated carboxyl groups with ethanolamine, NHS 
activation of the carboxy terminal of grafted PEGs, its conjugation with 
N-terminal lysine group present in the model protein Cytochrome c and 
finally cleaving of the PEGylated Cytochrome c from the matrix under 
mild conditions.  
 
4.5.1 Sephadex modifications  
 
Sephadex G 25 coarse was dried at 100°C overnight before modifications 
and stored in a desiccator. 10 g dried Sephadex was treated with a 
solution of NaOH (9 g) in 80% aqueous IPA (180 mL, 18 vol.) at 55°C 
for 2 hour. A solution of monochloroacetic acid (11.2 g) in 80% aqueous 
IPA (20 mL, 2 vol. of Sephadex) was prepared and added into the 
reaction mass drop wise under stirring  over a period of 30 minutes, and 
maintained at the same temperature for further 4 hour. After cooling to 
room temperature the reaction mass was quenched into 70% aqueous 
ethanol and stirred for 30 minutes. Solids were filtered over a Buchner 
funnel and washed subsequently with 70% aqueous ethanol (2 x 100 
mL), DI water (2 x 100 mL) and finally with ethanol (2 x 100 mL).  
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The above prepared sodium salt of carboxymethyl Sephadex was 
resuspended in 80% aqueous ethanol and neutralised slowly with the 
addition of acetic acid. The mass was stirred for a further one hour with 
occasional addition of acetic acid to maintain the pH if necessary.  The 
product was filtered and washed thoroughly with 80% aqueous ethanol (2 
x 100 mL), DI water (2 x 100 mL) and finally with ethanol (2 x 100 mL). 
The CM Sephadex derivatives were then freeze dried till a constant 
weight was achieved, and stored at 4°C.  
 
OH Cl
O
x
 
OH
O
O
x
 
OH
Sp +
NaOH
Acetic acid
Sp
x = 1 for CM Sephadex
      5 for CP Sephadex
(17)
 
 
Figure 4-5: Scheme-6 Preparations of Sephadex carboxyl derivatives 
 
The same synthetic scheme (Figure 4-5) was followed for the preparation 
of CP Sephadex derivative using 6-bromohexanoic acid (23.1 g, 0.12 
moles, equivalent to 11.2 g MCA) in place of monochloroacetic acid.     
 
4.5.2 PEG grafting  
 
The PEG grafting of carboxylated solid matrices was performed by first 
converting the carboxyl terminals into their NHS esters followed by 
reacting with the amine terminal of alanine-PEG derivatives. Figure 4-6 
illustrates the detailed synthetic scheme for PEG grafting onto the various 
matrices under investigation.  
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Figure 4-6: Scheme-7 Synthetic Scheme for PEG grafting  
 
In the optimised and general method, carboxylated matrices were first 
converted into their corresponding NHS esters by treating them with 10 
molar equivalents of NHS (based on the carboxyl content of matrix) in 
the presence of EDC.HCl (10 eq.) in anhydrous DMF (20 vol. of solid 
matrix) under an N2 atmosphere. After stirring the reaction mixture for 4 
hour at 20°C, the matrix was separated, washed thoroughly with 
anhydrous DMF (2 x 5 vol.) and used immediately for the subsequent 
step.   
 
The optimised PEG grafting procedure involves reacting NHS activated 
matrix with 5 molar equivalent amount β-alanine PEG derivative (based 
on the carboxyl content of original matrix) in the presence of DIEA (10 
eq.) in anhydrous DMF (1.5 vol. of PEG amount) under an N2 
atmosphere at  40°C for 72 hour. After the reaction, unreacted PEG 
derivatives were removed by washing thoroughly with anhydrous DMF 
(2 x 20 vol.).  
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4.5.3 Hydrolysis of grafted PEG 
 
Hydrolysis kinetics was monitored by grafting α-(β-alanine)-ω-benzyl 
amide PEG derivative (14) onto the NHS activated CH Sephadex 
following the non-aqueous grafting method. Hydrolysis was performed 
using 0.2 M glycine–NaOH (pH 8.5), 0.2 M hydroxylamine–NaOH (pH 
8.5), 0.2 M acetate (pH 4.5) buffers and 0.2% TFA (pH 2.35) under 
various conditions.  
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Figure 4-7: Scheme-8 PEG grafting and hydrolysis 
 
Hydrolysed fractions were separated by centrifuging the matrix at 4°C. 
The matrix was then thoroughly washed with 2 M NaCl solution (2 x 20 
vol.) followed by DI water (2 x 20 vol.) and all the combined fractions 
were concentrated by freeze drying under high vacuum. The concentrated 
residual mass was re-dissolved in 1 mL 10% methanol and analysed by 
SEC following the method given in Section 3.4.3.  
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4.5.4 Solid-phase protein PEGylation 
 
After incorporating the optimised grafting and hydrolysis conditions, 
Scheme-7 (Figure 4-6) was further extended to afford solid-phase protein 
PEGylation as illustrated in Scheme-9 (Figure 4-8). NHS ester 
preparation of carboxylated matrices and subsequent β-alanine PEG 
coupling were performed following the method given in Section 4.5.2 
and the corresponding PEG grafted solid matrices (19) were prepared. 
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Figure 4-8: Scheme-9 Solid-phase protein PEGylation 
 
4.5.4.1 Ethanolamine blocking 
 
Blocking of unreacted NHS activated carboxyl groups present with the 
PEG grafted intermediate 19 was performed by treating with excess 
ethanolamine (15 eq. based on carboxyl content of the original matrix) in 
the presence of DIEA (30 eq.) in anhydrous DMF (20 vol. of solid 
matrix) under an N2 atmosphere at 40°C for a further 12 hour. After the 
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reaction, the matrix was washed with DMF (2 x 20 vol.) and was further 
washed thoroughly by sonicating with DI water (2 x 20 vol.), 2 M NaCl 
solution (2 x 20 vol.) and finally again with DI water (2 x 20 vol.). The 
PEG grafted product was then freeze dried until a constant weight was 
achieved and stored under N2 atmosphere at 4°C.  
 
4.5.4.2 NHS activation of PEG carboxyl terminal 
 
Carboxy functionalized PEG grafted solid matrices (22) were treated with 
5 molar equivalent of NHS (based on the carboxyl content of the original 
base matrix) in the presence of EDC.HCl (5 eq.) in anhydrous DMF (20 
vol. of solid matrix) under an N2 atmosphere overnight. After this, the 
matrix was washed with DMF (2 x 5 vol.) and PBS buffer (2 x 5 vol.) at 
4°C and used immediately for protein conjugation.  
 
4.5.4.3 Cytochrome c conjugation 
 
NHS activated PEG grafted matrices (23) were immediately reacted with 
a solution containing 5 mg/mL Cytochrome c in PBS buffer (1 mL for 
every 50 mg PEG grafted matrix) at pH 7.4 for 2 hour at 20°C. Clear 
filtrate was separated after the reaction by centrifuging the material at 
4°C (used for estimating unreacted Cytochrome c using UV) and the 
matrix was washed with PBS buffer (2 x 20 vol.), 2 M NaCl (2 x 20 vol.) 
and finally with PBS buffer (2 x 20 vol.).  
 
4.5.4.4 Hydrolysis and release of PEGylated Cytochrome c  
 
Cytochrome c conjugated PEG grafted matrices (24) were treated with 
0.2 M glycine-NaOH buffer (pH 8.5) at 20°C for 24 hour. The 
hydrolysed PEGylated (26) fractions were separated by centrifuging the 
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matrix at 4°C. The matrix was washed with 2 M NaCl solution (2 x 20 
vol.) and with DI water (2 x 20 vol.) and all the combined fractions were 
freeze dried and the concentrated residual mass redissolved in 1 mL PBS 
buffer and analysed by SEC following the method given in Section 3.4.3.  
 
4.6 Results and discussion  
4.6.1 Carboxylated solid matrices 
 
Carboxy derivatives of Sephadex were prepared by modifying its 
hydroxyl groups with carboxylic tethers having varying chain lengths. 
Initial experiments were done by following the procedure of Flodin 
(1962) using benzene as the solvent. Even though carboxymethyl 
derivatives with a comparable ion exchange capacity to that of the 
reported literature (Flodin 1962; Armarego and Chai 2003) were 
prepared, better results and product profile were obtained after using 80% 
IPA solution instead of benzene. The carboxymethyl content was 
estimated by using the acidimetric titration (Section 4.4.5) and the 
summary of results is given in Table 4-1. 
 
Table 4-1: Carboxymethylation of Sephadex using different solvents 
 
Ion exchange capacity (millieq./g) Solvent 
In house analysis Reported 
Benzene 2.95 ± 0.19 3.0 * 
  4.5 ± 0.5 # 
80% IPA 6.30 ± 0.36  
*Using benzene (Flodin 1962) and # Solvent unknown (Armarego and 
Chai 2003)  
 
During carboxymethylation using benzene according to Flodin’s method, 
a heterogeneous reaction mixture and the formation of lumps were 
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observed, owing to the immiscible nature of the solvents and the 
subsequent uneven distribution of the reagents. However, with aqueous 
IPA solution, the Sephadex beads were swelled enough to allow a 
uniform contact with the reagents and were distributed homogeneously 
throughout the reaction mass, resulting in an increased carboxyl content 
of the product obtained.    
 
CP Sephadex prepared from 6-bromohexanoic acid using 80% IPA 
solution resulted in a carboxyl content of 0.98 ± 0.07 millieq./g. The acid 
content of PS AM COOH procured from Sigma-Aldrich was also 
estimated following the same method and was found to be 0.91 ± 0.11 
milliequivalents/g (reported as per COA: 0.8 – 1.2 millieq./g). 
 
4.6.2 NHS ester preparation 
 
Optimization of the reaction parameters was performed with CM 
Sephadex and the optimised process was later extended to other matrices. 
As convincing evidence to quantify NHS formation, NHS activated 
resins were treated with a known quantity of Cytochrome c in PBS buffer 
(Section 4.5.4.3) and the amount of Cytochrome c conjugated onto the 
activated resin was estimated by comparing the UV absorptions of 
Cytochrome c solution before and after conjugation against a standard 
curve of known concentrations (Section 4.4.3).  
 
4.6.2.1 EDC-NHS molar ratio 
 
Initial experiments were performed with approximately equimolar 
amount of reagents, but later experiments were optimised with 10 molar 
equivalents of EDC and NHS to get maximum NHS activation of the 
available carboxyl groups (Figure 4-9). Reaction saturation was observed 
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with 10 equivalents and more, hence further experiments were performed 
with 10 molar equivalents of EDC and NHS.  
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Figure 4-9: Influence of EDC-NHS molar ratio on NHS preparation 
 
4.6.2.2 NHS ester preparation of other matrices 
 
As with the CM Sephadex derivative, NHS esters of CP Sephadex and 
polystyrene were also conjugated with Cytochrome c and the results are 
tabulated in Table 4-2.  Even after prolonged conjugation and the use of 
varying amount of salts, no protein conjugation was observed onto the 
polystyrene matrix due to its hydrophobic nature, which may retard the 
approaching protein for the conjugation (Wang et al. 1995). 
 
Table 4-2: Cytochrome c conjugated to CP Sephadex and polystyrene 
matrices (10 eq. EDC/NHS) 
 
Resin Amount of Cytochrome c 
conjugated onto the resin mg/g 
CP Sephadex 14.46 ± 0.64 
Polystyrene COOH Nil 
                                                                                          
 
4-24 
4.6.3 PEG grafting 
 
Grafting of the alanine PEG derivative onto carboxylated matrices was 
studied in detail to obtain the maximum grafting density and the preferred 
PEG brush conformation in view of the proposed solid-phase protein 
PEGylation. Literature cited the requirement of a very high molar excess 
of PEG derivatives ranging from 2 to 150 equivalents (Zalipsky et al. 
1994; De Cuyper et al. 2002; Meng et al. 2004a; Meng et al. 2004b; 
Popielarski et al. 2005; Pan and Feng 2008) to obtain a satisfactory 
grafting density on the surface, depending on the nature of the matrix. To 
have uniformity in the process and also due to the operational constraints, 
five molar equivalents of PEG-alanine derivative was used for surface 
grafting with all matrices.   
 
FTIR spectra were recorded initially to confirm the presence of PEG on 
the solid matrix. IR spectra of polystyrene and PEG grafted polystyrene 
(PEG 4000 Da, 72 hr, 25°C) for example are given in Figure 4-10. The 
characteristic broad peak around 2900 cm-1of PEG back bone arising 
from the strong absorption of –CH2-CH2- stretching, and also the broad 
peak occurring at 1000 to 1100 cm-1 due to the characteristic -C-O-C- 
stretching of PEG moiety, confirms the presence of PEG molecules on 
the surface (Alcantar et al. 2000; Xu et al. 2003; Feng et al. 2005; Mert et 
al. 2008).   
  
4-25 
 
Figure 4-10: IR spectra of polystyrene and PEG grafted polystyrene 
(  PS and   PSPEG)  
 
Due to the lack of quantification capability with the available FTIR 
instrument and also due to the detailed surface characterization using the 
highly sensitive XPS technique (Chapter 5), no efforts to estimate the 
amount of grafted PEG using FTIR were made. A relative quantification 
method was adopted in which the gain in weight of the matrix after 
modification was directly correlated to the amount of PEG grafted onto 
the surface. In order to have maximum accuracy and minimum variations 
between the samples, experiments were repeated at least three times and 
the resins were extensively washed to remove any adhered PEG 
molecules on the surface. Blank experiments were performed with the 
corresponding NHS esters and were worked up following the same 
procedure.  Samples were freeze dried till a constant weight was achieved 
and the average of all these results was taken as the quantitative measure 
of the amount of PEG grafted. But later these results were validated using 
XPS and a close linearity was found between both the results.  
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4.6.3.1 Influence of base and solvent  
 
Among the various available polar aprotic solvents, those with higher 
dielectric constants such as acetonitrile (36.6), dimethyl formamide 
(38.3) and dimethyl sulfoxide (47.2) were initially chosen for PEG 
grafting.  DIEA, TEA and pyridine were selected as base to catalyse the 
PEG conjugation and graftings were performed at 25°C for 72 hours 
under an N2 atmosphere. Even though the overall difference is relatively 
very small (Figure 4-11), combination of DMSO with DIEA resulted in 
maximum PEG grafting followed by DMF-DIEA. But the recovery of 
PEG derivative was difficult from its DMSO solution, as the recovered 
product became amorphous and of a waxy nature, which requires 
repeated crystallization for further use. But from the DMF-DIEA system, 
PEG derivative was recovered almost quantitatively. Consequently DMF-
DIEA was selected for all PEG surface grafting experiments.  
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Figure 4-11: Influence of base and solvent on PEG grafting (  DMF, 
 DMSO and Acetonitrile)  
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4.6.3.2 Influence of reaction parameters and nature of matrix on 
PEG grafting 
 
Grafting kinetics were found to be greatly influenced by a number of 
parameters such as temperature, time, molecular weight of PEG used and 
also by the nature of the matrix used for grafting. The impact of 
temperature on PEG grafting profile is illustrated in Figure 4-12, showing 
a substantial increase up to 40°C. But a further increase in temperature 
does not favour any significant improvement in grafting as it inversely 
affected the grafting by favouring an increased NHS ester as well as β-
alanine ester hydrolysis. 
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Figure 4-12: Influence of temperature on grafting profile for PEG4000 
after 72 hr in terms of gain in wt. ( PS4000,  CP4000 and 
CM4000) 
 
With all resins, PEG grafting increases with time at a given temperature 
and it reaches saturation after a certain period of time (Figure 4-13 and 
Figure 4-14). As the reaction proceeds there is an increase in steric 
hindrance and repulsive forces exerted by the already grafted PEG 
molecules on the approaching molecules, and hence further conjugation 
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becomes virtually impossible after a period of time. These steric 
repulsive forces are more noticeable with CM Sephadex compared with 
CP Sephadex, due to the short carbon length.  The grafting profiles of all 
these matrices (Figure 4-12 to 4-14) were found to have a similar pattern 
obtained from that of XPS results (Figure 5-8 to 5-10) and a detailed 
explanation for these patterns is given in Section 5.4.1.3.  
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Figure 4-13: Grafting profile for PEG4000 at 40°C in terms of gain in 
wt. ( PS4000,  CP4000 and CM4000) 
 
  
4-29 
0
10
20
30
40
50
60
70
80
24 48 72 96
Time Hr
%
 
G
a
in
 
in
 
w
t
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
~
 
m
m
o
l P
E
G
/g
 
Figure 4-14: Grafting profile for PEG2000 at 40°C in terms of gain in wt. 
( PS2000,  CP2000 and CM2000) 
 
Based on these results, covalent grafting at 40°C for 72 hour was taken as 
the optimised condition for preparing PEG grafted solid matrices for 
solid-phase protein PEGylation.   
 
4.6.3.3 Size comparison of PEG grafted matrices and their swelling 
behaviour 
 
Size comparisons of various PEG grafted matrices with their parent 
matrices were done under both dry and wet conditions, by measuring the 
diameter of a number of individual particles using an optical microscope 
(Section 4.4.4).  Using a 10x resolution optical lens, distances in pixel 
were calibrated against a 10 mm graduated optical slide at a fixed focal 
length, and sample diameters were measured in the same focal length 
without disturbing the setup. The diameters of 50 single beads were 
measured with all dry samples and 30 beads were measured with the wet 
samples.  The averages of all respective diameters were measured along 
with their standard deviation and are summarized in Figure 4-15.  
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Figure 4-15: Size comparison of various PEG grafted matrices under dry 
and aqueous conditions (Using PEG 4000 Da, 72 hr, 40°C) 
 
Sephadex derivatives, including those grafted with PEG, showed a very 
high swelling behaviour and they swelled to about 1.5 times their initial 
size, but the polystyrene particles remained in their initial size under 
aqueous conditions. On the other hand, the behaviour of these matrices 
was exactly reversed in non-aqueous solvents, as during experimentation 
it was observed that polystyrene beads swelled to almost double their 
initial size in anhydrous reaction media, whereas the Sephadex 
derivatives remained unswelled in their initial sizes. These differences in 
the swelling behaviour of these matrices played a key influential role in 
grafting kinetics as well as during protein conjugation with the solid-
phase PEGylation system. The swelling behaviour of the polystyrene 
particles in the anhydrous reaction media resulted in maximum available 
sites for PEG conjugation, whereas the unswelled Sephadex matrices 
were left with fewer active sites for modifications. During protein 
conjugation, swelling of the Sephadex matrix resulted in the exposure of 
a number of active sites as well as unmodified carboxyl terminals, and 
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resulted in protein conjugation through amine coupling as well as through 
ion exchange interactions.  
 
4.6.4 PEG hydrolysis  
 
The labile nature of alanine ester linkages was well documented (Section 
3.2.1.3), but the extent of its hydrolysis in heterogeneous reaction media 
was not exactly known. Hence it was necessary to carry out a detailed 
study to understand the kinetic behaviour of this linkage under various 
conditions, in order to assess the yield and viability of the novel solid-
phase system. In order to prevent the possible protein denaturation, the 
main focus of hydrolysis studies was to get the maximum possible PEG 
hydrolysis under mild conditions such as using moderate temperature and 
pH.  
 
An estimation of hydrolyzed PEG with methods such as Nessler’s 
reagent, ammonium ferrothiocyanate and barium chloride–iodine resulted 
in non linear and non reproducible results, due to interferences from the 
presence of various reaction by-products and cleaving buffer with the 
hydrolyzed product. Furthermore the absence of any UV absorption by 
the PEG molecule alone restricts any chromatographic analysis, which 
normally follows UV absorption of the sample under elution for 
qualitative and quantitative purposes. These analytical constraints 
necessitate finding an alternative way of estimating the hydrolyzed PEG 
by modifying it with a benzyl amide chromophore, and its quantification 
using SEC (Section 3.2.2). A standard curve of known concentrations 
was plotted against peak areas of PEG benzamide derivative (11) 
obtained from SEC analysis. A standard SEC chromatogram of 
intermediate 11 is given in Figure 4-16. Intermediate 11 was selected for 
these estimations because it is the final product obtained after alanine 
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ester hydrolysis from the solid matrix. The peak areas of the hydrolyzed 
samples were compared with the standard curve and their corresponding 
concentrations were calculated.   
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Figure 4-16: SEC of HO-PEG-CONHBz (Retention vol. 16.969 mL) 
 
The hydrolysis profile obtained using various buffer solutions at 20°C is 
summarized in Figure 4-17. All other buffers except TFA resulted in a 
very poor hydrolysis yield even after a prolonged time. The initial rate of 
hydrolysis with hydroxylamine buffer was comparatively higher than that 
with glycine-NaOH and acetate buffer, but after a period of time there 
seems to be a decrease in hydrolysed PEG concentration, as shown from 
the graph. This is probably due to the slow reaction of hydroxylamine 
with amides under neutral as well as alkaline conditions (Jencks and 
Gilchrist 1964), which cleaves off the benzyl amide moiety from the PEG 
terminal and thereby results in a reduced UV absorption for the products 
obtained. Consequently hydroxylamine can be an alternate option for a 
shorter hydrolysis period, but better yields were obtained with glycine-
NaOH buffer for prolonged durations.     
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Figure 4-17: Hydrolysis using various buffers at 20°C TFA, 
Glycine-NaOH,  Acetate and  Hydroxylamine-NaOH.   
 
4.6.5 Solid-phase protein PEGylation 
 
Conceptualization of the solid-phase protein PEGylation was achieved by 
following Scheme-9 (Figure 4-8). After PEG grafting, unreacted NHS 
activated resins were blocked with excess ethanolamine and further 
conjugated to the N-terminal lysine of Cytochrome c by NHS activation 
of the terminal PEG carboxyl group (Section 4.5.4). PEGylated 
Cytochrome c was then cleaved off from the resin by the alkaline 
hydrolysis of the alanine ester linkage using 0.2 M glycine-NaOH buffer 
at pH 8.5 and was further characterized using size exclusion 
chromatography.  
 
In brief, even though there is a lack of consistency and reproducibility of 
results with all batches, both Sephadex based derivatives resulted in some 
positive results, as characterized from their SEC analysis. Typical SEC 
chromatographs obtained from the hydrolysis of CP Sephadex and CM 
Sephadex derivatives modified with PEG 4000 Da are given in Figure 4-
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18 and 4-19 respectively. But none of the polystyrene based derivatives 
resulted in any positive results in any of the experiments. Both Sephadex 
derivatives were characterised by a reddish-brown coloration before and 
after hydrolysis, indicating a non-specific conjugation of Cytochrome c 
on the matrix surface, along with that through the PEG terminal. CM 
Sephadex derivatives resulted in very intense coloration, but the intensity 
was much less with CP Sephadex and was absent with polystyrene 
derivatives in all cases.   
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Figure 4-18: SEC of PEGylated Cytochrome c from CP Sephadex 
( trial 1 and trial 2) 
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Figure 4-19: SEC of PEGylated Cytochrome c from CM Sephadex 
( trial 1 and trial 2) 
 
Based on the SE chromatograph obtained from the corresponding 
solution-phase PEGylation (Figure 3-14), the peak for the mono-
PEGylated Cytochrome c was expected to be at a column volume of 
~15.8 mL. But none of these results showed any traces of mono-
PEGylated species with either of the Sephadex derivatives.  Peaks 
corresponding to column volumes ~14.6, 13, 11.2, 10 mL were detected, 
indicating the presence of di, tri, and multi-PEGylated species.   
 
Size exclusion chromatograms obtained from PEG 2000 Da grafted 
Sephadex derivatives are given in Figure 4-20, which also shows the 
presence of multi-PEGylated species in their products. In order to 
distinguish between the various PEGylated species, fractions were 
pooled, freeze dried and analysed for SDS PAGE. However, due to the 
very low concentrations of the samples involved (as measured at 215 
nm), gel pictures were not clear enough to distinguish between the 
various PEGylated species, and hence it was not possible to identify the 
products eluted at 16.17 and 14.29 mL with CP Sephadex and 15.37 mL 
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with CM Sephadex. Along with the PEGylated product, some 
Cytochrome c was also found eluted at 18.33 mL column volume with 
CM Sephadex. This trace amount of Cytochrome c was found with both 
Sephadex derivatives, in some cases even in the absence of PEGylated 
products, which may be due to some protein bound to the unblocked 
carboxyl terminal of the resin through ion exchange interactions, which 
may be left behind even after repeated washings.  
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Figure 4-20: SEC of PEGylated Cytochrome c using PEG 2000 
( CP Sephadex derivative  and CM Sephadex derivative) 
 
SE chromatograms obtained with polystyrene derivatised with both 2000 
and 4000 Da PEG derivatives does not shown any traces of the 
PEGylated species (Figure 4-21).  They were characterized with the 
presence of only hydrolysed NHS by-products under all hydrolysis 
conditions. 
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Figure 4-21: SEC obtained using polystyrene derivatives ( trial 1 and 
trial 2) 
 
4.7 Conclusions 
 
Carboxylated Sephadex derivatives were prepared with sufficient ion 
exchange capacity and tether lengths for surface PEG graftings. Non-
aqueous PEG grafting methods were optimised to have a range of PEG 
grafted matrices with varying grafting densities, using specific amine 
coupling chemistry. Hydrolysis parameters were optimised to have a 
reasonable PEG cleaving yield under mild hydrolysis conditions in order 
to prevent protein denaturation.  
 
Optimised grafting and hydrolysis conditions were extended for solid-
phase protein PEGylation and the presence of traces of PEGylated 
species obtained from both Sephadex derivatives was characterized by 
SEC. Even though this provided a proof of concept for this novel 
technology, the process was unable to produce the expected mono-
PEGylated species and is associated with lack of consistency and 
reproducibility in producing other multi-PEGylated products with 
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reasonable yield and quality. The nature of the matrix is found to have a 
great influence on protein conjugation and solid-phase PEGylation, as 
only hydrophilic Sephadex derivatives resulted positively, whereas 
polystyrene derivatives did not provide any positive results. 
Consequently, these results prompted an investigation into various factors 
which influenced the overall process performance and the findings are 
summarized in the following chapters.  
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5 Surface characterization of solid-phase 
PEGylation matrices using microanalytical 
tools 
 
5.1 Introduction 
 
In this chapter, studies on the surface characterization and morphology of 
PEG grafted solid matrices are described with a special emphasis on the 
conformational behaviour of tethered PEG molecules. Conformational 
behaviour of tethered PEGs can be entirely different from that of the 
original unbound PEG molecules and can vary with its molecular weight, 
grafting density and nature of the surface grafted. Because the tethering 
property of grafted PEG molecules is a function of their conformational 
behaviour, a clear understanding of conformation is necessary to study 
and interpret the behaviour of the newly developed solid-phase 
PEGylation system described in Chapter 4.  
 
de Gennes’s theory (de Gennes 1980; de Gennes 1987) postulates the 
correlation of grafting density of PEG chains with its preferred 
conformations but no systematic investigation to confirm this correlation 
has been reported and hence the conformation of the grafted PEG layers 
has merely been assumed in many cases (Vermette and Meagher 2003). 
Thus one of the main objectives of this chapter is to provide valuable 
information to bridge the knowledge gap between the theoretical and 
actual conformation of grafted PEGs and latter’s dependence on grafting 
density and layer thickness. Finally, based on these surface quantification 
data, the nature of interactions between the matrix and protein are 
analysed in detail and their influence on the results of solid-phase 
PEGylation method are ascertained.   
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Table 5-1: Various microanalytical surface characterization techniques used and their properties (Miyoshi 2002) 
 
Resolution Technique Information 
Vertical Lateral 
Sample Popularity 
X-ray photoelectron 
spectroscopy (XPS) 
Elemental composition, 
chemical state, depth 
profiling, imaging and 
mapping 
A few to 
several nm 
5 µm to 5 mm Ultra high vacuum 
compatible solids 
Extensive 
Scanning electron 
microscopy (SEM) 
Imaging, morphology, 
elemental composition, 
damages, defects, 
crystallography, grain 
structure, magnetic domain 
Variable from a 
few nm to a 
few µm 
1 to 50 nm in 
secondary 
electron mode 
Conductors and 
coated insulators 
Extensive 
Confocal laser scanning 
microscopy (CLSM) 
3D and 2D imaging, 
morphology, profilometry, 
topographic imaging, film 
thickness, wear volume, scar 
and crater depth, defects 
Variable from a 
few nm to a 
few µm 
0.5 to 4 µm 
(optical) 
All Medium 
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5.2 Microanalytical surface characterization tools 
 
Microanalytical tools are characterised with their ability to identify, 
characterize and estimate the trace components and composition of solid 
surfaces down to extremely low concentrations. These techniques will 
provide valuable and in-depth information regarding the physical, 
chemical and mechanical properties of surfaces. Each technique will 
provide unique but often complementary information. Various surface 
analytical tools used in this study are summarized in Table 5-1. 
 
5.2.1 X-ray photoelectron microscopy (XPS) 
 
XPS, also known as electron spectroscopy for chemical analysis (ESCA), 
is a very powerful surface analytical tool with its characteristic elemental 
detection, chemical state identification and quantitative capabilities (de 
Vries 1998; Wolstenholme 1999). The basic principle behind XPS is a 
photoelectric effect, which involves the emission of electrons due to the 
absorption of X-rays (Figure 5-1).   
 
 
Figure 5-1: XPS principle (de Vries 1998) 
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In XPS, samples are irradiated with a monochromatic beam of X-rays 
with a known energy that penetrates through 1–10 µm into the sample 
surface, resulting in the emission of electrons. Due to very small 
difference in the mean-free paths, only the electrons emitted from the few 
top atomic layers are detected. The kinetic energy (Ek) of the emitted 
electrons will be 
  
 EK =  hν – EB – w      (5-1) 
 
where hν is the energy of interacting photon, EB is the binding energy of 
electron in the atomic orbital from which it originates and w is the work 
function of the spectrometer. Binding energy (EB) can be interpreted as 
the ionization energy of a particular atom and hence it is characteristic of 
the atom in a particular orbital with a particular bonding environment. 
This results in a distinctive energy position and intensity distribution for a 
particular atom, enabling its identification and quantification.     
 
5.2.1.1 Characterization and quantification of PEG grafted solid 
matrices using XPS 
 
XPS survey scans are known to be very effective in characterizing PEG 
grafted onto various solid matrices such as silicon (Sofia et al. 1998; 
Popat and Desai 2004; Popat et al. 2004; Michel et al. 2005), polystyrene 
(Brindley et al. 1995; Cairns et al. 1999), nonporous alumina (Popat et al. 
2004), other metal surfaces (Feller et al. 2005; Tanaka et al. 2007) and 
even functionalized nanoparticles (Pourcelle et al. 2007; Hu et al. 2008; 
Wang et al. 2008).  The presence of PEG on a matrix surface can be 
characterised by a sharp increase in the C 1s and O 1s peaks at 285 eV 
and 528 eV, respectively. High resolution C 1s scans provide more in-
depth information from the characteristic C-O peak, with its intensity 
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directly proportional to the PEG concentration on the surface. Popat and 
his co-workers correlated the relative intensities of the C-O (at 286.5 eV) 
and C-C (at 285 eV) peaks with PEG concentration using both Langmuir 
and exponential models (Popat et al. 2004). The relative ratio of oxygen 
to carbon (O/C) will vary with the amount of PEG attached to the solid 
surface, thus enabling the quantitative determination of PEG on the 
surface (Kingshott et al. 2002).  
 
Thickness (t, nm) of the PEG layer can be calculated by measuring the 
electron attenuation length (EL, nm) of the carbon peak, using Equation 5-
2 (Sofia et al. 1998) 
 
 I = I0 




−1
sin. θLE
t
      (5-2) 
 
where I0 and I are the relative intensities (eV) of C-O peaks within the 
high resolution C 1s scans before and after PEG grafting and θ  is the  
angle of incidence of the X-rays on the sample surface. Electron 
attenuation length of the carbon peak is characteristic of its electron 
energy (E) and can be calculated from Equation 5-3 (Tao et al. 2008), 
 
 EL = ρ2
49
E
+0.11
ρ
E
      (5-3) 
 
where ρ is the density of PEG (1.1 g/cm3) and the electron energy E can 
be given as   
 
 E =  (X-ray core energy – core binding energy of C)  (5-4) 
    =  (1486 – 285) = 1201 eV. 
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Knowing the thickness, the surface concentration (Г, g/nm2) and the 
average distance between grafted PEG chains (D, nm) can be calculated 
using Equations 5-5 and 5-6, respectively (Tao et al. 2008) 
 
 Г = ρ t        (5-5) 
 
 D = 
2/1






Γ AN
M
       (5-6) 
 
where  M is PEG molecular weight (Da) and NA is Avogadro’s number 
(6.023 x 1023 mol-1). Finally, the grafting density (σ) (de Gennes 1980) 
can be calculated from Equation 5-7, 
 
 σ = 
2






D
a
       (5-7) 
 
where a is the size of a PEG monomer unit.  
 
5.2.1.2 Conformational studies of grafted PEG molecules using XPS 
 
XPS core line and valence band spectra are sensitive to changes in 
polymer chain conformations due to their influence in the valance 
molecular orbitals. Beamson and his co-workers found that the XPS 
valance band spectra for PEG constitutes two distinguishing peaks, 
named “a” and “b” (Figure 5-2), representing antibonding and bonding 
molecular orbitals, in the valance band region of the spectrum (Beamson 
et al. 2000).  
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Figure 5-2: Valence band spectra of PEG [Region A,B,C and D 
corresponding to ionization from MOs consisting largely of O 2s, (C 2s + 
O 2s), (C 2p + O 2s + H 1s) and (O 2s + O 2p] (Beamson et al. 2000) 
 
In the case of PEG chains with a brush conformation, there is a 
stabilization of the molecular orbitals (MOs) through methylene 
hyperconjugation between the alternate carbon atoms, resulting in a 
crowding of energy levels above the C 2s orbitals, which produces a 
sharp antibonding peak in the spectrum (peak “a”). In contrast, as in the 
mushroom conformation with random coils, stabilization through 
hyperconjugation is significantly reduced, resulting in a dispersion of 
energy levels above the MOs. This results in a reduction in the height of 
peak “a”. Thus, comparing the relative heights of these antibonding and 
bonding peaks provides a useful tool in studying the conformational 
changes of PEG polymers.  
 
Because the sensitivity for detecting local conformational changes with 
XPS can be extended only for a few repeating units and also because of 
the very small effective core level and valence band shifts induced by 
conformational changes, highly sensitive and  accurate experimentation 
and instrumental performances are required to characterize these changes. 
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For these reasons, despite the fact that Beamson and his colleagues 
(Beamson et al. 2000; Beamson 2007) could detect conformational 
changes of pure PEG molecules using this methodology, its sensitivity 
for distinguishing various conformational isomers of PEG grafted onto a 
solid matrix is doubtful. 
 
In an alternative and simplified manner, the thickness of a grafted PEG 
layer can be correlated with its conformation behaviour (Su et al. 1997).  
With a lower thickness, PEG molecules will be predominantly in the 
mushroom conformation, whereas a higher thickness indicates stretching 
out of the PEG molecule as polymer brushes. As a corollary, the 
conformational properties of a tethered PEG molecule at the surface can 
be precisely predicted by comparing the distance between the grafted 
PEG chains with the Flory radius (RF) of the polymer. RF can be 
calculated knowing the size and the number (N) of its monomer units 
(Meng et al. 2004a). 
 
  RF  =  a  N 3/5       (5-8) 
 
In the case of PEGs with a mushroom conformation, D will be greater 
than RF and the thickness of the PEG layer will be equal to RF (Figure 5-
3a). However, if the PEG polymer exists in its brush form, D will be 
smaller than RF and the thickness will be greater than RF (Figure 5-3b).  
Although the transformation of mushroom to brush conformation begins 
immediately once the distance between grafted PEG chains increases 
above RF, brush forms will not be fully developed until the surface 
concentration is sufficiently large to have a very compact packing of the 
grafted molecules (Hansen et al. 2003). Taking this into consideration, 
assignment of a brush conformation is proposed only when the layer 
thickness is significantly larger than the RF values, say when t  > 2RF.   
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a) 
 
b) 
 
   
 
Figure 5-3: a) PEG with mushroom conformation and b) PEG with brush 
conformation (Not to scale) 
 
Thus, a detailed comparison of the three parameters D, RF and t, will 
provide a useful tool in distinguishing the possible PEG conformations 
on the solid interface. Based on these, the following hypothesis can be 
derived to distinguish the various conformers as summarized in Table 5-
2.  
 
 
t  
RF 
t  
RF 
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Table 5-2: Hypotheses to distinguish the PEG conformations  
 
Hypothesis Conditions (and / or) Conformation 
A D > RF    
t  ≤  RF 
Mushroom 
B RF < t < 2RF Intermediate 
C D < RF   
t  > 2RF 
Brush 
 
5.2.1.3 Comparison with literature 
 
In the absence of a detailed PEG conformational assignment based on 
XPS data, the correlation between PEG layer thickness and 
conformational behaviour of PEGs reported in other literature was 
considered to validate the methodology. Comparing the results, 
summarized in Table 5-3, a brush conformation is assigned generally 
when t > 2RF. Various methods were adopted for these conformational 
assignments such as force measurements (Xu and Marchant 2000; 
Heuberger et al. 2005; Nnebe and Schneider 2006), changes in ζ- 
potential (Meng et al. 2004a) and use of ellipsometry (Zdyrko et al. 2004; 
Zdyrko et al. 2009) indicates a generalized validity of the concept and 
hypothesis.  
 
Table 5-3: Conformational assignment from literature and its match with 
the hypothesis 
 
PEG 
MW 
t nm D 
nm 
RF 
nm 
Confo-
rmation 
Hypo-
thesis 
Reference 
2000 7 -- 3.43 Brush C (Xu and Marchant 
2000) 
2000 8.2 1.4 3.43 Brush C (Heuberger et al. 
2005) 
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Table 5-3 continued 
3400 9.55 1.66 4.74 Brush C (Meng et al. 2004a) 
5000 11.5 0.9 5.96 Brush C (Zdyrko et al. 2004) 
5000 13 -- 5.96 Brush C (Nnebe and Schneider 
2006) 
5000 7 to 9 -- 5.96 Interm-
ediate 
B (Zdyrko et al. 2009) 
 
5.2.1.4 Study of protein interaction with PEG grafted matrices using 
XPS data 
 
According to de Gennes (1987), interactive forces exerted between two 
surfaces having end grafted polymers is a function of polymer grafting 
density and distance between the two surfaces (Equation 2-1). Kim and 
Luckham extended this equation to predict the force of interaction 
between two spherical matrices bearing polymeric chains and is given by 
Equation 5-9 (Kim and Luckham 1992), 
 
 F =  





3D
kT
r
β
pi
( )
( ) 

−











75.0
75.2
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1
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2
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h
h
t
 
   






+


+ htht
7
8
5
8 ( )[ ] 


−
223636.4 t   (5-9) 
 
where r is the matrix radius and β is a constant (β = 12 (Kim and 
Luckham 1992)). Thus, considering aqueous solutions of globular 
proteins as colloidal spheres, this equation can be extended to measure 
the interactive forces by knowing the PEG grafting profile and the 
distance between the approaching protein and matrix.  
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5.2.2 Scanning electron microscopy (SEM) 
 
SEM is a very powerful imaging technique characterised by its capability 
of producing detailed surface morphological and topological 
informations.  In SEM, a stream of monochromatic electrons produced by 
an electron gun are focused through a  fine probe and scanned over a 
small rectangular area of the sample specimen (Flegler et al. 1993; 
Vernon-Parry 2000). Interaction of electron beam with the specimen 
generates various signals such as secondary, back scattered, photon 
emission etc which are detected by appropriate detectors in the specimen 
chamber, based on their varying level of energies.  The secondary 
electrons produced within the first few nanometres of the sample surface, 
having an average energy less between 3 to 5 eV, provide the highest 
spatial resolution images and help in studying the useful topographic 
informations.  
 
5.2.3 Confocal laser scanning microscopy (CLSM) 
 
Confocal microscopy, based on the concept developed by Minsky (1988), 
is characterized by point-wise illumination and detection. Its unique 
capability for eliminating scattered and reflected lights from out of focus 
planes yields images with an improved resolution and contrast over other 
conventional microscopes (Miyoshi 2002).  
 
The principle of confocal microscopy is illustrated in Figure 5-4 (Prasad 
et al. 2007). With the help of a dichromatic mirror and a pair of rotating 
mirrors, laser light is directed through the microscope object and excites 
the fluorescent sample. The reflected fluoresced light from the sample is 
then allowed to pass through the dichromic mirror after descanning by 
the same pair of rotating mirrors.   
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Figure 5-4:  Schematic representation of confocal microscope (Prasad et 
al. 2007). 
 
Light coming from the dichromic mirror is then passed through a pinhole 
placed in the conjugate focal plane of the sample, which rejects all out of 
focus light. Finally, these rays are recorded by a photomultiplier 
detection tube without scattering in the lateral resolution. The capability 
for reconstructing a three dimensional image of the sample by combining 
a series of two dimensional image planes is one of the main advantages 
of CLSM over other microscopic techniques.    
 
The core importance of confocal microscopy in this context is to make 
use of its special capability for fluorescent imaging (Pygall et al. 2007) 
with its high sensitivity and low intrinsic backgrounds. Fluorescent 
imaging of fluorescein isothiocyanate (FITC) labelled Cytochrome c 
conjugated solid matrixes were recorded to confirm any conjugation of 
the protein on the matrix.  
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5.3 Methods  
5.3.1 XPS 
 
PEG grafted solid matrices were analysed by XPS to characterise and 
quantify the PEG concentrations and to study conformational properties. 
PEG grafted samples were prepared with polystyrene, CM Sephadex and 
CP Sephadex, following the method given in Section 4.5.2. In general, 
samples grafted at 40°C with a grafting time of 12, 24, 48 and 72 hour 
were taken for XPS characterizations. In order to study the influence of 
temperature, PEG-grafted polystyrene and CP Sephadex were also 
prepared at 25 and 55°C with a 72 hour grafting period. Hereinafter, PEG 
grafted samples are abbreviated by matrix, PEG MW, reaction time and 
temperature. For example, PS200012H40C, denotes a polystyrene matrix, 
2000 molecular weight PEG, a 12 hour grafting time and 40°C grafting 
temperature.  
 
XPS analysis was performed on a PHI-5800 spectrometer (Physical 
Electronics, MN, USA) (Figure 5-5). Analyses were performed using a 
monochromatic Al Kα X-ray source (1486.6 eV) with an Omni Focus III 
small area lens and multichannel detector.  Measurements were taken at 
an electron take-off angle of 45° (θ = 45°) from a normal sampling 
surface depth of ~50 Å. The spectrometer samples a surface area of 
approximately 400 µm by 700 µm and a concentric hemispherical 
analyser, which operates in the constant analyzer transmission mode, 
measures the binding energies of the emitted photo electrons. The 
binding energy scale was calibrated prior to analysis by the Au4f7/2 peak 
at 83.9 eV and linearity was verified by the Cu3p1/2 and Cu2p3/2 peaks at 
76.5 and 932.5 eV, respectively. 
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A uniform, thin layer of samples was prepared on a double-sided 
adhesive graphite tape and degassed at 10-7 to 10-9 mbar vacuum for 
approximately one hour before introducing to the XPS stage.  Survey 
scans were collected from 10 to 1100 eV with a pass energy of 187.85 
eV. All spectra were referenced by setting the C1s peak to 285.0 eV to 
compensate for residual charging effects. High resolution spectra for C1s 
were recorded between 282.0 eV and 294.0 eV, with a pass energy of 
23.50 eV. The peak areas were quantified using a Gaussian-Lorentzian 
fitting procedure using the XPSPeak 4.1 software provided with the 
instrument.  
 
 Dual anode source 
 Camera 
 Monochromator 
 Concentric    
hemispherical analyser 
  
Electron gun 
Sample entry stage 
Sample manipulator  
Monochromatic X-
ray source 
Figure 5-5:  PHI-5800 spectrometer and its components 
 
5.3.2 SEM 
 
The surface morphologies of Sephadex and polystyrene derivatives 
before and after PEG grafting were examined by SEM using a Leica 
Cambridge S440 Scanning Electron Microscope (Leica, Rockleigh, NJ, 
USA) operating at an acceleration voltage of 5.0 kV with a probe current 
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of 50 Pa and a working distance of10 mm. All samples were sputter 
coated with 100 Å Gold thicknesses using a sputter-coater (EMITECH 
K550X, Emitech, Ltd., Ashford, UK) for 2 minutes at 20 mA with a high 
tension 1.2 kV.  
 
5.3.3 Fluorescent imaging by CLSM 
5.3.3.1 FITC labelling of Cytochrome c and its conjugation with NHS 
activated PEG resins.  
 
Labelling of Cytochrome c with fluorescein isothiocyanate (FITC, 
Sigma-Aldrich) was carried out based on the methodology reported by 
Zalk et al. (2005). To a solution of Cytochrome c (2 mg/mL) in 100 mM 
carbonate buffer (pH 9.0),  1 mg/mL FITC in DMSO solution (50 µL 
FITC solution for 1 mL of Cytochrome c solution) was added very 
slowly under gentle stirring. After completing the addition of FITC 
solution, the resulting mass was stirred at 30°C for 2 hour. Unreacted 
FITC was separated from the resulting mixture by overnight dialysis 
(Dialysis buffer: 50 mM KCl, 5 mM MgCl2, 5 mM NaHCO3 and 20 mM 
Hepes, pH 7.35) with multiple change of dialysis buffer. The ratio of 
FITC to Cytochrome c was estimated by measuring the absorbance at 495 
nm and 280 nm and found to be 2.35 ± 0.19.  
 
Carboxymethyl Sephadex, carboxypentyl Sephadex and carboxylated 
polystyrene solid matrices were grafted with the α-(β-alanine)-ω-carboxy 
PEG derivative (6), followed by ethanolamine blocking. The free carboxy 
terminal of the tethered PEG was then further activated with NHS ester 
and treated with FITC labelled Cytochrome c. Cytochrome c conjugated 
matrices were then washed thoroughly with PBS buffer (x2), 2 M NaCl 
(x2) and PBS buffer (x2).    
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5.3.3.2 CLSM 
 
Fluorescence released from the FITC labelled Cytochrome c was 
analyzed with Leica TCS SP5 confocal laser scanning microscope (Leica 
Microsystems, Wetzlar, Germany) equipped with a 63×planapo objective 
(numerical aperture 1.4). A Kr/Ar laser was tuned to produce a 488 nm 
beam and images were recorded with a line average of 6 images.  
 
5.4 Results and discussion 
5.4.1 XPS – Surface characterization and conformational studies 
 
Survey scans were taken to determine the elemental surface composition 
and high resolution C1s scans were performed to study the PEG 
chemistry in detail. 
 
 5.4.1.1 Survey scans 
 
Survey scans were characterized by distinctive peaks for O1s at 528 eV 
and C1s at 285 eV with a minor peak at 400 eV corresponding to N1s 
(Figure 5-6). The relative composition of O and C atoms for various PEG 
grafted matrices are summarized from their survey scans and given in 
Table 5-4 as their oxygen to carbon (O/C) ratios. As the PEG 
concentration increases, the relative O/C ratio decreases for both PEG 
molecular weights. This decrease in O/C ratio with increasing PEG 
concentration matches well with the theoretical expectation and serves as 
very clear evidence for the presence of PEG and increasing grafting 
densities on these matrices. Because all the matrices under investigation 
were abundant with residual C and O atoms, it was difficult to extract 
quantitative information regarding PEG grafting from these survey scans 
alone. Therefore, high resolution C 1s scans were performed to provide 
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more precise information regarding PEG grafting chemistry and 
conformational behaviour.  A summary of survey scans for various PEG 
grafted polystyrene, CM Sephadex and CP Sephadex matrices are given 
in Appendix B (Figure B-1 to B-6). 
 
 
Figure 5-6:   XPS survey scans (PS400012H40C) 
 
Table 5-4: Surface O/C ratio for various PEG grafted matrices 
 
O/C ratio for PEG grafting parameters 
(Time (hr) / Temperature (°C)) 
PEG matrix 
 
12/40 24/40 48/40 72/40 72/25 72/55 
PS2000 0.26 0.24 0.18 0.15 -- -- 
PS4000 0.41 0.36 0.33 0.33 0.41 0.34 
CMSP2000 0.74 0.72 0.69 0.68 -- -- 
CMSP4000 0.73 0.71 0.71 0.70 -- -- 
CPSP2000 0.62 0.57 0.56 0.56 -- -- 
CPSP4000 0.62 0.61 0.59 0.54 0.61 0.52 
 
 
O 1s 528 eV 
C 1s 285 eV 
N 1s 400 eV 
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5.4.1.2 High resolution C 1s scans 
 
High resolution C 1s scans can be resolved into various components, 
corresponding to C-C and C-H bonds at 285.0 eV, C-O bond at 286.5 eV, 
>C=O bond at 288.0 eV and –COO- and –NH-CO- bonds at 289.0 eV 
(Nakao et al. 1996; Zhang et al. 2006). In the case of PEG grafted solid 
matrices and surfaces, there will be a substantial increase in the intensity 
of the C-O peak at 286.5 eV with increasing PEG concentration, which is 
a characteristic indication of PEG coupling (Popat et al. 2004) (Figure 5-
7).  
 
 
Figure 5-7:   XPS high resolution  C 1s scans (PS400072H40C) 
 
The relative percentages of the C-O peak in the overall C 1s high 
resolution scans were calculated with the help of XPSPeak 4.1 software 
provided with the instrument and were used as the measure of PEG 
grafting profile. Peak areas were quantified with a Gaussian-Lorentzian 
fitting procedure for the C-O peak and this was, in turn, used for further 
estimation of PEG and its conformation. The choice of C-O peak 
intensities exclusively for these calculations was based on its direct 
C-O 286.5 eV 
C-H 285 eV 
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correlation with the PEG concentration, as reported in the literature 
(Popat et al. 2004; Popat et al. 2004; Sharma et al. 2004; Tao et al. 2008) 
and also due its compatibility with the standard uniform overlay model 
given by Equation 5-2 (Sofia et al. 1998).   
 
(Note: Overlay of C 1s high resolution scans obtained for various PEG 
grafted matrices under different grafting conditions are summarized in 
Appendix B (Figure B-7 to B-14).  
 
5.4.1.3 Characterization and quantification of grafted PEG 
 
The thickness of the PEG layer was calculated using Equation 5-2, 
knowing intensities of the matrix before and after PEG grafting. In the 
case of PEG grafted polystyrene samples, the intensity of C-O peak for 
the unmodified polystyrene matrix was taken as the initial intensity and 
compared with that of each PEG grafted matrix to calculate the layer 
thickness. Similarly, for CM Sephadex and CP Sephadex derivatives, C-
O intensities from the base, unmodified matrices were taken as the initial 
intensities for calculating PEG thickness for the respective PEG modified 
matrices.  
 
When PEG thickness was calculated using Equation 5-2, a residual 
thickness of 4.901 nm was observed when I = I0. This arbitrary residual 
thickness is a characteristic of a particular instrument, peak and electron 
take-off angle and was subtracted from the calculated values to obtain the 
absolute thickness. By knowing the PEG layer thickness, other important 
quantification parameters, such as surface concentration and grafting 
densities, were calculated using Equations 5-5 and 5-7, respectively. A 
summary of these results is given in Tables 5-5 to 5-7. 
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Table 5-5: Surface characterization of PEG grafted polystyrene matrices 
 
PEG quantification Matrix I0 
eV 
I  
eV Thickness 
t, nm 
Surface 
concentration 
Г g/nm2 
Grafting 
density 
σ 
PSCOOH 652     
PS200012H40C  1414 2.86 3.15 x10-21 0.116 
PS200024H40C  1498 3.18 3.50 x10-21 0.129 
PS200048H40C  1655 3.77 4.15 x10-21 0.153 
PS200072H40C  2059 5.29 5.82 x10-21 0.215 
PS400012H40C  2139 5.59 6.15 x10-21 0.113 
PS400024H40C  2405 6.59 7.25 x10-21 0.134 
PS400048H40C  2991 8.79 9.67 x10-21 0.178 
PS400072H40C  3811 11.87 1.31 x10-20 0.241 
PS400072H25C  3.22 8.91 9.80 x10-21 0.181 
PS400072H55C  4323 13.80 1.52 x10-20 0.280 
 
Table 5-6: Surface characterization of PEG grafted CM Sephadex 
matrices 
 
PEG quantification Matrix I0 
eV 
I  
eV Thickness 
t, nm 
Surface 
concentration 
Г g/nm2 
Grafting 
density 
σ 
CM Sephadex 351     
CMSP200012H40C  347 0 0 0 
CMSP200024H40C  363 0.08 9.22 x10-23 0.003 
CMSP200048H40C  406 0.38 4.22 x10-22 0.016 
CMSP200072H40C  408 0.40 4.38 x10-22 0.016 
CMSP400012H40C  351 0 0 0 
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Table 5-6 continued 
CMSP400024H40C  457 0.74 8.14 x10-22 0.015 
CMSP400048H40C  554 1.42 1.56 x10-21 0.029 
CMSP400072H40C  727 2.62 2.89 x10-21 0.053 
 
Table 5-7: Surface characterization of PEG grafted CP Sephadex 
matrices 
 
PEG quantification Matrix I0 
eV 
I  
eV Thickness 
t, nm 
Surface 
concentration 
Г g/nm2 
Grafting 
density 
σ 
CP Sephadex 720     
CPSP200012H40C  692 0 0 0 
CPSP200024H40C  873 0.52 5.73 x10-22 0.021 
CPSP200048H40C  1067 1.18 1.30 x10-21 0.048 
CPSP200072H40C  1485 2.60 2.86 x10-21 0.106 
CPSP400012H40C  1031 1.06 1.16 x10-21 0.022 
CPSP400024H40C  1474 2.57 2.82 x10-21 0.052 
CPSP400048H40C  1814 3.72 4.10 x10-21 0.075 
CPSP400072H40C  1936 4.14 4.55 x10-21 0.084 
CPSP400072H25C  856 0.46 5.09 x10-22 0.009 
CPSP400072H55C  1642 3.14 3.45 x10-21 0.064 
 
Only a limited number of samples were repeated to check the accuracy of 
the analysis.  A summary of the results obtained from repeat analysis are 
given in Table 5-8 and were found to be fairly consistent with the initial 
results. These results provided a convincing proof for the fair accuracy of 
the entire results in absence of an elaborate error analysis of the entire 
samples due to the analysis constraints.    
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Table 5-8: XPS standard deviations 
 
Matrix I 
eV 
PEG Thickness 
t, nm 
SD % SD 
PS400072H40C 3811 11.878   
PS400072H40C (R) 3953 12.41 0.38 3.11 
CMSP400072H40C 727 2.63   
CMSP400072H40C (R) 674 2.26 0.26 10.72 
CPSP400072H40C 1936 4.14   
CPSP400072H40C (R) 2016 4.41 0.19 4.50 
 
Figures 5-8 and 5-9 illustrate the grafting profile for these matrices.  
Analyzing these results, higher PEG grafting was observed on 
polystyrene matrices than either of the Sephadex derivatives with both 
PEG molecular weights. The likely reason for this is the difference in 
swelling behaviour of these matrices in the anhydrous reaction 
environments where the PEG grafting was performed. Polystyrene 
matrices swelled significantly in anhydrous organic solvents, whereas the 
Sephadex matrices remained unswelled, leaving fewer active sites for 
PEG conjugation.  
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Figure 5-8: Grafting profile for PEG2000 at 40°C ( PS2000, 
CP2000 and CM2000) 
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Figure 5-9: Grafting profile for PEG4000 at 40°C ( PS4000, 
CP4000 and CM4000) 
 
In the case of Sephadex derivatives, the chain length of the carboxyl 
tether greatly influenced PEG grafting density. The presence of a 
relatively long carboxypentyl tether resulted in comparatively less steric 
crowding during PEG grafting compared with that of its shorter 
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carboxymethyl analogue. Consequently, slightly higher PEG grafting 
concentrations were achieved with the CP Sephadex derivative than with 
its CM analogue under similar grafting conditions. The thickness of PEG 
layers obtained with 4000 Da PEG were found to be almost double that 
obtained with 2000 Da PEG for all matrices at each grafting condition. 
PEG molecular weight therefore influenced layer thickness, irrespective 
of the nature of matrix used.  
 
In order to study the influence of temperature on PEG grafting kinetics, 
polystyrene and CP Sephadex derivatives were conjugated with 4000 Da 
PEG for 72 hour at 25°C, 40°C and 55°C. The impact of temperature on 
the layer thickness and grafting density is illustrated in Figure 5-10, 
showing a substantial increase up to 40°C. However, on further increases 
in temperature, a decrease in the PEG surface concentration was 
observed, due to an increase in the competing hydrolysis reaction of the 
NHS active ester, resulting in less available sites for conjugation.  
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Figure 5-10: Influence of temperature on grafting profile (Parameters: 
PEG MW: 4000 and grafting time 72 hr) ( PS4000 and 
CP4000) 
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5.4.1.4 Conformational studies of the grafted PEG 
 
Although XPS has been proven to be a very powerful tool for 
characterization and quantification of surface grafted PEG molecules, 
only limited efforts have been reported to date to understand the 
conformational behaviour of the grafted molecules. Using the proposed 
hypothesis (Table 5-2), a detailed study into the conformational 
behaviour of grafted PEG layers was initiated. The present hypothesis 
correlates the conformational properties of the grafted PEG molecules 
with its Flory radius, distance between the grafted molecules and 
thickness of the polymer layer on the matrix.  
 
Flory radii of the PEG chains were calculated using Equation 5-8. In this 
case, PEGs with molecular weights 2000 Da and 4000 Da were used, 
which have a numbers of monomer units N = 45 and 90, respectively, and 
the size of the monomer unit is 0.35 nm (Hansen et al. 2003). Therefore, 
RF values for PEG 2000 Da and 4000 Da will be equal to 3.435 nm and 
5.207 nm, respectively. Knowing these RF values, the distance between 
the PEG molecules on various solid matrices under investigation were 
calculated using Equation 5-6. Finally thickness, distance between the 
PEG molecules and Flory radius were correlated with hypotheses A, B 
and C in Table 5-2 to assign the possible conformations for the grafted 
polymer. Conformational assignments for various PEG grafted 
polystyrene matrices are summarized in Table 5-9.  
 
 
 
 
 
 
  
5-27 
Table 5-9: Conformational properties of PEG grafted polystyrene 
matrices 
 
PEG Matrix t, nm D, 
nm 
RF, 
nm 
Hypothesis Conform- 
ation 
PS200012H40C 2.86 1.27 3.44 A Mushroom 
PS200024H40C 3.18 0.97  A Mushroom 
PS200048H40C 3.77 0.89  B Intermediate 
PS200072H40C 5.29 0.76  B Intermediate 
PS400012H40C 5.59 1.04 5.21 B Intermediate 
PS400024H40C 6.59 0.96  B Intermediate 
PS400048H40C 8.79 0.83  B Intermediate 
PS400072H40C 11.87 0.71  C Brush 
PS400072H25C 8.91 0.82  B Intermediate 
PS400072H55C 13.80 0.66  C Brush 
 
With both 2000 and 4000 Da PEGs, the layer thickness increases with 
reaction time, with a simultaneous decrease in distance between the 
grafted PEG molecules (Figure 5-11). This indicates a more compact 
grafting profile on the surface. Applying the proposed hypothesis for 
conformational assignments to these samples was quite straight forward, 
in that the thickness of the PEG layers on the matrices can be easily 
correlated with the Flory radius of the PEG chains. In the case of 
polystyrene, grafted with 2000 Da PEG, the thickness of the PEG layers 
obtained after 12 and 24 hour grafting at 40°C were well below the RF 
value. These values were clearly in accordance with the criteria of 
hypothesis A and the mushroom conformation can therefore be assigned 
for these grafted PEG molecules. As the grafting time increased, the layer 
thickness increased above the RF value, thus changing to a brush-
mushroom intermediate conformation following hypothesis B.  
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Figure 5-11: Relationship between PEG layer thickness and distance 
between the PEG molecules with PEG grafted polystyrene matrices (at 
40°C) 
 
With 4000 Da PEG, the layer thickness on the polystyrene matrices was 
greater than RF even after 12 hour of grafting (at 40°C), resulting in an 
intermediate brush-mushroom conformation for these samples. The 
thickness of the matrix obtained after 72 hour grafting at the same 
temperature was much higher (t  > 2RF), indicating a brush conformation 
for its grafted PEG molecules (hypothesis C). Hypothesis C is 
undoubtedly validated under this highest grafting density condition 
resulting in the smallest distance between the grafted PEG chains (D << 
RF). This indicates that polymer chains were stretched out from the 
matrix surface to accommodate more PEG molecules, resulting in the 
formation of polymer brushes on the surface.  
 
To support these results, with independent observations, layer thickness 
and conformation of grafted PEGs summarized in Table 5-3 can be 
compared with the present results. Meng et al. (2004a) reported a layer 
thickness of 9.55 nm and surface concentration of 2.04 x 10-21 g/nm2 for a 
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3400 Da PEG grafted on polystyrene matrices for a brush conformation. 
This surface concentration was measured by an indirect assay method by 
estimating the amine content, based on UV absorption. Thus, assigning a 
brush conformation for PEG 4000 Da grafted surfaces with a layer 
thickness of 11.87 nm and above appears to be justified within the 
experimental errors and uncertainties. In many cases conformational 
assignments were performed based only on measuring the layer 
thickness, or the distance between the polymer chains were measured 
independently using another instrument and compared with the results. 
One of the advantages of XPS over these methodologies is their inherent 
capability to measure both the layer thickness and the distance 
simultaneously making the results and predictions more accurately than 
other methods.     
 
The influence of reaction temperature on the grafted PEG conformation is 
clearly demonstrated with a change in conformation from an intermediate 
brush-mushroom to the brush form with an increase in temperature from 
25°C to 55°C at a given grafting period.  This change in conformation is 
manifested by an increase in the PEG layer thickness, followed by a 
reduced distance between the grafted PEG chains (Figure 5-12).  
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Figure 5-12: Influence of temperature on PEG layer thickness and 
distance between the PEG molecules with PEG grafted polystyrene 
matrices (at 72 hour) 
 
With CM Sephadex (Table 5-10) and CP Sephadex derivatives (Table 5-
11), the thickness of PEG layers obtained with both 2000 and 4000 Da 
PEGs were well below their RF values, indicating the presence of 
mushroom conformations under all grafting conditions. The PEG grafted 
matrix obtained with 2000 Da PEG after 24 hour shows a very large 
distance between the PEG molecules compared to RF, further validating 
hypothesis A to confirm the existence of a mushroom conformation with 
these grafted PEG molecules.  
 
The influence of temperature on the grafting kinetics does not show any 
predominant conformational changes in the case of PEG grafted CP 
Sephadex derivatives, as it could impart only small changes in the layer 
thickness and grafting density (Table 5-11). Consequently, the grafted 
PEG molecules on CP Sephadex derivatives remained in their mushroom 
conformations even when grafting was carried out at higher temperatures.  
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Table 5-10: Conformational properties of PEG grafted CM Sephadex 
matrices 
 
PEG Matrix t, nm D, nm RF, 
nm 
Hypo-
thesis 
Conform-
ation 
CMSP200012H40C 0 0 3.44 - - 
CMSP200024H40C 0.08 6.00  A Mushroom 
CMSP200048H40C 0.38 2.80  A Mushroom 
CMSP200072H40C 0.40 2.75  A Mushroom 
CMSP400012H40C 0 0 5.21 - - 
CMSP400024H40C 0.74 2.86  A Mushroom 
CMSP400048H40C 1.42 2.06  A Mushroom 
CMSP400072H40C 2.62 1.52  A Mushroom 
 
Table 5-11: Conformational properties of PEG grafted CP Sephadex 
matrices 
 
PEG Matrix t, nm D, nm RF, 
nm 
Hypo-
thesis 
Conform-
ation 
CPSP200012H40C 0 0 3.44 - - 
CPSP200024H40C 0.52 2.41  A Mushroom 
CPSP200048H40C 1.18 1.60  A Mushroom 
CPSP200072H40C 2.60 1.08  A Mushroom 
CPSP400012H40C 1.06 2.39 5.21 A Mushroom 
CPSP400024H40C 2.57 1.53  A Mushroom 
CPSP400048H40C 3.72 1.27  A Mushroom 
CPSP400072H40C 4.14 1.21  A Mushroom 
CPSP400072H25C 0.46 3.61  A Mushroom 
CPSP400072H55C 3.14 1.39  A Mushroom 
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The relationship between the layer thickness and the distance between 
grafted PEG molecules shows a very similar trend to that of polystyrene 
derivatives and is summarized in Figure 5-13. As the grafting density 
increased, layer thickness also increased, with a decrease in distance 
between the grafted PEGs to accommodate more molecules on the 
matrix.  
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Figure 5-13: Relationship between PEG layer thickness and distance 
between the PEG molecules with PEG grafted CM and CP Sephadex 
matrices (at 40°C) 
 
5.4.1.5 Force of interaction between protein and PEG grafted matrix 
 
Interactive forces exerted between PEG grafted matrices and approaching 
proteins during conjugation can be studied by following the equation 
derived by Kim and Luckham (1992) (Equation 5-9), assuming both PEG 
grafted matrices and proteins were in spherical nature while in aqueous 
solution during conjugation. In order to evaluate the magnitude of these 
forces, a hypothetical case was considered in which the proteins were in 
the secondary potential energy minima (Figure 2-26) close to the end 
terminal of grafted PEG molecules. Consequently, the distance between 
  
5-33 
the matrix and protein will be equivalent to the PEG layer thickness (h = 
t, Equation 5-9). Applying this to Equation 5-9, the equation can be 
rearranged as 
 
 





= 3D
kT
rF βpi  23849.0 t      (5-10) 
 
The force of interaction between approaching protein and various PEG 
grafted matrices were calculated using Equation 5-10 and is illustrated in 
Figure 5-14 as a function of PEG layer thickness.  
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Figure 5-14: Force of interaction between protein and PEG grafted 
matrices ( PS4000, PS2000, CPSP4000,  
CPSP2000, CMSP4000 and CMSP2000) 
 
Comparing these results, the magnitude of interactive forces tends to 
increases sharply with the layer thickness and have a highest calculated 
value for polystyrene derivatives with PEG brush conformations at a 
layer thickness of 11.87 nm. The profile for PS4000 matrices clearly 
illustrates the change in interactive forces from a lower level associated 
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with the less grafted mushroom conformation to a higher repulsive 
densely grafted brush form, through an intermediate brush-mushroom 
overlap region. Sephadex derivatives showed a much lower interactive 
force, having least with CM Sephadex derivative associated with a lower 
PEG grafting density.   
 
There is a possibility of discrepancies in the results due to changes in 
PEG layer thickness between dry and aqueous conditions, as XPS 
measurements were done at dry conditions and the predictions were for 
aqueous conditions. The values of matrix radius used in these 
calculations were that for the corresponding swollen matrices (Section 
4.6.3.3), therefore, the only variable in these calculations is the difference 
in PEG layer thickness between the two conditions. However, from 
Equation 5.10 it is very clear that the interactive force is directly 
proportional to the PEG layer thickness ( 2tF ∝ ), hence the magnitude 
on these force of interactions tends to increase substantially with increase 
in layer thickness but to follow the same pattern with all matrices, 
because all other parameters should remain the same. Consequently, 
these results provided a useful tool for predicting and interpreting the 
interaction between protein and various PEG grafted matrices.  
 
5.4.2 Surface morphology by SEM 
 
Morphological changes of the matrix surface before and after PEG 
grafting were observed by SEM at 5000x and 20000x magnifications. 
Even though it is obvious that the surface morphology of the dry and wet 
samples may vary substantially, the analytical constraints with the SEM 
technique allows the characterization of dry samples only. Surface 
morphologies of Sephadex, its derivatives and polystyrene beads before 
PEG grafting are given in Figure 5-15.  
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a) Sephadex G25 bead b) Sephadex G25 surface 
c) CM Sephadex bead d) CM Sephadex surface 
e) CP Sephadex bead f) CP Sephadex surface 
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g) PS COOH bead h) PS COOH Surface 
 
Figure 5-15: Surface morphology of Sephadex, its derivatives and 
polystyrene before PEG grafting (scale bars for a, c, e and g 10 µm; for b, 
d, f and h 1 µm) 
 
Comparing Figures 5-15a to 5-15f, a significant difference in the nature 
of surface characteristics between Sephadex G-25 beads and their 
carboxy modified derivatives was noted. The surface structure of 
unmodified Sephadex G 25 beads (Figure 5-15a) shows very distinctive 
regular convolutions, supporting the similar observation by Kocon et al. 
(1977). However, the introduction of carboxy functional groups into the 
Sephadex matrix caused considerable changes with a smoothening of the 
surface.  
 
 
 
a) CM Sp-PEG bead  b) CM Sp-PEG surface 
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c) CP Sp-PEG bead d) CP Sp-PEG surface 
 
 
e) PS-PEG bead f) PS-PEG surface 
Figure 5-16: Surface morphology of PEG grafted Sephadex and 
polystyrene derivatives (PEG MW 4000, 40°C/72 hr) (scale bars for a, c 
and e 10 µm; for b, d and f 1 µm) 
 
 
Figure 5-16 shows the surface morphologies of PEG grafted matrices, 
confirming the presence of PEG as a dense surface skin layer on all the 
samples. As seen from these figures, the surface of PEG grafted 
Sephadex derivatives were characterised with the formation of furrows 
and crests, while uniform thick coatings were observed in the case of 
polystyrene PEG derivatives. Formation of the distinctive surface layers 
of PEG on Sephadex and polystyrene matrices may arise from 
differences in their swelling nature in aqueous and non aqueous media. 
During PEG grafting, in the presence of non-aqueous media (DMF) 
Sephadex derivatives remained in its minimal size due to its inability to 
swell, while during washings it swells to its maximum size followed by 
shrinking during its subsequent freeze drying.  
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Swelling properties of polystyrene derivatives were in fact quite opposite 
to that of the Sephadex derivative and were in their swollen form during 
PEG grafting reactions, allowing maximum grafting of PEG molecules. 
While during its aqueous washings and freeze drying, the material 
shrinks to their initial size, resulting in a compact packing of the densely 
grafted PEG molecules and forming a uniform smooth surface throughout 
the matrix.  
 
 5.4.3 Fluorescent imaging by CLSM 
 
Fluorescent images obtained from the FITC labelled Cytochrome c 
conjugated solid matrices were recorded by confocal laser scanning 
microscopy. Very distinctive fluorescent images were obtained with 
Sephadex derivatives confirming the presence of conjugated protein but 
the nature of their distribution was varied with the matrix.  
 
Images obtained from FITC labelled Cytochrome c conjugated with the 
PEG grafted CM Sephadex derivative (Figure 5-17a) showed a 
fluorescent distribution throughout the matrix indicating an overall 
distribution of conjugated protein all over the matrix external and internal 
surfaces.  In contrast, in the case of CP Sephadex PEG derivative (Figure 
5-17b), fluorescence intensity was concentrated on their spherical surface 
which indicates a more localised conjugation of protein on their surface.  
Also the 3D stacking of the images (data not shown) clearly confirms the 
distribution of fluorescence throughout the matrix with the CM Sephadex 
PEG derivative but a more surface localization with the CP derivative.  
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a) CMSP4000–Cytochrome c FITC 
 
b) CPSP4000–Cytochrome c FITC 
Figure 5-17: Confocal fluorescent micrographs of FITC-Cytochrome c 
conjugated PEG-solid matrices  
 
One of the probable reasons for this can be attributed due to the higher 
degree of carboxymethylation with the CM Sephadex (6.30 ± 0.36 
milliequivalent/g) compared with that of CP derivative (0.98 ± 0.07 
milliequivalent/g) (Section 4.6.1) and with differences in their PEG 
grafting densities. Lower grafting densities with higher carboxyl contents 
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associated with CM Sephadex derivative resulted in a substantially higher 
amount of unreacted carboxyl terminals on the matrix. Steric repulsive 
forces exerted by the grafted PEG chains resulted in an insufficient 
blocking of these terminals and thus generated many unblocked carboxyl 
group on the matrix. During subsequent NHS activation of the PEG 
terminal these unblocked carboxyl groups were also get activated and 
then conjugated with FITC labelled protein. In the case of CP Sephadex 
derivative, lower carboxyl content with a relatively higher PEG grafting 
density and subsequent ethanolamine blocking resulted in a significant 
reduction of unreacted carboxyl groups on the matrix. However with 
PEG grafted polystyrene derivatives, conjugation with Cytochrome c was 
not successful even after prolonged conjugation time and hence resulted 
in no colouration and no fluorescence in the resultant matrix.  
 
These observations showed a very significant correlation with the 
predicted results using Equation 5-10, illustrated in Figure 5-14. CM 
Sephadex-PEG derivatives, which showed the lowest interaction energy 
among the PEG grafted matrices, allows a substantial amount of proteins 
conjugated on the matrix surfaces, arising from primary adsorption. 
Consequently, there is an overall fluorescent distribution observed along 
the matrix surface. With an increase in repulsive interactions, a 
comparatively lower fluorescent intensity was observed with CP 
Sephadex derivatives, resulting from less protein conjugation. The 
repulsive interactions showed the highest values with polystyrene 
matrices, which prevented protein conjugation, even on the secondary 
potential energy minima region near the PEG terminals, and hence no 
fluorescent emission was observed with this matrix.     
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5.5 Conclusions 
 
Surface characterization and quantification of various PEG grafted solid 
matrices contributed towards much valuable information regarding their 
surface concentration, morphology, conformational properties and the 
nature of interaction between the matrix and approaching protein during 
conjugation. Correlating the C-O peak intensities obtained from a high 
resolution C 1s XPS scan provided a useful tool for quantifying surface 
grafted PEG molecules. Quantification, followed by measuring grafting 
densities and distance between grafted molecules, yielded a very useful 
methodology to distinguish the various conformational forms of surface 
grafted PEG molecules.  
 
A layer thickness of 11.87 nm, calculated for PEG grafted polystyrene 
matrices with a brush conformation, is comparable with that of other 
reported results, indicating the validity of these results. Simultaneous 
determination of layer thickness as well as the distance between the 
polymer chains using XPS provided a superior methodology for 
conformational assignment of the grafted PEG molecules than other 
reported methods. XPS results also showed that the nature of the solid 
matrix has a great impact on the grafting kinetics and conformational 
properties, with polystyrene matrices resulting in PEG brush 
conformations at a high grafting density, whereas Sephadex derivatives 
resulted in only mushroom conformations, with lower grafting densities. 
Also, the influence of tether length and steric hindrance near the 
conjugation sites were demonstrated by the XPS results, showing CP 
Sephadex (with a comparatively longer carboxyl terminus) yielded a 
higher PEG grafting density than that of the CM Sephadex derivative 
with only a single carbon tether length. Correlation of PEG layer 
thickness with energy of interaction between protein and PEG grafted 
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matrix confirmed the existence of a higher energy barrier for the 
approaching protein and polystyrene derivative with brush conformations 
compared to other PEG grafted matrices and conformations.   
 
Surface morphological information provided by SEM shows distinctive 
differences between various PEG grafted matrices due to their differences 
in grafting densities. Fluorescent imaging by confocal microscopy 
provided a visual conformation for the protein conjugation on the solid-
phase PEGylation matrix.  
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6 Constraints behind solid-phase protein 
PEGylation – a comprehensive discussion 
 
6.1 Introduction 
 
This chapter is aimed at a detailed discussion of the current results of the 
solid-phase protein PEGylation system and various molecular 
mechanisms and forces underlying the constraints and bottlenecks of the 
process. Solution-phase PEGylation using the same PEG derivatives was 
performed satisfactorily, as expected from the reported literature, whereas 
the same PEG derivatives resulted in a very different product profile and 
performed in an entirely different way when grafted onto a solid matrix. 
Quantification and conformational studies of grafted PEG molecules 
using XPS provided very useful understanding and insights into the 
various mechanisms and reasons for all these observations and results.   
 
6.2 Solid-phase protein PEGylation – proof of concept 
 
The presence of PEGylated Cytochrome c derivatives in the hydrolysed 
fractions obtained from both CM and CP Sephadex derivatives 
characterised by SEC analysis (Figure 4.18 to 4.20) provided a proof for 
the concept. Even though the process was expected to deliver 
predominantly mono-PEGylated species using tethered PEG molecules, 
by limiting the mobility of the polymer, only multi-PEGylated species 
were present in the hydrolysed fractions.  SEC results of solution-phase 
PEGylation using the same PEG derivatives (Figure 3-14 and 3-15) also 
resulted in a mixture of PEGylated products but they were characterised 
by a substantial amount of mono-PEGylated species in the product 
mixture. Comparing these two set of results; it is quite obvious that the 
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product obtained from the solid-phase system comprises a variety of 
multi-PEGylated product with very little or almost nil mono-PEGylated 
species.   
 
The formation of a multi-PEGylated product from PEG derivatives of 
two different matrices is very unlikely, due to the continuous uniform 
movement of the reaction mass during protein conjugation. Therefore the 
source of PEG molecules for this multiple conjugation on a single protein 
should be from a single matrix with close proximity to the protein.  This 
suggests the possibility of Cytochrome c attached to surface carboxyl 
groups of the matrix through ion exchange interactions resulting from 
primary adsorptions, which were then conjugated with the NHS activated 
PEG molecules present nearby, resulting in multiple conjugated products. 
The presence of an ion exchange interaction between the matrix and the 
protein is obvious, because if the protein was conjugated through an 
amide bonding through NHS activation, its release under the mild 
hydrolysis conditions was not possible due to the stability of amide 
linkages. Based on these findings, the following mechanism can be 
formulated for this result, as illustrated in Figure 6-1.  
 
 
Step 1 and 2  Swelling of Sephadex matrix during protein conjugation in 
aqueous solution and ion exchange interaction between the positively 
charged protein N-terminal and negatively charged unmodified carboxyl 
group on the surface 
1 2 
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Step 3 Conjugation of near by NHS activated PEG molecules with 
protein 
 
Step 4 Hydrolysis and release of multi-PEGylated species 
Figure 6-1: Mechanism for formation of multi-PEGylated products  
 
The swelling nature of Sephadex derivatives is well known and a size 
comparison using the optical microscopic studies (Section 4.6.3.3) 
showed the sizes of particle were increased between 1.5 to 1.8 times their 
initial sizes when swelled in aqueous medium. This swelling of the 
porous Sephadex derivatives can be broadly divided into two steps, first 
an instantaneous filling of the cavities of the porous matrix by capillary 
force, followed by the osmotic diffusion of aqueous solution into the 
matrix (Pratt and Coony 1973; Ikkai and Shibayama 1996). This process 
is accompanied by the ionisation of a number of unblocked carboxylic 
groups, which were hidden underneath the matrix surface and were 
unavailable for NHS activation and for the subsequent ethanolamine 
blocking, resulting in an increase in hydrophilicity of the matrix 
(Zagorodni 2007). Consequently, a net attractive force was exerted on the 
approaching protein towards the matrix surface. This was further 
4 
3 
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favoured by the presence of lower PEG grafting densities, confirmed 
from their gain in weights (Figure 4-12 to 4-14) and XPS studies (Figure 
5-8 to 5-10), and provides sufficient space for the conjugation of 
Cytochrome c on some of their unmodified surface carboxylic groups 
without much repulsive interaction. The presence of traces of 
Cytochrome c with some SEC results, even in the absence of any 
PEGylated species, confirm these ion exchange interactions and thus 
support this hypothesis for the formation of multi-PEGylated products.  
 
A reduced number of repulsive interface interactions, exerted by PEG 
grafted Sephadex derivatives towards the approaching protein, were 
anticipated, due to their inherent swelling property and porosity (Section 
2.6.2.1). However the reduced grafting density and resulting random coil 
mushroom conformation of PEG molecules inversely affected the 
process, mainly resulted in primary adsorptions of proteins on the matrix 
surface. Higher grafting concentrations were not achieved due to 
increased repulsive interactions between PEG molecules during grafting 
and also due to the small surface area of the matrix under non-aqueous 
conditions and the resulted crowding near the reaction sites. A better 
product profile could have been achieved with these Sephadex 
derivatives if they had a high grafting density and then the interchain 
repulsions between the hydrated chains (Kingshott et al. 2002) would 
enable the polymer chains to keep them apart to facilitate a 
predominantly single chain conjugation on the approaching protein 
(Figure 6-2).  
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Figure 6-2: A) PEG low grafting density and mushroom conformation 
and B) PEG high grafting density and brush conformation using 
Sephadex derivatives  (proposed) 
 
6.3 Solid-phase protein PEGylation – constraints and bottlenecks 
 
Overall, from the various positive and negative results obtained, it is 
clearly understood that cumulative surface force interactions contributed 
by various thermodynamic and kinetic controlled factors predominate 
over the specificity of chemical conjugation. A localised protein 
concentration near the NHS activated PEG terminals were anticipated as 
a result of the net outcome of the repulsive and attractive interactions 
(Figure 2-26) and thereby expected selective mono-PEGylation through 
NHS activated PEG terminals, which were separated from each others 
due to interchain repulsions. The following factors were found to 
influence the outcome of the process to a great extent.  
 
A B 
Favourable 
osmotic 
diffusion 
towards matrix 
Interchain 
repulsion
s 
Repulsive 
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6.3.1 PEG grafting density 
 
Very low PEG grafting densities were obtained with both Sephadex 
derivatives, which resulted in predominantly primary adsorption of 
Cytochrome c on the surface matrix.  The use of five carbon spacer with 
an improved grafting profile also did not provide satisfactory results. The 
difference in the swelling nature of the Sephadex matrix between the 
solvents during PEG grafting and protein conjugation resulted in several 
unblocked carboxyl functional groups becoming available for nonspecific 
protein interactions.  
 
6.3.2 Surface force interactions and nature of the matrix 
 
Surface force interactions as well as the nature of the matrix played key 
roles in this process. The directions of the cumulative force of the 
interactions were entirely different with Sephadex and polystyrene 
matrices. In the case of Sephadex derivatives, with very high porosity and 
swelling behaviour in aqueous medium, there was an overall attractive 
osmotic diffusion towards the matrix during swelling (Pratt and Coony 
1973), which resulted mainly in the primary adsorption of protein on the 
matrix surface due to lower PEG grafting density and mushroom 
conformations. Sephadex derivatives were reported with a net inner 
osmotic pressure of the order of 105 Pa (Ogston and Wells 1972), 
confirming the possibility of a very high positive solvent intake towards 
the matrix while swelling.  
 
In the case of polystyrene, the hydration of grafted PEG molecules 
resulted in the formation of a highly concentrated polymer solution 
surrounding the matrix. This resulted in an increased repulsive force 
towards the approaching protein according to Equation 2-1, caused 
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mainly by the increased osmotic pressure. Unlike in the case of Sephadex 
matrices, where the highly swollen and porous matrix facilitated an 
inward osmotic diffusion towards the matrix, the non-swelling behaviour 
of polystyrene in aqueous solution resulted in collective repulsive 
interactions away from the matrix surface.  An increase in PEG surface 
concentrations contributed a proportional increase in the concentration of 
this virtual polymer solution and reached a maximum value with the PEG 
brush conformation. This resulted in the maximum possible repulsive 
interaction during protein conjugation, thereby preventing protein from 
being directed towards the NHS-activated PEG terminal.  
 
The magnitude of repulsive interactions between the approaching protein 
and various PEG grafted matrices, illustrated in Figure 5-14, clearly 
indicates the existence of a  very high interaction energy with polystyrene 
matrices with PEGs in their brush conformations. Due to lack of 
dissipation of this high energy through the matrix surface, proteins were 
repelled farther away even from the PEG terminals; thereby preventing 
conjugation through the NHS-activated terminals. Furthermore, these 
predictions showed that the repulsive interactions were a function of PEG 
grafting density and molecular weights of PEG used and increased with 
increasing surface concentration and molecular weight. Consequently, 
overall protein repulsion was associated with densely grafted PEG 
polystyrene matrices, with PEGs in their brush conformations that 
prevented protein from conjugation to the NHS-activated PEG terminals.  
 
6.3.3 Parallel hydrolysis of NHS ester 
 
Although NHS ester is used extensively for protein conjugation due to its 
selectivity and specificity towards N-terminal amine coupling, the half-
life period of NHS ester under aqueous conditions is between 20 and 30 
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minutes only (Roberts et al. 2002). This contributed another important 
constraint for conjugation in the presence of repulsive surface 
interactions especially with the polystyrene derivatives.  
  
6.3.4 Yield of hydrolysis 
 
The present yield of hydrolysis using 0.2 M glycine-NaOH buffer (pH 
8.5) at 20°C was only about 12% of the grafted PEG, suggesting a very 
low rate of efficiency of the hydrolysis (Figure 4-17). Because the 
primary objective was to prove the chemistry of this novel technology, 
the yield of hydrolysed product was only of secondary concern and it 
might be hoped that yield could be improved through further research. 
However, the use of an alternative, stronger hydrolysing agent and 
conditions to achieve a better yield were restricted, due to the presence of 
protein in the reaction media and the high possibility of denaturation in 
the presence of strong chemicals and reaction conditions.  
 
6.4 Conclusions 
 
From a detailed analysis of the various results and a number of 
contributing factors, it can be concluded that the results were greatly 
influenced by thermodynamic and kinetic factors, rather than the 
specificity and selectivity of the chemistry involved. The structural 
properties of the polymer chain, as well as nature of the matrix, 
contributed adversely towards the overall outcome of the process. The 
protein repulsion behaviour of grafted PEG chains predominates, rather 
than the anticipated selective conjugation behaviour of the tethered 
molecule.  
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7 Conclusions and recommendations 
 
7.1 Conclusions 
 
The requirement of an improved PEGylation technology to meet its 
growing pharmaceutical importance is a significant issue in modern drug 
delivery research.  To contribute towards this important field of research, 
the development of a novel solid-phase protein PEGylation was 
attempted with a major emphasis on reducing the product heterogeneity 
and improving the yield. The overall outcomes of the research are 
summarised in the following sub-topics: 
 
7.1.1 Synthesis of heterobifunctional PEG derivatives 
 
A range of novel heterobifunctional PEG derivatives were prepared and 
characterized in the laboratory. PEG derivatives functionalized with the 
cleavable β-alanine terminal can be used for a wide variety of 
applications, including releasable drug delivery and solid-phase 
synthesis, due to their characteristic kinetic labile nature. A solution-
phase protein PEGylation using PEG derivatives prepared in this work 
resulted in comparable product profiles to those obtained using 
commercially available activated PEGs. 
 
7.1.2 PEG surface grafting and characterization 
 
Optimized PEG grafting conditions were established using non-aqueous 
amine conjugation chemistry and the influence of various parameters and 
the nature of the solid matrix on PEG grafting were studied. The 
characterization of PEG grafted matrices using XPS resulted in the 
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drafting of a useful methodology to differentiate the various 
conformational behaviours of grafted PEGs. The approach to 
distinguishing between PEG conformations using XPS, described in this 
thesis, has potential as a useful tool in characterising and studying the 
conformational behaviour of various PEG grafted matrices for a wide 
variety of applications.  
 
7.1.3 Performance of the solid-phase PEGylation system  
 
Using the solid-phase PEGylation resin developed in this work, 
conjugation with the model protein Cytochrome c was attempted. Even 
though a predominant mono-PEGylation, as anticipated based on the 
theoretical predictions, was not achieved, experiments with Sephadex 
derivatives resulted in multi-PEGylated products, which to our 
knowledge is the first attempt at protein conjugation using a convalently 
attached, solid-phase PEGylation resin.  
 
7.1.4 Constraints behind the solid-phase PEGylation system  
 
The overall performance of this system is a cumulative outcome of a 
number of factors operating simultaneously, including various surface 
force interactions, PEG grafting density, the nature of the solid matrix, 
the half-life of the PEG terminal functional group, the latter’s availability 
near the suitable protein functional group for conjugation and finally the 
yield of hydrolysis of PEGylated protein from the matrix. Summarizing 
the detailed interpretation of these results and various contributing factors 
given in Chapter 6, it can be concluded that surface force interactions 
dominated over conjugation chemistry and contributed adversely to the 
process. A systematic and detailed study of various parameters imparted 
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a very good understanding of various constraints and provided a useful 
scientific background for future developments.  
 
7.2 Recommendations 
 
The following recommendations are identified for further improvement 
to the solid-phase PEGylation technique:  
 
• The use of PEG derivatives activated with a stable functional 
group other than NHS group to withstand the parallel hydrolysis 
during protein conjugation. Such a long stable functional group 
may be useful particularly with polystyrene derivatives, where the 
initial high osmotic pressure when immersed in the aqueous 
solution may subside over a period of time and thereby protein 
can reach the PEG terminal.  
• The use of selectively and quantitatively cleavable protein tags 
(Section 2.6.3) to increase the yield of hydrolysed PEGylated 
product without denaturing the protein. 
• The use of a porous matrix capable of providing a very good PEG 
loading (compared with polystyrene) but capable of reducing the 
osmotic pressure around the interface, through an inward osmotic 
diffusion as in the case of Sephadex derivatives. The use of such 
matrices enables the formation of PEG brushes on the matrix 
surfaces, and the inward osmotic diffusion towards the matrix 
surface enables protein accumulation on the secondary potential 
energy minima near the PEG terminals and thereby facilitates 
protein conjugations.  
• This concept can be successfully extended for PEGylating 
synthetic drugs and similar applications. In this case, parallel 
hydrolysis of the NHS group can be avoided by conducting non-
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aqueous conjugations or directly applying a catalyst mediated 
covalent coupling between the terminal PEG functional group and 
a suitable functional analogue available with the drug. 
Furthermore, quantitative cleavage of the product can be achieved 
with the help of a suitable reagent without affecting the 
PEGylated product.    
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9 Appendix-A: Use of succinyl ester as the 
cleavable linker for solid-phase protein 
PEGylation 
 
A.1 Introduction 
 
Initial methodology for preparing a solid-phase protein PEGylation 
system was proposed based on using a succinyl ester as the cleavable 
linker between the functionalized PEG and the solid matrix. The 
heterobifunctional PEG derivative for this modification was prepared 
from its monocarboxy derivative as mentioned in Chapter 3. The carboxy 
terminal of the PEG derivative was first protected and the unmodified 
hydroxyl terminal was then converted into its succinyl ester derivative 
and finally grafted onto the solid matrix. The concept behind this was to 
conjugate protein through deprotected carboxy terminal of the PEG 
derivative after activating with its NHS ester and finally cleaving off 
from the resin through the hydrolysis of the labile succinyl ester linkage.  
 
A.2 Synthetic scheme 
 
The overall reaction scheme used for the process is summarized in Figure 
A-1. α-hydroxy-ω-carboxy PEG (1) was prepared by following the same 
method given in Scheme-1 and Scheme-2 (Figure 3-4 and 3-5) by using 
acrylonitrile and conc. H2SO4.   
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Figure A-1: Synthetic scheme for the solid-phase protein PEGylation 
using succinyl ester linkage 
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A. 3 PEG grafting  
 
Because the postulated synthetic scheme utilizes a solid-phase 
deprotection of the grafted PEG, carboxyl protecting groups were 
selected accordingly which can be easily removed under heterogeneous 
reaction conditions. In one strategy the carboxyl protection was 
performed by converting into its p-methoxy-α-methyl benzyl ester due to 
its selectivity towards the oxidative cleavage under mild conditions using 
2,3-dichloro-5,6-dicyano benzoquinone (DDQ)(Yoo et al. 1990; Wu et 
al. 2001) or by using ceric ammonium nitrate (CAN) (Johansson and 
Samuelsson 1984; Jarowicki and Kocienski 2001).  p-methoxy-α-methyl 
benzyl PEG ester was prepared by using DCC and DMAP in anhydrous 
DCM, following the same conditions as referred in Section 3.5.1.2. 1H 
NMR (CDCl3): PEG back bone (δ 3.6292 ppm), -CH2-CH2-COO- (t, δ 
2.629 ppm), -COO-CH-(CH3)-benzyl (q, δ 5.845 ppm), -COO-CH-
(CH3)-benzyl (d, δ 1.496 ppm), benzyl Ar Hs (dd, δ 6.845 and 7.258 
ppm) and benzyl-O-CH3 (s, δ 3.782 ppm).  
 
Solution-phase deprotection of the PEG-benzyl ester using both DDQ 
(2.5 molar eq. in DCM/H2O) and CAN (2.8 molar eq. in acetonitrile/ 
H2O) were resulted in only the partial removal (60 to 70%) of the benzyl 
ester group (monitored by 1H NMR). Simultaneous reduction of the 
oxidizing agents during the deprotection imparted dark reddish brown 
colouration to the PEG derivative in both cases. The reduced quinol 
product of DDQ crystallises along with the PEG derivative from the 
diethyl ether due to its insolubility in nonpolar solvents (Lee-Ruff and 
Ablenas 1989) and hence it was difficult to remove from the products 
during the solution-phase reaction monitoring studies.    Also the solid-
phase oxidative deprotection of the grafted PEG with these reagents 
resulted in intensive colouration to the resin, even after extensive 
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washing with aqueous sodium chloride solution and water. Lack of a 
complete deprotection even with a homogenous solution-phase reaction 
and the inability for complete removal of reaction by-products with a 
heterogeneous reaction system insists the requirement for an alternative 
deprotection method.  
 
Merits of allyl protection and its deprotection using soluble palladium 
catalysts were described in Section 3.2.1.6. A complete removal of allyl 
protecting group was achieved with Pd(PPh3)4 in presence of various 
nucleophilic allyl scavengers such as phenylsilane, NMM and pyrrolidine 
(Section 3.5.1.4).   
 
After protecting the ω-carboxyl terminal by converting into its allyl ester 
(Section 3.5.1.2), succinyl ester moiety was introduced on the free 
hydroxy terminal of the PEG derivative. Succinyl ester of the allyl 
protected PEG derivative was prepared by reacting with succinic 
anhydride in anhydrous pyridine in presence of DMAP (Douglas et al. 
1991; Krepinsky et al. 1994).  1H NMR (CDCl3) (Figure A-2): Succinyl –
CH2-CH2- (m, δ 2.573 ppm), -CO2-CH2-CH2-O- (t, δ 4.191 ppm), PEG 
back bone (δ 3.587 ppm), -O-CH2-CH=CH2 (d, δ 4.534, 4.545 ppm), -O-
CH2-CH=CH2 ( m, δ 5.849 ppm), -O-CH2-CH=CH2 (dd, δ 5.162, 5.183 
and 5.242, 5.279 ppm), DMAP pyridine Hs (d, δ 6.675, 6.689 and 8.171, 
8.184 ppm) and DMAP –N(CH3)2 (s, δ 3.173). (NMR spectrum indicates 
that the product exist as DMAP salt of the succinic acid derivative.) 
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Figure A-2: 1H NMR of α-succinyl-ω-allyl PEG derivative 
 
Grafting of this succinyl PEG derivative onto Sephadex was attempted by 
various methods.  In all experiments 25 molar eq. of PEG derivative per g 
dried Sephadex were reacted and after completion of the reaction 
products were washed extensively and successively with DI water, 2 M 
NaCl and DI water and freeze dried for 48 hour, till a constant weight is 
achieved. Experiments were performed in triplicates and the averages 
values were taken for yield calculations. The gain in weight was directly 
correlated to the amount of PEG grafted and finally expressed in terms of 
its molar equivalents. The results are summarized in Table A-1. 
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Table A-1: Summary of PEG grafting through succinyl ester linkage 
 
Reaction conditions Reference PEG µmol/g 
modified Sephadex 
DMF / Toluene (1:2), 
100°C / 12 hr.  
(Huang et al. 2006) 1.10 ± 0.19 
Sephadex modified with p-
toluene sulfonyl chloride 
(TsCl) (1.6g TsCl / g dry 
Sephadex), followed by 
reaction in anhydrous 
pyridine, 25°C/72 hr. 
(Köster and Heyns 
1972; Dharmaratne 
et al. 1982) 
1.31 ± 0.28 
 p-Toluene sulfonic acid 
(TsOH, 0.1 eq#) / EDC(1.5 
eq# ) / DMSO, 25°C / 72 
hr. 
(Holmberg and 
Hansen 1979) 
1.56 ± 0.25 
DPTS* (0.15 eq#) / EDC 
(1.5 eq#) / DMSO, 25°C / 
72 hr. 
(Hiemstra et al. 
2007) 
24.81 ± 4.51 
Notes: *Based on PEG derivative molar ratio. 
*DPTS: 4-(N,N-dimethylamino) pyridinium-4-toluene sulfonate, prepared 
from TsOH and DMAP in anhydrous THF (Zubarev et al. 2006). 
 
Comparing the above results, a better PEG grafting density was observed 
when DPTS was used as the catalyst. FTIR spectra of Sephadex and PEG 
grafted Sephadex (using DPTS) were given in Figure A-2.  Characteristic 
broad peak around 2900 cm-1and from 1000 to 1100 cm-1 confirming the 
presence of PEG on the modified Sephadex derivative (Section 4.6.3). 
This can be further confirmed from the diminished intensity of the –O-H 
stretching frequency at 3650 cm-1 of Sephadex derivatives due to the 
PEG grafting.   
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Figure A-3: FTIR of Sephadex and its PEG derivatives ( Sephadex 
and CM Sp-PEG (using DPTS) 
 
A. 4 PEG hydrolysis from the resin  
 
Succinyl ester linkages are characterised with its labile nature under mild 
conditions (Section 3.2.1.2).   Use of mild and non nucleophilic bases 
such as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in cleaving this linker 
are getting more attraction in solid-phase synthesis due to its versatility in 
cleaving this ester linkage almost quantitatively, under mild reaction 
conditions. DBU is particularly proved its capability in cleaving PEG 
molecules anchored through succinyl ester linkage onto various 
oligosaccharides without affecting any other functional groups in many 
solid-phase peptide syntheses (Baptistella et al. 1989; Douglas et al. 
1991; Seebach et al. 1991; Krepinsky et al. 1994).   
 
PEG grafted Sephadex derivatives through succinyl ester linkage were 
treated with DBU under various conditions and the amount of PEG 
cleaved off from the solid matrix were estimated by using the ammonium 
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ferrothiocyanate-chloroform method (UV estimation at 510 nm) against 
standard solutions of known concentrations (Nag et al. 1996). Reaction 
profile of PEG release from its Sephadex derivative under various 
conditions are summarised in Figure A-3.  
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Figure A-4: Release of PEG by hydrolysis of succinyl linkage (♦- 2 eq. 
DBU/5 eq. LiBr/MeOH,  ♦- 5 eq. DBU (in H2O), ♦- 2 eq. DBU (in H2O) 
and ♦- 0.2 M Glycine-NaOH buffer pH 8.6) 
 
Almost quantitative release of PEG was observed when 
DBU/LiBr/MeOH mixture was used (Seebach et al. 1991). But this 
method was not adaptable for cleaving the protein conjugated PEG 
derivatives, since presence of lithium bromide can induce denaturing of 
the protein. Aqueous solutions of DBU were also resulted in hydrolysis 
of the succinyl linkage, but with lower yields. Use of 0.2 M Glycine- 
NaOH buffer resulted in a comparatively similar hydrolysis profile with 
these aqueous DBU solutions, with a steady increase in the yield with 
reaction time.  With a compromise in the yield of PEG release, 0.2 M 
Glycine-NaOH buffer was selected for further experiments in order to 
prevent any protein denaturing.  
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A. 5 Solid-phase protein conjugation  
 
After establishing the grafting and cleaving conditions, PEG grafted 
Sephadex derivative was subjected for allyl deprotection using Pd(PPh3)4 
under anhydrous reaction conditions (Section 3.5.1.4). Experiments were 
performed with phenylsilane, NMM and pyrrolidine as the nucleophilic 
allyl scavengers. Due to heterogeneity of the reaction media, it was not 
possible to understand the reaction kinetics and extend of allyl 
deprotection. In absence of a suitable reaction monitoring methodology, 
the deprotection was repeated twice, and the resin after the deprotection 
was reacted with NHS in presence of DCC in anhydrous DMF for the 
activation of the free terminal carboxyl groups.  
 
The NHS activated resin was then tried to conjugate with Cytochrome c 
(1mg/ mL) in 10 mM PBS buffer after equilibrating the resin in the same 
buffer. After treating the resin with protein solution for 2 hour at 20°C, 
the resin was filtered and washed thoroughly with 2 M NaCl solution and 
then with DI water. Compared the UV absorption (at 280 nm) of the 
filtrate after conjugation with that of the initial Cytochrome c solution 
and found absence of any protein conjugated onto the solid matrix. This 
was also confirmed from the absence of any characteristic reddish brown 
colouration to the solid matrix after washings, arising from the 
Cytochrome c conjugation. In order to reconfirm this, the resins were 
further treated with 0.2 M Glycine-NaOH buffer solution and fractions 
were analysed by SEC.  But none of the fractions were detected any 
PEGylated species in any of these analysis.  
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A.6 Conclusions 
 
Because the only available carboxy functional group is with the PEG 
terminal, any nonspecific protein conjugation with the solid matrix was 
not possible with this modified resin, which was the main advantage and 
characteristic feature of this reaction scheme. Also the presence of highly 
labile succinyl ester linkage between the PEG and the matrix provided a 
comparatively higher yield of PEG after hydrolysis than compared with 
that from the β-alanine linkage.   
 
One of the main reasons for the failure of this scheme can be attributed to 
the heterogeneity of the reaction media while deallylation, which restricts 
the availability of a suitable methodology for reaction monitoring. Even 
though it was possible to monitor and understand the reaction profile in 
homogenous solution-phase very accurately, the extent of deallylation 
with the solid-phase system is still uncertain. During this development, 
the conformational constraints of the tethered PEG molecule were not 
well understood and studied due to the unavailability of its analytical 
tools. This important factor may also played a crucial role during the 
protein conjugation.   
 
With the high mobility of the PEG chain in the aqueous media and 
increased osmotic pressure due to the hydrated PEG coils, there is an 
increased repulsive forces exerted on the approaching proteins for 
conjugation. Along with these repulsive forces, the conformational 
behaviour of the tethered PEG molecule and the very less half life values 
of the active NHS ester may resulted in the complete hydrolysis of the 
available NHS activated PEG terminals, before a protein could reach 
these active sites.  
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10 Appendix-B: Supplementary XPS results 
 
B.1 Survey scans 
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Figure B-1:  Survey scans of PEG (2000 Da) grafted polystyrene 
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Figure B-2:  Survey scans of PEG (4000 Da) grafted polystyrene 
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Figure B-3:  Survey scans of PEG (2000 Da) grafted CM Sephadex 
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Figure B-4:  Survey scans of PEG (4000 Da) grafted CM Sephadex 
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Figure B-5:  Survey scans of PEG (2000 Da) grafted CP Sephadex 
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Figure B-6:  Survey scans of PEG (4000 Da) grafted CP Sephadex 
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B.2 High resolution scans 
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Figure B-7:  HR scans of PEG (2000 Da) grafted polystyrene at 40°C 
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Figure B-8:  HR scans of PEG (4000 Da) grafted polystyrene at 40°C 
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Figure B-9:  HR scans of PEG (4000 Da) grafted polystyrene at various 
temperatures 
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Figure B-10:  HR scans of PEG (2000 Da) grafted CM Sephadex at 40°C 
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Figure B-11:  HR scans of PEG (4000 Da) grafted CM Sephadex at 40°C 
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Figure B-12:  HR scans of PEG (2000 Da) grafted CP Sephadex at 40°C 
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Figure B-13:  HR scans of PEG (4000 Da) grafted CP Sephadex at 40°C 
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Figure B-14:  HR scans of PEG (4000 Da) grafted CP Sephadex at 
various temperatures 
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